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Cardiac optical mapping provides unparalleled spatio-temporal resolution
information of cardiac electrophysiology. It has hence emerged as an important
technology in understanding cardiac electrical behaviour in physiological and
pathophysiological states. There is a requirement for effective data analysis
tools that are high-throughput, robustly characterised and flexible with regards to
a growing array of experimental models.
In this thesis a MATLAB based software, ElectroMap, was developed for analysis
of diverse optical mapping datasets. ElectroMap incorporates existing and novel
methods to allow quantification and mapping of action potential and calcium
transient morphology and activation/repolarisation times. Automated pacing
cycle length detection and segmentation were implemented, realising
high-throughput analysis of beat-to-beat responses and transient behaviour.
Standalone modules dedicated to calculation of conduction velocity and
alternans were introduced, allowing thorough integration of key factors in
arrhythmogenesis. Semi-automated analysis of temporal variations in wave
morphology were developed from previous methodologies for electrogram
analysis. Algorithms to use fractional rate of change of fluorescence as a
measure of conduction were also introduced to the software. Algorithms were
tested in silico datasets, mouse and guinea pig optical mapping datasets and
preliminary experiments also showed use for in vivo human electrogram
mapping of atrial fibrillation.
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This chapter provides an overview of the physiology of the heart, focusing on
electrical activity, the action potential, cardiac arrhythmias and methodologies
used to measure the action potential. In particular, the application, advantages,
implementation and processing of cardiac optical mapping are discussed.




1.1.1 Heart anatomy and function
The heart acts to pump blood throughout the pulmonary and systemic
circulation. Newly oxygenated blood from the lungs enters the left atrium (LA)
from the pulmonary veins and is pumped down into the left ventricle (LV). From
the LV, it is pumped via the aorta to the rest of the body. After travelling through
the systemic circulation, the de-oxygenated blood enters the right atrium via the
superior and inferior vena cave (SVC/IVC) and is pumped into the right ventricle
(RV). From here, it is directed to the pulmonary circulation via the pulmonary
artery for re-oxygenation, Figure 1.1 [1]. This process is repeated for every
heartbeat, as the heart fills with (diastole) and expels (systole) blood. The
process is collectively known as the cardiac cycle [2].
Figure 1.1: Anatomy and blood flow of the heart. Blue denotes deoxygenated
blood, red shows oxygenated blood. Dark red denotes the cardiac tissue
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Owing to its primary role of pumping blood, the heart is a muscular organ. The
cardiac tissue is organised into three layers: the inner endocardium, the middle
myocardium and the outer epicardium. The heart is made up primarily (by
volume) of cardiac muscle cells, cardiomyocytes (CMs). CMs in the myocardium
are electrically and mechanically coupled to each other at junctions known as
intercalated discs which contain gap junctional (electrical coupling) and
adherence proteins (for dynamic mechanical coupling via the adherence
junctions and cell adhesion at the desmosomes), Figure 1.2 [3]–[5]. These
junctions exist predominantly at the cell ends, and the connected CMs make up
muscle fibres. The coupling of CMs in this way means electrical and mechanical
impulses are conducted from cell to cell, meaning the heart forms an
Figure 1.2: Cardiac intercalated disk. Diagram of the connection of
neighbouring cardiomyocytes via the intercalated disk. Inset shows the
connection of the cell at the gap junctions (electrical coupling), adherence
junctions (dynamic mechanical coupling) and desmosomes (strong cell to cell
adhesion). Extracted from [5].
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electrical/functional syncytium. Fibres are further arranged into sheets (4 to 6
CMs thick) separated by connective tissue. The directionality of these sheets
varies throughout the myocardium, giving rise to a complex 3D architecture to
ensure multidirectional contraction to maximise cardiac output [6].
Due to the differing functions of the four cardiac chambers, there is substantial
heterogeneity in anatomy. The ventricular walls are thicker than the atria for
example, and the LV is approximately three times thicker than the RV due to the
greater force required for delivery of blood to the systemic compared to
pulmonary circulation. There are also regional differences. The inner
endocardial layer of the heart contains mainly endothelial cells. Meanwhile, the
epicardium connects the heart to the pericardium, the double sac of connective
tissue and serous fluid that protects the heart. The epicardium hence is made up
primarily of connective tissue [6].
1.1.2 Cardiac conduction system
Efficient pumping of the blood is achieved through the coordinated contraction
and relaxation of the cardiac muscle in all four chambers. The contraction of the
individual cardiomyocytes, like other muscle cells in the body, is initiated by the
electrical excitation of the cell. For the heart to contract, electrical impulses must
therefore propagate through the tissue in a coordinated manner. In a healthy
heart, rhythmic activity is known as sinus rhythm. During sinus rhythm, electrical
impulses, known as cardiac action potentials (AP) begin in the sinoatrial node
(SAN), a region located in the RA, near the SVC, which contains pacemaker CMs
4
[7]. Pacemaker cells are specialised, exhibiting automaticity – they depolarise
without an impulse from a neighbouring cell. It is these cells in the SAN therefore
that set the heart rate and begin the conduction of electrical impulses through the
cardiac tissue. A schematic diagram of the electrical conduction system is shown
in Figure 1.3 [1].
From the SAN, electrical impulses must spread throughout the rest of the heart.
In the healthy myocardium, CMs are electrically coupled by low resistance gap
junctions [8]. Gap junctions are formed of connexins, transmembrane proteins
that form a connexon (or connexin hemichannel), an assembly of six connexins
with a pore domain. The connection of two connexons from neighbouring cells
creates the gap junction, which allows for bi-directional flow of ions (and signalling
molecules) between the two cells [9].
Owing to the gap junctions, current from a depolarised cell can flow to its
electrically coupled neighbouring cell, assuming that the neighbouring cell is less
Figure 1.3: Electrical conduction system of the heart. The primary conduction
pathways and nodal regions are shown in green.
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depolarised. The transmembrane voltage (Vm) of the neighbouring cell will then
increase until it reaches threshold potential. At this point, voltage gated Na+
channels will open, causing a large influx of Na+ and initiating the AP. This
cell-cell communication is the process by which electrical impulses are spread
throughout the heart [10].
To facilitate conduction, specialised tracts with very fast conduction speeds
connect the SAN to the LA (Bachmann’s bundle) and to the atrioventricular node
(AVN) which sits at the interatrial septum at the junction between the atria and
ventricles. Electrical impulses in the AVN are slowed, travelling at a slower
conduction velocity (CV), hence allowing the ventricles to fill following atrial
contraction. Following the AVN, the electrical impulses enter the bundle of His,
which splits into left and right branches, and are spread throughout the ventricles
via the Purkinje fibres [8]. The CV in the fibres is ca. 200-400cm/s, ensuring
coordinated muscular contraction. Within the ventricular muscle itself, the
impulse travels at ca. 50cm/s, generally from the endo- to epicardium [10], [11].
Several factors dictate the directionality and speed of impulse transmission in
cardiac tissue. CMs are elongated cells that form strands, with the gap junctions
forming preferentially at cell ends. The result is larger CVs in the longitudinal
direction, parallel to cell alignment, compared to transverse or perpendicular
direction [12].
A larger cell size and lower cell-cell resistance will increase CV as it will increase
the amount of axial current that flows from one cell to the next [10]. Hence, cells
in the specialised conduction fibres described above are larger and contract less
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than others in the heart [6]. In contrast, both gap junction uncoupling (reduction
of electrical conductivity between the cells) and reduction in fast sodium current
(via loss, block or reduced function of sodium channels) are prominent
mechanisms by which conduction can slow in cardiac tissue [10], [13], [14]. The
causes of conduction slowing can be genetic in origin, for example expression or
functional changes in ion channels altering electrical properties,
pharmacological or in response to lifestyle or injury [13]–[16]. Understanding
slowed cardiac conduction is paramount as it is a key mechanism underlying
arrhythmia [17],[18].
The cardiac action potential
The electrical impulse that propagates and causes the contraction of CMs is the
cardiac action potential (AP) [19], [20]. The cardiac AP is a transient de- and
repolarisation of a CMs transmembrane voltage (Vm). It is initiated and controlled
by the movement of ions such as Na+, Ca2+, and K+, into and out of the intra-
and extracellular environment, both through the cell membrane (via ion channels
and pumps) and through intracellular stores such as the sarcoplasmic reticulum
(SR) [20], [21].
An example human ventricular AP is shown in Figure 1.4A [22], alongside the
associated time courses of the various currents which contribute to generation
AP. The AP consists of four phases [2], [6] –
Phase 0 (Depolarisation): The AP of a neighbouring myocyte raises the Vm
from the resting membrane potential (RMP) to a threshold value (ca. -60mV).
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This triggers the opening of voltage gated Na+ channels, rapidly increasing Na+
membrane conductivity and hence generating a large depolarising influx of Na+
ions, INa. The Vm rapidly depolarises to around +20 to +30mV, and the sodium
channels inactivate automatically due to the short-lived time dependence of their
open state.
Phase 1 (Initial Repolarisation): The Vm then begins to initially repolarise
quickly due to the transient outward current, Ito. Ito results from voltage gated K+
channels which open at positive potentials, allowing K+ ions to flow out of the
cell along the electrochemical gradient. Chloride influx (Cl-) is also known to
contribute to Ito. The rise in intracellular Na+ also leads to an increase in
Figure 1.4: Example human and mouse action potentials. A) Example human
action potential and ionic currents. B) Example mouse action potential and ionic
currents. Inward (depolarising) currents are shown as negative values while
outward (repolarising) currents are shown as positive values. Extracted from [22]
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sodium-potassium pump activity (NaK) which expels three Na+ for two K+,
increasing the repolarising INaK current during the AP.
Phase 2 (Plateau): The rapid depolarisation of the cell also initiates voltage gated
channels known as long opening (L-type) Ca2+ channels. These channels carry a
depolarising current, ICaL, bringing Ca
2+ ions into the cell. These channels open
and inactivate more slowly than the fast sodium channels, prolonging the action
potential and starting the plateau phase of the human (and other large animal)
ventricular AP. Peak ICaL occurs approximately 2-7ms after the AP initiation, and
subsequently slowly decreases. ICaL closely matches the outward K
+ current,
which is reduced during the plateau phase due to obstruction of inward rectifier
channels (IKir, or also referred to as IK1) at depolarised Vm.
As the time dependent L-type Ca channels begin to close, reducing ICaL, the
late plateau phase is maintained by the Na+-Ca2+ exchanger (NCX). The influx
of Ca2+ into the sarcoplasm from both the L-type Ca2+ channels and calcium
induced calcium release from the SR activates NCX. NCX exchanges three Na+
for one Ca2+, and is hence electrogenic, creating depolarising current INCX.
Phase 3 (Repolarisation): In the late plateau phase, K+ conductance begins to
rise due to activation of delayed and slow rectifier K+ channels (IKr and IKs).
These channels are voltage gated, like the Na+ and Ca2+ channels, but are
much more slowly activated, driving repolarisation in the late phase of the AP.
Furthermore, the repolarisation of Vm leads to reactivation of IKir, further driving
late repolarisation.
Phase 4 (RMP): In non-pacemaker cells, Vm will then sit at the RMP of ca.-90mV
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owing to the constant outward flow of K+ (IKir), the closed state of the Na+ and
Ca2+ channels and activity of the NaK pump.
Following phase 1 depolarisation, healthy CMs enter an effective refractory
period (ERP). During this period, increased Vm and inactivated Na+ channels
means that the cell is un-excitable. This mechanism prevents retrograde
excitation and ensures the electrical impulse travels throughout the heart as
described above. As the cell repolarises and the Na+ channels reactivate, the
cell can be reactivated by a depolarised neighbouring cell, ending the ERP.
Changes in the ERP, like CV, are implicated in arrhythmogenesis (see section
1.2) [18].
The AP described above relates to a human ventricular AP. However, just as
there is heterogeneity in the anatomical structure of the heart, the same is true
for the cellular and EP properties of the heart. For example, CMs can be broadly
classified into three classes [6], [23].
(i) Working CMs: These cells form the bulk of the myocardium and are
connected as described above to create a mechanical and electrical syncytium.
The sarcolemma of most cardiomyocytes contains invaginations knowns as
t-tubules, allowing ion transfer deep into the cells during the AP, vital for
excitation-contraction (EC) coupling.
(ii) Pacemaker CMs: These cells make up the SAN and AVN and exhibit
automaticity: the ability to spontaneously initiate an action potential without an
external stimulus. They achieve this through spontaneous diastolic
depolarisation thanks to specialised ion channels, primarily HCN4. These
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channels, at negative Vm, slowly conduct Na+. The current produced by these
channels is the funny current (If), and during diastole If depolarises the
membrane towards AP initiation threshold. These cells are smaller than the
working cardiomyocytes, exhibit limited contraction and are highly innervated to
realise regulation of cardiac function by the autonomic nervous system. In a
healthy heart, cells in the SAN exhibit the fastest rate of spontaneous activity,
and hence set the heart rate by overdrive pacing.
(iii) Conduction CMs: These cells are found in fibres such as the bundles of His
and Purkinje fibres. They are similar to the working CMs but are larger and
contract less to realise increased conduction speeds.
These three cell types show marked differences in AP morphology throughout
the heart. However, AP heterogeneity is not simply limited to these three broad
cell types. The CMs throughout the heart will differ depending on location and
function. The atrial and ventricular APs are morphologically distinct. Furthermore
transmural dispersion, alterations in AP morphology in the epicardial, myocardial
and endocardial layers, has been reported in human [24] and animal models [25].
Work which forms sections of this thesis (chapter 5) has shown that the mouse, a
widely utilised model within cardiac research, also exhibits significant transmural
gradients in line with large animal models [26], [27]. Differences are also present
between the LA versus RA and LV versus RV [28].
11
Excitation-contraction coupling
The purpose of the coordinated spread of electrical stimuli throughout the
cardiac tissue is to elicit contraction. The process by which an AP causes
cellular contraction is known as excitation-contraction (EC) coupling and is
mediated by Ca2+. At rest, the intracellular Ca2+ concentration ([Ca2+]) is 0.1µM
[29]. However, as Ca2+ enters the cell via L-type Ca2+ channels during the AP,
[Ca2+] rises.
The initial rise in [Ca2+] via the L-type channels initiates a process termed
calcium-induced calcium release. The sarcoplasmic reticulum (SR) is an
intracellular organelle which is a large store of Ca2+, and within its membrane
contains ion channels and pumps. One of these channels is the Ca2+ activated
release channel, the ryanodine receptor (RyR) [30]. Large amounts of Ca2+ is
therefore released from the SR. The result is an increase in [Ca2+] to around
100µM, although substantial buffering of the Ca2+ ions limits the concentration
of free Ca2+ to ca. 1µM [21].
The free Ca2+ is then able to activate myofibrils within the CM sarcomere, the
functional unit responsible for contraction [21]. Within the sarcomere, free Ca2+
binds to troponin-C, which forms part of the wider troponin complex. The troponin
complex acts to regulate the action of the thin actin and thick myosin filaments. At
rest, troponin-I blocks actin binding sites, preventing crossbridge formation with
myosin. On Ca2+ binding to troponin-C, a conformational change in induced that
initiates troponin-I to expose a binding site on the actin molecule [1]. This actin
site can then bind to the ATPase head of myosin, forming a crossbridge. Through
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ATP hydrolysis, flexion of the myosin head is induced, bringing the thin filament
closer to the sarcomere centre, shortening the sarcomere length and contracting
the cell [29].
For the cell to subsequently relax, [Ca2+] must be removed from the cytoplasm
to allow unbinding from troponin-C, resetting the sarcomere to its resting length.
Ca2+ removal back into the SR is mediated by the action of the SR Ca2+-ATPase
(SERCA). Concurrently, Ca2+ is also extruded from the cell via NCX. There is
also some minor contribution (<1% in rabbit CMs) from mitochondrial channels
(mitochondrial Ca2+ uniporter) and the membrane pump Ca2+-ATPase [31]. EC
coupling therefore is the basis by which electrical impulses, namely the cardiac
AP described above, control and coordinates the contraction of the heart. The
rise and fall of [Ca2+] that mediates ECs coupling is known as the calcium
transient (CaT) [21].
1.2 Cardiac Arrhythmias
The previous sections describe healthy cardiac rhythm and electrical function
and conduction, known as sinus rhythm. However, disturbances in the electrical
function of the heart can cause the heart, or specific areas of heart, to develop
an irregular rhythm known as an arrhythmia. Disturbances in heart electrical
function can arise for several reasons. These include acute periods of ischemia
or hypoxia, genetic variants which alter electrical or mechanical function,
dysregulation by the autonomic nervous system, tissue remodelling such as
cardiac hypertrophy or fibrosis, ionic disturbances and hormonal or
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pharmacological influences that alter ion handling properties [13], [15], [20],
[32]–[34]. Cardiac arrhythmias present a substantial health burden [35]. The
most commonly sustained arrhythmia for example, atrial fibrillation (AF), is
diagnosed in between 2-3% of adults in US and Europe [36], with actual
occurrence likely to be higher owing to undiagnosed or silent AF [37].
1.2.1 Mechanisms of cardiac arrhythmias
The primary mechanism by which an arrhythmia, such as AF, is sustained is
known as the driver and can result from problems in either the generation or
propagation of APs.
Disturbances in action potential generation: ectopic activity
In the healthy heart SAN pacemaker cells generate an AP, which then
propagates throughout the conduction system [8]. However, the sinus node
function can become pathophysiological through influences such as changes in
autonomic regulation or injury [7]. Furthermore, electrical stimuli can arise
outside of the SAN, a phenomenon known as ectopic activity [32]. Due to injury,
genetic factors, aging and other factors, CMs throughout the heart can develop
their own pacemaker activity (‘latent’ pacemakers) [38]. Cells that develop their
own pacemaker activity can become uncoupled from the SAN activity, causing
new activation sites from which depolarising waves propagate and thus disrupt
the normal coordination of the heart, resulting in arrhythmia [39]. This disruption
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Figure 1.5: Triggered activity examples A) Early afterdepolarisation. B) Phase
3 afterdepolarisation. C) Delayed afterdepolarisation. Extracted from [40].
can result in the initiation of spiral wave activity, see below.
Additionally, cells can exhibit abnormal depolarisation events during or just after
the repolarisation phase of the AP, known as afterdepolarisations. If the amplitude
of afterdepolarisation is sufficient, it can trigger an AP, which may then activate
neighbouring cells, resulting in a triggering site which again decouples cells from
SAN activity.
Afterdepolarisations are split into 2 subclasses. Early after depolarisations
(EADs, Figure 1.5A-B) occur during phase 2 or 3 of the AP. EADs develop
because of a shifting of the normal outward current during repolarisation to a net
inward current, and frequently occur with a prolongation of APD. The
prolongation of the AP allows recovery of L-type Ca2+, allowing regeneration of
depolarising ICaL [41].
Delayed after depolarisations (DADs, Figure 1.5C) occur in phase 4, and can
often be linked to alterations in intracellular Ca2+ concentrations or malfunctions
in the SR Ca2+ channels, RyRs [42]. These factors can cause abnormal
diastolic levels of [Ca2+], activating Ca2+ extrusion via NCX, increasing
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depolarising current INCX.
Disturbances in action potential propagation: re-entry
Abnormalities in the propagation of APs can also lead to arrhythmias, in
particular the initiation of self-sustaining depolarisation wavefronts [10]. An
example is the genesis of re-entrant circuits in cardiac tissue. Re-entry can
occur when a block within cardiac tissue blocks the activation wavefront. The
wavefront hence propagates around the block. If there is an area of
unidirectional block, the activation wave will travel around the block in one
direction. In certain circumstances, the circular wavefront can become
self-sustained and rapidly activated, as shown in Figure 1.6, causing arrhythmia
[40], [43], [44]. This phenomenon is described as leading circle re-entry.
The likelihood of a reentrant circuit forming in this manner is described by the
cardiac wavelength (WL) which is equal to ERP x CV, and hence describes the
distance travelled by a wavefront in one refractory period. With a shorter
wavelength (short ERP and/or slow CV), it is more likely that a retrograde
wavefront will not collide with its refractory tail, meaning the activity becomes
self-sustained. Several pathophysiological mechanisms can alter ERP or CV,
including altered ionic handling, cardiomyocyte gap junctional and adherence
coupling, and tissue remodelling. Prolongation of cardiac WL, for example by
increasing ERP by pharmacological ion channel modulation, is hence a key
therapeutic strategy used to treat arrhythmia [45] .
Although the first appreciation of leading-circle re-entry dates back to the late
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Figure 1.6: Model of re-entry. Example of re-entry around an area of functional
or anatomical block. Excited/refractory tissue is shown in black, and relative
refractory period is shown in grey. In the top example, a long effective refractory
period and/or fast conduction leads to the wave colliding with its own refractory
tail, terminating activity. In the bottom panels, short effective refractory period
and/or slow conduction means the wavefront does not collide with its refractory
tail and continues to propagate indefinitely. Adapted from [44]
1800s [44], [46], [47], the related but distinct concept of spiral-wave re-entry has
only more recently been studied [47]–[50]. The chemical Belousov–Zhabotinsky
reaction demonstrates that a fundamental property of excitable media, like
cardiac tissue, is the potential emergence of complex and dynamic macroscopic
activity such as spiral excitation waves [51], [52]. Well before the first
experimental observations [50], in silico studies had shown the possibility of
spiral waves in cardiac tissue [49], [53].
A spiral wave rotates outwards from a centre with a curved activation front,
Figure 1.7A. A curved wavefront is a key distinguishing feature of spiral waves.
In contrast to a planar wavefront, a cell at the curved wavefront edge is coupled
to more than one cell if the spiral wave is convex, and less than one cell if the
wavefront is concave, Figure 1.7B. This has important consequences for CV, as
it alters the ratio between the excited (source) and excitable (sink) cells. In the
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Figure 1.7: Spiral wave re-entry. A) Diagram of a spiral wave. The activation
wavefront is shown in black while the repolarisation wavetail is shown in red.
The point where the wavefront and tail meet is the phase singularity point which
has undefined voltage state, marked in green. The blue area marks a possible
region within which the phase singularity point may meander. B) Effects of
wavefront curvature on conduction velocity (CV) compare to the CV of planar
wave (CVplanar). In both panels, black arrows indicate activation direction.
Adapted from [47]
case of a convex wavefront, CV is reduced as the current flow from one cell is
spread, leading to less current flow into the individual cells and a greater time for
activation threshold Vm to be reached. The opposite holds for concave waves,
where CV is increased compared to planar waves owing to a larger source-sink
ratio [47].
The spiral waves are often anchored to unexcitable tissue, such as small arteries
or connective tissue [50]. However, they can also rotate around a normally
excitable core where the depolarising wavefront meets the repolarisation
wavetail. The meeting of the fronts at this point renders this region unexcited
and is known as the phase-singularity point. The core of such a spiral wave can
circle a small region or even meander through the cardiac tissue depending on
the interaction between the activation wavefront and repolarisation wavetail
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(black and red in Figure 1.7A respectively), unlike when a spiral wave is
anchored to an anatomical feature [47], [50].
A spiral wave can be initiated by disturbance of a normal, sinus, wavefront by
an anatomical feature or by spontaneous activity, such as ectopic activation of a
competing wavefront. In the case of an ectopic wavefront, it will propagate until it
meets refractory tissue created by the sinus wavefront, where ectopic activation
is blocked. However, as the refractory cells recover, the ectopic wavefront will
begin to excite cells preferentially in the direction that the sinus recovery wavetail
travels, curving the wavefront of the ectopic wave. If the conditions are such
that the now curved ectopic wavefront continuously encounters excitable cells, a
sustained spiral wave is setup. Again, as with leading circle re-entry, the likelihood
of this occurring depends on CV (and therefore wavefront shape for the reasons
described above) and ERP. A shorter ERP promotes the re-entrant behaviour by
increasing the probability of cells at the wavefront being non-refractory, as does a
slowing of CV.
1.2.2 Atrial Fibrillation
Arrhythmogenesis is hence multifaceted, and there are many subtypes of
arrhythmias with distinct pathophysiological causes, manifestations and
localisations. As already highlighted, Atrial fibrillation (AF) is the most common
arrhythmia and increases the risk of stroke, heart failure and sudden death [54],
[55]. AF is a supraventricular arrhythmia, characterised by the rapid and
disorganised activation of atrial cardiomyocytes at rates of up to 600
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depolarisations per minute [56]. Both triggered activity and re-entry have been
proposed as mechanisms by which AF is induced and maintained [48], [56], [57].
Current treatment for AF includes pharmacological rate or rhythm therapy [45],
and surgical interventions such as electrical isolation through catheter ablation
procedures [54]. All treatment options however demonstrate variable results and
inconsistent outcomes for patients [15], [37], [58], highlighting the requirement
for further study of the causes and mechanisms of AF, alongside other
arrhythmias.
1.3 Measuring cardiac electrical activity
The electrical activity of the heart, both in health and disease, has long been
studied. The first electrocardiogram (ECG) for example was reported in 1887
[59]. The ECG remains a staple of clinical cardiac electrophysiology to
non-invasively study the electrical activity of the heart. By placing electrodes at
the body surface, changes in the extracellular potential of the heart during the
initiation and propagation of APs can be recorded. A ‘normal’ ECG waveform in
sinus rhythm is shown in Figure 1.8 [1], and its various deflections are split to aid
interpretation. The P wave for example is associated with atrial depolarisation,
the QRS complex with ventricular depolarisation and the T wave with ventricular
repolarisation [60]. Changes in the timing, duration or morphology of these
deflections are used to diagnose arrhythmia [61], [62].
Single trace electrograms as in the case of ECG signals give a summative signal
of the electrical activity of the heart. However, electrograms can also be mapped
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across the heart surface using both invasive and non-invasive techniques.
Invasive catheters with electrodes on their surface can record electrograms from
the endocardial or epicardial surface [63], [64]. Both single electrode and
multielectrode catheters are used, and by manoeuvring the catheter across the
cardiac tissue high resolution maps of electrograms can be constructed.
Features of these electrograms, for example, activation time, voltage amplitude
or fractionation, are often used for monitoring or in guiding interventional
procedures such as ablation [65]. Non-invasively, an array of several electrodes
(>100) on the body can be used to map the electrical activity at body surface.
From this information, the potential at the epicardial surface can be calculated
and mapped [66], in a procedure known as body-surface mapping [67].
Electrograms can also be mapped using multi-electrode arrays, which have
found use both clinically [63] and pre-clinically [68].
An electrogram is a multiphasic recording of changes in extracellular potential,
and not directly of the transmembrane potential, which is the difference between
Figure 1.8: Sinus rhythm echocardiogram. The P wave represents atrial
depolarisation, the QRS complex represents ventricular repolarisation, while the
T wave represents ventricular repolarisation [1]
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the extracellular and intracellular potential, i.e. the potential that changes during
the action potential. Action potentials can be directly recorded using
microelectrodes, where one electrode records the intracellular potential while
another records extracellularly. The difference between the two electrodes then
gives the transmembrane AP (TAP) recording from a single cell [32]. Similarly,
intracellular potential changes can be measured by patch clamp technique,
where suction is used to probe the intracellular space, and current controlled
(‘current clamp’) to record voltage changes compared to an extracellular
reference, again from a single cell [69]. Patch clamp can also be operated in
‘voltage clamp’ mode, to probe specific ionic currents by using intracellular and
extracellular solutions to isolate currents of interest [69], [70].
Furthermore, the AP can be measured using electrodes without direct contract
with the intracellular space as monophasic APs (MAPs). Compared to
microelectrodes used in patch clamp or to record TAPs, MAP electrodes are
larger (>0.1mm diameter), thereby recording from many cells, and consist of a
proximal and distal electrode, neither of which crosses the membrane [71], [72].
However, by inactivating one part of the tissue, signals can be recorded with
similar morphology to those obtained via microelectrodes. MAP recordings
match those of TAPs with extremely high fidelity [73]. The exact mechanisms
behind the origin of MAPs however is still under debate [74].
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1.4 Optical mapping
Electrode techniques are either indirect recordings of the AP (in the case of
electrograms) or inherently low spatial resolution (from single cells/region). Even
high-density electrogram arrays and catheters are spatially limited by the
physical size of electrodes. These drawbacks have led to the adoption of optical
mapping.
Optical mapping is a fluorescence-based technique, where cardiac preparations
are ‘stained’ with dyes sensitive either to transmembrane voltage or intracellular
calcium concentration. By appropriate imaging of these preparations, high
spatiotemporal resolution mapping of AP and CaT activation and morphology
can be achieved, far exceeding the resolutions possible with electrode
techniques [69]. As a result, since the first demonstration in cardiac tissue with
voltage sensitive dyes in 1976 [75], optical mapping has furthered our
understanding of cardiac EP and arrhythmias in several ways. Among others
areas, optical mapping has expanded our knowledge of the role of spiral wave
and genetic predispositions in AF [15], [48], gap junctional remodelling in sudden
cardiac death [76], transmural heterogeneity in cardiac tissue [27], [77] and
autonomic regulation in health and disease [34], [78], [79]. Optical mapping has
been applied in cardiac preparations including whole hearts [80], isolated atria
[32], [81], [82], ventricular wedges [83], cardiac slices [26], [27], [79] and cellular
monolayers [84].
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1.4.1 Voltage sensitive dyes
Optical mapping relies on the use of fluorescent dyes, i.e. synthetic or biological
molecules that emit light with a spectrum that is shifted in wavelength when
compared to excitation wavelength [85], [86]. Commonly, the emission
wavelength is longer than the excitation wavelength. An electron transitions to a
higher energy state when it absorbs a photon of appropriate wavelength. In the
excited state several mechanisms mean the excited electron can undergo
non-radiative transitions to lower energy levels (but not back to ground state).
The result is the energy difference of electron relaxation back to ground state is
lower compared to is excitation, and so the photon emitted during relaxation is
lower energy and longer wavelength than the excitation/illumination photon,
Figure 1.9A [87].
In the case of voltage sensitive dyes (VSDs), the most commonly used for
Figure 1.9: Jablonski diagram and chemical structure of di-4-ANEPPS. A)
Jablonski diagram of excitation of a dye by absorption of an incoming photon
(green), While excited, the molecule undergoes non radiative energy transitions
(grey) and emits a photon of lower energy (red). B) Chemical structure of Di-4-
ANEPPS in both its ground (bottom) and excited (top) state. Blue circle highlights
the shift of charge distribution on excitation
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cardiac optical mapping are synthetic styryl dyes, such as Di-4-ANEPPS
(di-4-amino-naphthyl-ethylene-pyridinium-propyl-sulfonate, Figure 1.9B).
Di-4-ANEPPS imbeds within the cellular membrane. Excitation of Di-4-ANEPPS
can shift the molecule from a ground state to an excitation state with an altered
charge distribution (Figure 1.9B) [88]. However, the electric dipole of the
molecule means the surrounding electric field shifts the energy levels of the
electronic field. This phenomenon is known as electrochromic shift [89]. Thus,
the wavelength spectra emitted by dyes such as Di-4-ANEPPS is proportional to
the surrounding electric field, and hence the transmembrane voltage when the
dye is embedded in the cellular membrane. In the case of Di-4-ANEPPS, there
is a ‘blue shift’ in the emission spectra, i.e. at more positive membrane
potentials, the peak emission wavelength decreases, Figure 1.10 [88], [90].
Hence, by recording the fluorescence intensity through a long-pass filter, an
(inverted) optical recording of the AP is obtained, Figure 1.10 [91].
Several other synthetic VSDs used in optical mapping work on similar principles,
such as Di-8-ANEPPS (an analogue of Di-4-ANEPPS with altered chemical
structure to avoid dye internalisation) and Rh-237 [34], [43]. Synthetic
electrochromic dyes are the mostly widely utilised in optical mapping. However,
alternative strategies are available. Some dyes, in particular genetically encoded
VSDs, use Förster energy resonance transfer (FRET) to sense voltage [85].
These dyes are thought to overcome some drawbacks of electrochromic dyes
with respect to signal quality, phototoxicity and photobleaching [92], although
limitations persist with response times and delivery [93]. Newly developed dyes
(e.g. FluoVolt) work on the principle of photon-induced electron transfer [92] and
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Figure 1.10: Principle of optically recorded action potentials using voltage
sensitive dye (VSD). Example spectra of emitted fluorescence of a VSD at
different transmembrane potentials (Vm). The red line represents a long pass
filter. As the increase in Vm during depolarisation induces spectral shift, the
number of photons passing through the filter (red region) decreases. The result
is a measured fluorescence intensity that is inversely proportional to Vm, and an
inverted optical recording of the action potential as shown on the right. Figure
adapted from [91]
have been shown to outperform electrochromic indicators for signal quality and
experimental lifetime. However, their use remains sparse [94] and studies have
also suggested these dyes may induce side effects on cardiomyocyte properties
[95], although the same can be said for other VSDs [85], [96].
1.4.2 Intracellular calcium dyes
A separate class of dyes used in optical mapping are intracellular Ca2+ sensors
that internalise within the cell. They are commonly esterified to neutralise the
charge, aiding intracellular uptake. The ester is then enzymatically cleaved once
in the cell, leaving behind a Ca2+ chelator and a fluorophore. As Ca2+ is chelated,
fluorescence output increases, and subsequently decreases upon dissociation,
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reporting the changing Ca2+ concentration in the intracellular space where the
sensor localises, either in the cytosol or sarcoplasmic reticulum [97].
1.4.3 Optical mapping hardware
A full review of optical mapping setups as part of a wider technical review into
all-optical electrophysiology through the combination of optical mapping with
optogenetic technologies is provided as part of section 4.1 [98]. The specific
setup predominantly used in this thesis is described in detail in section 2, while
other setups from which data is presented are described where appropriate.
Briefly, an optical mapping setup consists of the following key components. An
illumination source is required to excite fluorescent dyes. An ideal illumination
source will be spatially and temporally homogeneous in order to reduce
non-physiological fluorescent alterations. The most commonly used illumination
sources are therefore LEDs, which benefit from narrow wavelength spectra, long
operational lifetimes and low heat emission [99], though Tungsten-Halogen
lamps, Mercury/Xeon arc lamps and lasers have also been used. Optical filters
are then required to separate the excitation light from the emitted fluorescence
light. The emitted fluorescence is then imaged by a camera. In modern optical
mapping setups, charge-coupled device (CCD) and complementary metal oxide
semiconductor (CMOS) cameras are most commonly used. These cameras are
utilised as they allow collection of high spatial resolution images (>10,000 pixels)
at kHz sampling rates to effectively capture the millisecond dynamics of cardiac
activity [100].
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1.4.4 Optical mapping data processing
The high spatio-temporal imaging of cardiac electrical behaviour afforded by
optical mapping results in large raw datasets, commonly composed of
thousands of image frames each individually made up of multiple pixels [101].
Each one of these pixels contains one or more optically recorded AP and/or CaT.
Therefore, there is a necessity for high throughput and automated analysis of
optical mapping datasets. [102], [103]
Pre-processing
Sub millisecond exposure rates, small pixel sizes, inhomogeneous dye loading,
sub optimal illumination and small fractional fluorescence changes means optical
signals are often characterised by low signal to noise ratios. Hence, several pre-
processing steps are required for effective analysis [104]. Key pre-processing
steps and methods are described below.
Region of interest selection by image thresholding
As optical mapping images contain both tissue and background, data masking is
required to create a binary mask of 1 for areas to be analysed and 0 for
background pixels. Ideally, this process should be done automatically as manual
selection is time consuming and susceptible to user bias. Automatic thresholding
can be applied utilising the Otsu method [105]. The Otsu method calculates a
single threshold value to classify foreground and background pixels based on the
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image histogram (distribution of intensity values in an image, Figure 1.11). For a
given threshold value, T, the amount of the variance between the intensity of the
two classes (σ) is calculated as
σ(T) =
√
ω1(T)σ12(T) + ω2(T)σ22(T) (1.1)
where σ1,2 is the variance of class 1 and 2 respectively, and ω1,2 is the
probability of a pixel being in class 1 or 2 respectively. The threshold value is
then chosen so that the variance between the intensity of the two classes is
maximised (alternatively: so that the variance within each class is minimised).
Figure 1.11 shows an example of applying Otsu thresholding to an optical
Figure 1.11: Otsu thresholding of an optical mapping dataset. The image
histogram of the optical mapping image frame shown in inset is shown on the left
y axis. The class variance as a function of a pixel intensity threshold is shown on
the right y axis. The result of thresholding using the maximal variance intensity
value (dashed red line) is shown in the inset
.
29
mapping image. It is observed that the Otsu calculated threshold has
successfully removed all background pixels from analysis. However, several
tissue pixels have also been incorrectly masked and classified as belonging to
the background.
The image histogram shown in Figure 1.11 highlights limitations in using the
Otsu method for cardiac optical mapping images. Although a clear peak is
observed at lower intensities corresponding to background pixels, the rest of the
intensity values are widely and uniformly distributed across a wide intensity
range. Non-homogeneous dye loading and/or illumination means baseline
intensity can widely vary in optical mapping image sets, resulting in a
widespread and non-normal distribution in tissue brightness [101]. In these
situations, Otsu method is sub-optimal as the image histogram is not bimodally
distributed between background and foreground pixels, making distinction
difficult [106]. Initial intensity is also not the only criteria by which pixels may
warrant exclusion from analysis. Some tissue areas, despite good dye loading,
may exhibit low changes in fluorescence due to physiological or experimental
factors, or exhibit motion artefacts. For these reasons, manual region of interest
selection, despite being labour intensive, is also commonly used.
Spatial filtering
Spatial filtering or ‘binning’ is a commonly applied technique to denoise signals
recorded from multipixel images. When spatial filtering is applied, the intensity
value for a pixel at a given frame number is not an independent value, but rather
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an averaged value from neighbouring pixels. This is achieved by convolution
of the image frame with a kernel [101]. The main features of a kernel for spatial
filtering are size (for example 3x3, 5x5 pixels etc.) and morphology, which dictates
the weight of a given pixels location on the final value. For pixel at location x,y,









where fx+i,y+j is the pixel intensity before convolution with the kernel, m is N/2-0.5
assuming N is odd and wi,j is the weight at that kernel location, defining the centre
of the kernel as (0,0).
Figure 1.12: Principles of spatial filtering. A) An example of an ‘average’
3x3 spatial filter (orange/red) applied to an optical mapping image frame (grey)
in which each pixel has fluorescent value fx,y. The red value is the central pixel
to which the convolution will be applied. Following convolution with the average
filter, each location will have a fluorescent value Fx,y as shown by equation 1.2,
where the weights (w) are given by the relevant values in the convolution kernel.




If using average or ‘boxcar’ filtering, then each weight in the convolution kernel will
be 1/N2. Use of average kernels however may result in spatial broadening and
over smoothing of the optically recorded signals, which contain fast alterations for
example during depolarisation [101]. An alternative measure therefore is to use a
kernel morphology where the pixels closest to the pixel of interest (central pixel)
contribute most to the final intensity. Gaussian kernels achieve this by using a
Gaussian curve to decide the weight applied to each pixel location based on
distance from central pixel. Figure 1.12 for example shows two 3x3 pixel kernels,
one average filter (Figure 1.12A) and the other a Gaussian filter with standard
deviation of 1 (Figure 1.12B). All weights in the average filter are 0.11, (i.e. 1/32).
However, in the Gaussian filter the weight given to the central pixel (0.204) is
greater than that of the nearest neighbour pixels (0.124) or next nearest neighbour
pixels (0.075). This helps to preserve the underlying morphology of the pixel of
interest during spatial filtering denoising.
Temporal filtering
Temporal filtering can be applied in a similar sense to that described above for
spatial filtering, but instead with a kernel than spans a certain period in the
temporal domain [107]. A simple example of temporal filtering is unweighted
moving average filtering, where the value at a given time point is calculated as
the average of a set number of points before and after the time point of interest.
Unweighted average filtering in this manner can mask/distort impulse-like rapid
phenomena in signals, such as the rapidly changing fluorescent values during
depolarisation [101]. Savitzky-Golay filtering in contrast fits a low degree
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polynomial to datapoints around the point of interest via least-squares fitting
[108]. By filtering in this manner, short-lived variations in the signal will be
accounted for. Figure 1.13 for example shows the application of 11 point moving
average and Savitzky-Golay (3rd order) to a mouse atrial OAP.
An alternative to convolution-based temporal filtering is digital filtering.
Frequency spectra analysis of a variety of optically recorded APs from various
models shows that the majority of the signal has major frequency components
much less than 100Hz, corresponding to physiologically relevant phases of the
AP [109]. A well-designed digital filter therefore can directly remove
high-frequency (>100Hz) noise while leaving the low-frequency components of
the signal (i.e the action potential) unaltered. In practice however, such ideal
filtering is not possible as such a filter would be discontinuous and of infinite
order. Approximate filters therefore must be designed which can be split into two
broad classes: finite impulse response and infinite impulse response. Both filter
types contain numerous options including different filter design with varying
phase and ripple response, stopband and passband.
Figure 1.13: Example of convolution temporal filtering methods. Small
amplitude, high frequency variations in the raw optical signal (black) are removed




The cyclic nature of cardiac activity means that an alternative to use of spatial or
temporal filtering techniques is the use of temporal oversampling and multi-beat
(or ensemble) averaging. Here, consecutive APs (or calcium transients) are
aligned either by knowledge of pacing cycle length or by signal features such as
peak amplitudes [110]. The rationale is that averaging in this manner will reduce
the amplitude of signal noise due to its random nature, while preserving the
underlying physiological signal. Of course, successful application of ensemble
averaging relies on important criteria including accurate signal alignment and
temporal stability. The use of ensemble averaging in both model and
experimental datasets is explored in chapter 3.
Baseline correction
Factors such as bubbles, photobleaching and fluid motion can cause
non-physiological changes in fluorescent signal baselines which require
correction. Suggested methods to achieve baseline correction include the
application of low degree polynomials, with higher degree polynomials required
for more complex variations in baseline values [101]. However, previous studies
have suggested that linear top hat filtering may be a more robust method for
baseline correction [101]. Here, a structuring element of given length is utilised
so that changes with a time period less than the kernel length are removed
[101]. Baseline correction is explored in chapter 3.
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1.5 Thesis motivation and aims
Once data has been processed using all or a subset of the methods described
above, non-consistent techniques and definitions are applied for final analysis.
The approaches used are often specific to experimental setup, model, and
question. Equally, both processing and analysis requires computational
expertise to apply. Several research groups design and utilise custom
processing methods [100], [111]–[113], while others use commercial software
where the underlying algorithms are difficult to access [114], [115]. Some freely
available solutions are present [102], [116], [117], but even basic functionalities
such as multi-beat averaging and conduction velocity quantification remain only
accessible to a few specialised groups. These limitations prevent further uptake
and objective analysis of optical mapping technologies. Therefore, to address
these gaps, we pursued the development and utilisation of new tools and
software for analysis of optical mapping datasets.
The primary aim of this thesis were:
• To develop processing and analysis tools for optical mapping datasets
• To develop novel analysis approaches to increase automation of optical
mapping data analysis
• To use developed tools and techniques for the analysis of unique
pre-clinical models using optical mapping, including mouse ventricular
slices and genetically altered models




This thesis is an alternative format thesis, whereby following chapter 2, which
gives a detailed account to the biological experiments conducted, chapters 3-6
consist of published work.
An introduction is given to each chapter consisting of published articles to
explain the contribution of the thesis author and the wider context and
significance of the work. Specifically, chapter 3 outlines development and
validation of a MATLAB based software platform for analysis of EP mapping
datasets [103], [118]. Chapter 4 and 5 focus on the use of this platform to
analyse data from optogenetic models (chapter 4) [98], [119] and mouse
transverse cardiac slices (chapter 5) [26], [27]. Chapter 6 reports development
of a new analysis methodology, termed optical wave similarity, for automated
quantification of temporal instability in optical mapping datasets.
Chapter 7 summarises unpublished work using optical mapping to study the
effects of high fat diet on left atrial EP on a mouse model with heterozygous
deletion of pitx2, a transcription factor associated with the development of AF.
Chapter 8 is a summary of the work presented and discusses limitations and
future work. Due to the inclusion of published works with their own references,
individual references are provided for each chapter. All published work is
preceded by a short introduction to provide the wider context of the work and to
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set out author contributions.
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Chapter 2
Experimental methods - mouse atrial optical mapping
This chapter provides detailed experimental methods for optical mapping of
isolated mouse atria. Data collected using this protocol by myself is shown in
Chapters 3, 6 and 7.
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2.1 Experimental and analysis methods: Mouse atrial optical
mapping
The following sections detail the experimental methods for mouse atrial optical
mapping performed by the author of this thesis at the University of Birmingham.
This thesis also contains analysis of raw data obtained in separate experiments
conducted by other experimenters, and the relevant methodologies are presented
and attributed where appropriate throughout.
2.2 Animal procedures and models
All animal procedures were undertaken in accordance with ethical guidelines set
out by the UK Animals (Scientific Procedures) Act 1986 and Directive
2010/63/EU of the European Parliament on the protection of animals used for
scientific purposes. Experiments were approved by the home office (PPL
30/2967 and PFDAAF77F) and the institutional review board at University of
Birmingham. Mice were housed in individually ventilated cages, with
sex-matched littermates, under standard conditions: 12-hour light/dark circle,
22oC and 55% humidity. Food and water were available ad libitum. The general
health status of all mice (bearing, grooming, behaviour, body weight) was
monitored daily and immediately prior to surgery.
Experiments outlined below were performed on mice with heterozygous
expression of a Pitx2 null allele (pitx2null) [1], bred on a C57/BL6 background,
and wild-type (WT) littermates.
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2.3 Buffer solutions
A bicarbonate buffered Krebs-Henseleit (KHB) solution was used for mouse atrial
optical mapping experiments, containing in mM: NaCl 118; KCl 3.52; MgSO4
0.83; KH2PO4 1.18; NaHCO3 24.9; Glucose 11.0; CaCl2 1.8. The solution was
heated to 36oC-37oC and equilibrated with 95%O2/5%CO2 to maintain a pH of
7.4. Chemicals were purchased from Sigma-Aldrich.
2.4 Heart isolation
Mice were initially placed in an anaesthetisation chamber filled with 4% isoflurane
in O2 for 2minutes. Flow rate was 2-3L/min and gas continuously scavenged.
Mice were then transferred to the surgical bed, placed in the supine positions, and
supplied with continuous anaesthetisation by 4% isoflurane in O2 via a facemask.
The pedal reflex was tested to confirm deep anaesthesia. Once deep anaesthesia
was confirmed, the limbs were tapped down. An initial incision was made just
below the rib cage, and the rib cage bilaterally cut. The diaphragm was then
pierced, and the rib cage moved back to reveal the heart and lungs. The heart
was then lifted from behind with curve forceps, and the vessels cut to remove the
whole heart. Death was via exsanguination.
The isolated heart was then placed in a petri dish containing KHB solution at
4oC to temporally stop contraction (cardioplegia) [2]. The anticoagulant heparin
was added to the dish to prevent blood clot in the isolated heart. Excess tissue,
for example lungs, connective tissue or adipose tissue, was removed. The heart
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Figure 2.1: Isolated heart cannulation by the ascending aorta. Cannulated
heart as described. The syringe is filled with KHB, which was then injected into
the heart to remove blood.
was then placed into a petri dish containing clean KHB solution for cannulation
of the ascending aorta. The petri dish was placed on a custom stand for a 2ml
syringe with a 1mm (outer diameter) cannula attached, Figure 2.1. The syringe
contained 2ml of KHB solution. All air bubbles were removed before cannulation.
The ascending aorta was then cannulated, above the aortic valve. Sutures were
then used to tie the heart to the cannula, and KHB solution retrogradely perfused
through the aorta to clear remaining blood.
2.5 Langendorff perfusion
The cannulated heart was transferred to a vertical Langendorff system [3], and
the heart was retrogradely perfused with 37oC KHB solution, Figure 2.2. Initial
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Figure 2.2: Dye loading on Langendorff apparatus Schematic diagram of
Langendorff perfusion system used for dye loading showing relative locations of
heated water jacket, peristaltic pump, bubble trap, heater coil and cannulated
heart. White arrows show the direction of flow for KHB solution. Inset shows dye
introduction into the perfusion line via a three-way tap,
flow rate was 4ml/min, although this was reduced to 2ml/min for dye loading (see
below). In some studies, a cannula was placed into the left ventricle to allow
solution to drain from the heart. This was only done if signs of high pressure were
observed, for example poor flow through the heart and solution build up in the
bubble trap. Hearts were allowed to equilibrate until beating was again observed.
2.5.1 Di-4-ANEPPS dye loading
Potentiometric dye Di-4-ANEPPS (Invitrogen, UK) was stored at 4oC at a
concentration of 5mg/ml in DMSO in 25µl aliquots [4]. The dye was removed
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from storage and thawed for 5 to 10minutes. The dye was then dissolved in 1ml
37oC KHB solution and injected into the perfusion line of the Langendorff
apparatus via a three-way tap, immediately before the solution reached the
heart. Loading was via bolus injection (Figure 2.2), and the loading time was 3 to
5minutes. As the dye was loaded, solution that had passed through the heart
was collected and reapplied to the epicardial surface to maximise dye loading.
Once the heart had been loaded with the fluorescent dye, the heart was
removed from the Langendorff apparatus and placed in a petri dish containing
37oC KHB solution.
2.5.2 Rhod-2AM dye loading
In separate experiments intracellular Ca2+ dye Rhod-2AM was utilised. Rhod-
2AM (Invitrogen, UK) was stored at -20oC in 50µg aliquots in powder form [5]. The
dye was mixed with 60µl of DMSO containing 10% Pluronic F127, a surfactant
used to facilitate solubilisation [6]. The dye was then dissolved in 1ml 37oC KHB
solution and injected into the perfusion line of the Langendorff system as above
over 10 to 15minutes.
2.5.3 Rh-237 dye loading
Some experiments were performed using Rh-237 (Invitrogen, UK) [7]. The
isolation and loading protocols differ from that presented above, and were
performed by Dr James Winter, and not be the author of this thesis. Mouse
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hearts were isolated under terminal anaesthesia (4% isoflurane in 100% O2),
and Langendorff perfused at 70-80mmHg with a buffer solution containing in
mM: NaCl 114.0; KCl 4.0; CaCl 1.4; NaHCO3 24.0; NaH2PO4 1.1; glucose 11.0
and sodium pyruvate 1.0. Solution was heated to 37oC, equilibrated with 95%
O2/5%CO2 to maintain a pH of 7.4 and passed through a 5µm nitrocellulose
filter. Chemicals were purchased from Sigma-Aldrich. Rh-237 was stored at 4oC
at a concentration of 1.25mg/ml in DMSO in 70µl aliquots. The dye was
dissolved in 1ml of 37oC buffer solution and injected into the perfusion line over
a period of 4 to 5 minutes. As this setup allowed for continuous monitoring of dye
loading, 2 to 3 aliquots (140-210µl) of dye were added until sufficient signal was
observed.
All subsequent steps, including atrial pinning and optical mapping, were the same
for both preparations and performed by the author of this thesis.
2.6 Atrial isolation
The left atrium (LA) was dissected and placed into the optical mapping
superfusion chamber, Figure 2.3. In some studies, the right atrium (RA) was
also removed. The LA (and RA if applicable) were then pinned to the black
silicone surface of the optical mapping chamber using fine entomology pins. The
atria were pinned with the anterior surface facing up. Two or three pins were
used at the edges of the tissue, ensuring that 1) the pins would not block any
part of the atria from the camera and 2) stimulus electrodes could be placed on
the LA, near where the LA attached to the septal wall in vivo. The RA was not
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Figure 2.3: Dissected atria in optical mapping superfusion chamber.
paced to study spontaneous activity from the sinoatrial node.
2.7 Optical mapping
The atrial tissue was then placed in the optical mapping setup, Figure 2.4. 100ml
oxygenated (95%O2/5%CO2) KHB solution was continuously superfused across
the atrial surface and recirculated. 50µl Blebbistatin (Cayman Chemical, USA)
solution (25mg/ml in DMSO) was added into the superfusate. Blebbistatin
selectively inhibits myosin by stabilising myosin in a metastable state which
occurs before force generation [8], [9], decoupling the electrical and mechanical
coupling of the cardiomyocytes. This is vital for optical mapping experiments, as
contraction will introduce motion artefacts into the recorded signals, precluding
effective analysis [10], [11]. Blebbistatin was used as it has been reported that it
achieves uncoupling without alteration of several electrophysiological (EP)
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parameters, making it the most widely used excitation-contraction uncoupler in
optical experiments [9], [12]. There are however reports of blebbistatin affecting
electrically and optically recorded action potential duration, as well as other
parameters including restitution and arrhythmia inducibility, in isolated rabbit
hearts [12].
The superfusate (KHB and Blebbistatin) was pumped to the optical mapping
chamber via a custom-made heating element (Martyn Preston, University of
Oxford) and a bubble trap. The heating element was connected to a feedback
thermometer to maintain a temperature range of 35oC to 37oC at the optical
mapping chamber, checked by a digital thermocouple before and during
experiments. Peristaltic pumps were used both to pump the solution to the
chamber and remove excess solution, which was pumped back for recirculation.
The optical mapping superfusion chamber containing the atrium/atria was
placed in the optical mapping setup directly below the camera lens, Figure 2.4.
Bipolar platinum electrodes were then placed on the LA near to where the left
atrial appendage (LAA) connects to the posterior wall. Pacing rate was set at a
holding frequency of 1 or 3Hz depending on pacing protocol, and voltage
increased until optical action potentials (OAP) were seen. This defined the
diastolic threshold of the preparation, and the LA was paced at twice the
threshold. Pacing was achieved with 2ms pulses, generated using an isolated
constant voltage stimulator (Digitimer, UK). Spike2 software (Cambridge
Electronic Design, UK) was used to create and deliver pacing protocols. The
atria were then left to equilibrate on the system for a minimum of 10minutes.
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After 10minutes, illumination LEDs were switched on. Four LEDs (two twin
LEDs) at 530nm were used for illumination and directed towards the atrium/atria.
A 630nm longpass filter was used to collect emitted fluorescence from voltage
dyes Di-4-ANEPPS or Rh-237. When using Rhod-2AM, a 585/40nm bandpass
filter was used. Images were acquired using a 2nd generation, ‘scientific’ CMOS
camera with a single pixel area of 6.5µm2 (ORCA flash 4.0, Hamamatsu,
Japan). The maximal resolution of the images was 128 x 2048 pixels, and
unless stated images were acquired at 0.987kHz. Images were collected using
WinFluor (Dr John Dempster, University of Strathclyde, UK). WinFluor allowed
continuous monitoring of the OAPs from a selected region of interest. This
allowed for confirmation of the cessation of motion artefacts, and for the
Figure 2.4: Optical mapping setup. A schematic diagram of the optical mapping
setup used.
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identification of premature atrial activity or missed stimulus captures.
Experimental recording time was 60s, and illumination was turned off between
recordings to prevent photobleaching or phototoxic side effects [13], [14].
2.7.1 Pacing protocols
Two main pacing protocols were used for the optical mapping experiments. Raw
optical voltage signals, before any processing other than signal inversion, are
shown from these pacing protocols in Figure 2.5. The first protocol had a holding
cycle length (CL) of 1000ms (1Hz). During recordings, the atria were then paced
at CLs of 120ms, 100ms and 80ms (8.33Hz, 10Hz and 12.5Hz) respectively for
100 beats. There was a 5 second gap between each CL, Figure 2.5A. This
protocol was used so the atria has sufficient time to adapt to each new pacing
frequency, and to allow study of both adaptation time and beat to beat variability.
This protocol also included a burst of 20 pulses at 50ms CL.
The second protocol (’ramp’ protocol) had a holding cycle length (CL) of 333ms
(3Hz). On starting the protocol, the pacing CL was reduced to 150 or 120ms (6.67
or 8.33Hz) for 100 beats. The CL was then reduced by 10ms every 20 beats, until
the CL was 50ms (20Hz), Figure 2.5B. This protocol allowed investigation into
the restitution properties of the atria from one experimental recording, with one
‘ramp’ lasting 34s or 23.2s, depending on starting CL.
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Figure 2.5: Atrial pacing protocols A) Optical action potentials (arbitrary
intensity) as recorded when atria paced using 120-100-80ms protocol. B) Optical
action potentials as recorded when atria paced using the ‘ramp’ protocol.
.
2.7.2 Data analysis
Data was exported from WinFluor in uncompressed Tagged Image File Format
(TIFF), and the exported images analysed using a MATLAB built software that
was developed as part of this thesis, ElectroMap [11], [15]. See Chapter 3 for a
detailed description of the use and development of ElectroMap. ElectroMap
allowed application of spatial filtering, baseline correction, temporal filtering and
multi-beat (ensemble) averaging. Unless otherwise stated for data presented in
this thesis, images were processed using a 3x3 pixel Gaussian spatial filter,
standard deviation = 1. Non-physiological changes in baseline (as seen in the
raw traces in Figure 2.5) were corrected for with a top-hat filter with kernel length
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of 100ms. When analysing data from the first pacing protocol (CL =
120-100-80ms, Figure 2.5A), the final 20 of the 100 stimuli were ensemble
averaged.
Unless otherwise stated, the following analysis parameters were used. For
conduction velocity (CV), the Bayly multi-vector method was utilised with a 5x5
pixel window [16]. Action potential duration (APD)/calcium transient duration
(CaTD) was measured from time of maximum upstroke velocity (i.e. dF/dtmax) to
time of repolarisation/decay to chosen level from peak [17], [18]. Time to peak
(TTP) was defined as time from 10% to 90% rise [19].
2.7.3 Statistical analysis
All data are presented as mean ± standard error of the mean. Group differences
were tested using paired t-tests or one-way analysis of variance as appropriate
with Bonferroni test, and were accepted as significant when P < 0.05.
2.8 Chapter summary
This chapter has provided detailed experimental methodology for optical
mapping of isolated mouse atrial tissue. Due to the small size and high heart
rate of the mouse heart, robust protocols to study it’s cardiac
electrophysiological behaviour using high spatiotemporal temporal optical
mapping are vital, in particular in the context of the unique advantages of mouse
models. These include large litters, short gestation periods, rapid maturation
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and, potentially most importantly, established and widely used methods for
genetic manipulation. In the current thesis, data obtained using the protocol
outlined here is presented in Chapters 3, 6 and 7.
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ElectroMap: High-throughput open-source software for
analysis and mapping of cardiac electrophysiology
This chapter reports the development, validation and application of a MATLAB
based software package for analysis of both optical and electrogram mapping
datasets, ElectroMap. As outlined in chapter 1, optical mapping datasets require
significant processing of raw signals to realise effective analysis of key EP
parameters. Furthermore, different experimental models, hardware and
questions necessitate distinct processing and analysis pipelines. Commonly,
analysis of optical mapping data has hence been undertaken using either
commercial software or using custom, in-house algorithms. This prevents uptake
of the technique and objective analysis across research groups.
We therefore aimed to create an analysis platform for optical mapping datasets
with key features including:
• Easy to use graphical user interface
• Flexibility with regards to experimental model and hardware
• Established and validated novel methodologies for analysis of
pro-arrhythmic phenomena
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• High throughput, multi-beat analysis across long experimental timescales
• Freely available as both source code or standalone versions
This chapter consists of a publication (Publication 1 and Appendix A) detailing
the development, validation and application of a MATLAB based software
package for analysis of both optical and electrogram mapping datasets,
ElectroMap. Key features, such as conduction velocity quantification and
multi-beat analysis across long experimental timescales were validated using in
silco mouse datasets, experimental datasets from mouse, guinea pig and human
optically mapped samples and in vivo human electrogram mapping data from a
patient undergoing catheter ablation surgery for atrial fibrillation. ElectroMap has
been released open source and is available from
https://github.com/CXO531/ElectroMap.
Furthermore, unpublished work detailing comparisons of processing and analysis
techniques is provided in sections 3.2 to 3.5.
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3.1 ElectroMap: High-throughput open-source software for
analysis and mapping of cardiac electrophysiology
Publication 1.
This research was originally published in Scientific Reports.
C O’Shea, A P Holmes, T Y Yu, J Winter, S P Wells, J Correia, B J Boukens, J
R deGroot, G S Chu, X Li, G.A Ng, P Kirchhof, L Fabritz, K Rajpoot, D Pavlovic.
Sci. Rep. 9:1389, 1–13, 2019.
The supplementary information that accompanied publication 1 can be found in
appendix A. Supplementary Figures I-X referred to in the manuscript correspond
to Figures A1-A10. Supplementary videos I-III can be found at
https://www.nature.com/articles/s41598-018-38263-2#Sec15.
Author contributions in publication 1
I designed and wrote the software (building upon some pre-existing MATLAB
scripts for basic conduction and duration analysis designed by Ting Yue Yu),
designed the graphical user interface, produced model datasets, conducted
some experiments, analysed all included data using the software and wrote the
manuscript.
Simon Wells conducted the hypoxia experiments. James Winter conducted the
guinea pig experiments. Joris deGroot and Bastiaan Boukens conducted human
tissue optical mapping experiments. Gavin Chu and G.Angre Ng collected in-vivo
human electrogram data.
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electroMap: High-throughput 
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analysis and mapping of cardiac 
electrophysiology
Christopher o’shea1,2,3, Andrew P. Holmes1,4, Ting Y. Yu1, James Winter  1, Simon P. Wells1,11, 
Joao Correia5, Bastiaan J. Boukens6, Joris R. De Groot7, Gavin S. Chu8,9, Xin Li8, G. Andre Ng  8,9, 
paulus Kirchhof1,10, Larissa Fabritz 1,10, Kashif Rajpoot3 & Davor Pavlovic  1
The ability to record and analyse electrical behaviour across the heart using optical and electrode 
mapping has revolutionised cardiac research. However, wider uptake of these technologies is 
constrained by the lack of multi-functional and robustly characterised analysis and mapping software. 
We present ElectroMap, an adaptable, high-throughput, open-source software for processing, 
analysis and mapping of complex electrophysiology datasets from diverse experimental models and 
acquisition modalities. Key innovation is development of standalone module for quantification of 
conduction velocity, employing multiple methodologies, currently not widely available to researchers. 
electroMap has also been designed to support multiple methodologies for accurate calculation of 
activation, repolarisation, arrhythmia detection, calcium handling and beat-to-beat heterogeneity. 
ElectroMap implements automated signal segmentation, ensemble averaging and integrates 
optogenetic approaches. Here we employ ElectroMap for analysis, mapping and detection of pro-
arrhythmic phenomena in silico, in cellulo, animal model and in vivo patient datasets. We anticipate 
that ElectroMap will accelerate innovative cardiac research and enhance the uptake, application and 
interpretation of mapping technologies leading to novel approaches for arrhythmia prevention.
The incidence and prevalence of cardiac diseases continues to increase every year1,2. Adequate prevention and 
treatment requires a better understanding of the mechanistic drivers3. Detailed understanding of spatial and 
temporal electrical behaviour and ionic handling across the heart is integral to this.
Ability to measure field potentials and conduction from multiple sites can be achieved by contact/non-contact 
electrodes arrays. More recently, optical mapping has allowed measurement and mapping of action potential and 
calcium transient morphology and conduction, leading to a broader utilisation of mapping technologies in the 
cardiovascular sphere. Increasingly, electrode array mapping has made its way from pre-clinical to clinical arena 
whilst the use of optical mapping continues to expand in experimental research. Optically imaging intact tissue 
using voltage or calcium sensitive fluorescent dyes has advantages over surface electrodes but the requirement 
for contraction uncouplers and inability to perform in vivo experiments limits clinical utility of optical map-
ping4. Nevertheless, insights from optical mapping experiments have informed our understanding of complex 
arrhythmias and electrophysiological remodelling in heart disease5–8. Electrode mapping has equally provided 
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vital knowledge9,10, demonstrating that re-entry drives ventricular tachycardia11, actively guiding current clinical 
ablation strategies. Some arrhythmogenic principles, for example in atrial fibrillation (AF), remain poorly under-
stood from a mechanistic standpoint12,13 and thus require further experimentation.
Increased availability of optical mapping hardware in the laboratory has led to expansion of this technology. 
Further uptake and wider application is hindered by limitations with respect to data processing and analysis. This 
challenge is intensified as developing camera technology provides ever-increasing spatio-temporal resolution. 
Furthermore, multiple processing algorithms are employed before the underlying data can be interpreted14,15. 
These algorithms require computational expertise to implement and are commonly developed and used within 
individual research groups, utilising techniques specific to camera resolution, file type and animal species. Whilst 
some software solutions are accessible, even straightforward calculation of conduction velocity (CV) across the 
heart is currently unavailable, but to a few specialist groups. There is an unmet need for a robustly tested map-
ping software that allows high-throughput data processing, analysis, and mapping of electrophysiology from 
different acquisition modalities and diverse datasets with distinct electrophysiological (EP) properties (for exam-
ple: animal, human tissue and cell monolayers). Therefore, we present novel and robust open-source software, 
ElectroMap, for analysis of voltage and calcium optical mapping data. This work builds upon our previously pub-
lished algorithms15–17 while integrating analytic approaches developed and validated by others6,14,18,19. ElectroMap 
provides analysis of key EP parameters including action potential and calcium transient morphology, calcium 
decay constant (τ), activation and repolarisation times, diastolic interval (DI), time-to-peak, phase mapping and 
dominant frequency (DF). A key innovation is the introduction of a comprehensive CV module for robust inves-
tigation of CV changes. This module integrates established single vector18 and multi vector20 techniques for CV 
measurement as well as a novel “activation constant” analysis. Furthermore, semi-automated alternans analysis 
is enabled through development of a comprehensive alternans detection and quantification module. ElectroMap 
integrates automated pacing frequency recognition, ensemble (i.e. multi-beat) averaging and beat-to-beat analysis 
options. Here we employ ElectroMap for analysis, mapping and detection of pro-arrhythmic phenomena in silico, 
in cellulo, animal model and in vivo patient datasets, and thus demonstrate its utility for cardiac research.
Methods
Expanded details about methods are provided in the Supplementary Material. All animal procedures were under-
taken in accordance with ethical guidelines set out by the UK Animals (Scientific Procedures) Act 1986 and 
Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. 
Studies conformed to the Guide for the Care and Use of Laboratory Animals published by the U.S. National 
Institutes of Health under assurance number A5634-01. Experiments were approved by the home office (mouse: 
PPL 30/2967 and PFDAAF77F, guinea pig: PPL PF75E5F7F) and the institutional review boards at University of 
Birmingham (murine) and King’s College London (guinea pig). For optical mapping of human tissue, left atrial 
appendages were obtained from patients with atrial fibrillation (AF) during thoracoscopic surgery, as described 
before21. The study was in accordance with the declaration of Helsinki and approved by the Review Board of the 
Academic Medical Center, Amsterdam. In vivo intracardiac data were obtained in a clinical study approved by 
local ethics committee for patients undergoing AF ablation at the University Hospitals of Leicester NHS Trust as 
previously described22. All patients gave written informed consent.
Optical Mapping. Both mouse and guinea pig optical mapping experiments were conducted as previously 
reported. For experiments in mouse7,15,17 fluorescent dye (Voltage: DI-4-ANEPPS, Calcium: Rhod-2AM) was 
loaded into Langendorff perfused whole hearts. Left atria were isolated, with the posterior atrial surface exposed. 
Atria were superfused under normoxic (95%O2/5%CO2) or hypoxic (95%N2/5%CO2) conditions. Pacing was per-
formed via bipolar platinum electrode, and fluorescence captured using ORCA flash 4.0 camera (1 kHz sampling 
rate, maximum field of view: 200 × 2048 pixels, 71 µm/pixel, Hamamatsu Electronics, Japan). Isolated guinea pig 
hearts8 were loaded with voltage dye Di-8-ANEPPS, paced via silver bipolar electrodes and imaged using Evolve 
Delta 512 × 512 pixel EMCCD cameras (500 Hz sampling rate, 64 × 64 pixels, 320 µm/pixel, Photometrics, USA) 
mounted on a Olympus MVX10 stereomicroscope.
Human left atrial appendages21 were removed using an endoscopic stapling device (Endo Gia stapler, Tyco 
Healthcare Group) and transported to the optical mapping setup in 100 mL cooled superfusion fluid. Atrial 
preparation was submerged in a recording chamber, loaded with Di-4-ANEPPS and paced using an epicardial 
electrode. MiCAM Ultima camera (2 kHz sampling rate, 100 × 100pixels, 100 µm/pixel SciMedia, USA) was used 
to record epicardial images.
In-vivo Human Mapping. A high-density non-contact multi-electrode array catheter (Ensite Array, St. Jude 
Medical, USA) was positioned in the right atrium. Virtual unipolar electrograms were bandpass filtered from 
1–100 Hz with additional noise filtering, then exported from a 2048 node geometry as previously described22.
ElectroMap Design and Development. All data processing and analysis was performed using 
ElectroMap, Fig. 1a. ElectroMap is developed to run on multiple platforms. It can run either within MATLAB 
or as a standalone executable (.exe for Windows and.dmg for macOS) with download of the freely available 
MATLAB runtime (see Supplementary Material). Processing parameters and additional modules are adjustable 
using custom made graphical user interfaces. Software is designed to handle the widely used TIFF and MAT 
formats. Custom input of sampling frequency and pixel size makes it compatible with various cameras and acqui-
sition systems. ElectroMap allows automatic or adjusted region selection (Fig. 1b) and multiple filtering options 
(see Supplementary Material for full details of filtering options). Unless stated otherwise, all the signals in Figs 1–
8 underwent spatial (4 × 4 pixel Gaussian, sigma = 1.5) and temporal (3rd order Savitzky-Golay) filtering to allow 
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effective EP parameter quantification from single image pixels (Fig. 1c). The ElectroMap user interface permits 
signal inversion via a simple checkbox option. User-defined settings can be stored and recalled for future analysis.
Integration of automated pacing frequency recognition and numerous user-defined segmentation options 
(Supplementary Fig. I) enables simple and intuitive application of powerful analysis strategies including 
beat-to-beat analysis of long experimental files and multi-beat (ensemble) averaging to improve signal-to-noise 
ratio (SNR). Code optimization resulted in increased processing speed of up to five-times, compared to our pre-
viously published algorithms15 (Fig. 1d).
ElectroMap incorporates several definitions for activation (Start – d2F/dt2max, Upstroke – dF/dtmax, 
Depolarisation Midpoint, Peak) and repolarisation (Downstroke – dF/dtmin, Repolarization Percentage, End – 
d2F/dt2max), Supplementary Fig. II. Repolarisation percentage can be set to any custom value between 0 and 100% 
repolarisation/decay from peak for both repolarization and duration mapping (Supplementary Fig. III). Unless 
stated otherwise, depolarization midpoint was used to create activation maps, action potential duration (APD) 
was defined from upstroke to 50% repolarization and calcium transient duration (CaT) was defined from upstroke 
Figure 1. ElectroMap interface and function. (a) ElectroMap Graphical User Interface with automatic signal 
segmentation, image processing, signal processing, display and analysis options highlighted. (b) Illustration of 
4 different region selection methods available in ElectroMap. (c) Example of analysis from one pixel (top inset) 
within murine atrial images. Action potential duration (APD) 30 (blue), 50 (green) and 70 (red) are calculated 
from time of maximum upstroke velocity (vertical grey line) to 30%, 50%, 70% repolarisation respectively. Time 
of repolarisation calculated by linear interpolation (dotted line) between sampling points, as shown for 50% 
repolarisation in lower inset. (d) Time taken to process and analyse 5 image stacks of murine left atria from raw 
images to conduction velocity calculation, comparison of ElectroMap and our previously published algorithms. 
(e) Selection of pseudo-colour maps denoting some of the electrophysiological parameters measurable using 
ElectroMap.
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to 50% repolarization/decay. For calcium transient analysis, τ was calculated by fitting a mono-exponential model 
to a user defined region of decay from peak cytosolic calcium. Cardiac alternans were measured as change in 
duration or peak amplitude from one calcium transient to the previous. Additionally, effects of cytosolic calcium 
load were investigated by comparing ‘load’ and ‘release’ alternans amplitude, as in Wang et al.23. Analysis results 
can be exported from ElectroMap’s interface as TIFF files for individual maps, AVI/GIF files for multi-image 
analyses such as beat-to-beat (see Supplementary Video I), and comma separated value (.csv) files for parameter 
distribution and beat-to-beat analysis.
Statistical analysis. Data are presented as mean ± standard error. Differences between group means 
were examined using two-tailed, paired Student’s t-test or using One Way Analysis of Variance (ANOVA) with 
Bonferroni test, and were accepted as significant when P < 0.05.
Results
We have developed a novel, user-adaptable, semi-automated, robust, open-source software ElectroMap using 
MATLAB, see Fig. 1a for graphical user interface. The software is freely downloadable from https://github.com/
CXO531/ElectroMap, and is available as a standalone executable file or as source code which can be run and 
edited in MATLAB. Algorithms implemented within ElectroMap have previously been validated against mono-
phasic and transmembrane potentials in murine atria15. Here, we present the application and further validation of 
ElectroMap for the analysis and mapping of basic and complex cardiac electrophysiology from optical mapping 
datasets (Figs 1–8) and endocardial electrograms (Fig. 8).
Conduction Velocity Module. Analysis of the spread of electrical activation in cardiac tissue at high 
spatiotemporal resolution is one of the most powerful applications of optical mapping. We have developed a 
comprehensive CV analysis module within ElectroMap (Supplementary Fig. IV), to overcome a multitude of 
complexities and potential user-bias associated with CV calculations18,24. The module incorporates two estab-
lished methods that rely on superimposing a vector field upon the activation map: (i) multi-vector and (ii) single 
vector method (see Fig. 2a,b). Additionally, we have developed a novel method that quantifies time taken to 
activate a percentage of the tissue. This approach allows calculation of ‘activation constant’ (see Fig. 2c,d), thereby 
providing a measure of activation spread across the whole tissue.
To validate the three CV calculation methods, we generated computationally simulated model data (Fig. 3a 
and Supplementary Fig. V; for algorithms, see Supplementary Material). All three methods accurately measured 
conduction velocities ranging from 10 to 100 cm/s in isotropic model data (Fig. 3a(i)). As shown in Fig. 3b,c, 
single vector and multi-vector methods demonstrate a linear increase in CV with faster model conduction speed. 
Activation curve method accurately detected a change in CV (Fig. 3d), increase in model CV led to a reduction 
in the time taken to activate 50% (act50) of the tissue. We also validated CV analysis methods using models of ani-
sotropic activation (Fig. 3aii) and regional conduction block (Fig. 3aiii). Single vector analysis correctly detected 
slower CV along the transverse (1800/3600) compared to longitudinal (00/2700) direction in anisotropic waves, 
and conduction slowing adjacent to the region of conduction block (Fig. 3e). Similarly, multi-vector method 
successfully identified regions of reduced CV in anisotropic waves and severe conduction slowing around the 
area of conduction block (Fig. 3f). Activation curve analysis was able to detect the slowing of conduction in the 
anisotropic wave, as evident by a prolongation of the activation curve, and a delay in activation caused by con-
duction block (Fig. 3g). Additionally, Gaussian noise with incrementally increasing standard deviation (defined 
as percentage of action potential amplitude, Supplementary Fig. VII) was introduced to isotropic simulated data 
with CV of 50 cm/s, Fig. 3h. As expected, increased noise in single beat data decreases the ability to accurately 
calculate CV, with noise levels above 20% resulting in erroneous CV measurements (Fig. 3i). However, SNR can 
be improved using temporal and spatial filtering or multi-beat ensemble avenging within ElectroMap. Temporal 
filtering (Savitzky-Goaly filter) did not improve CV measurement, whereas both spatial filtering (3 × 3 Gaussian 
filter) and ensemble averaging of 10 beats substantially improved CV measurement accuracy.
Further validation was performed using experimental datasets acquired from murine left atrial tissue. We 
focused on two physiologically relevant stimuli known to reduce CV: an increase in pacing frequency25 and 
acute hypoxia26 (Fig. 4a). Indeed, significant slowing of CV, due to increased pacing frequency, was detected 
by multi-vector method (Fig. 4b, P = 0.0335) and activation curve method, as shown by an increase in the act50 
(Fig. 4c and D, P = 0.0119). Both methods also accurately detected a more severe slowing of CV caused by expo-
sure to acute hypoxia (Fig. 4e–g, P < 0.0001 and P = 0.0051 respectively).
High-Throughput Beat-to-Beat Analysis. Studies of beat-to-beat variation can provide important 
information about short periods of regional or whole tissue electrical instability, e.g. in response to pacing fre-
quency change, pharmacological agents or disease states. Therefore, we developed and tested algorithms to allow 
high-throughput analysis of beat-to-beat alterations in long experimental files. Guinea pig hearts were paced 
over 70 seconds with a 5-8-5 Hz pacing protocol27 and beat-to-beat changes in APD50 examined (Fig. 5a and 
Supplementary Videos I and II). Increasing the pacing frequency (from 5 Hz to 8 Hz) induced reversible short-
ening of mean ventricular APD (Fig. 5b). Furthermore, significant APD heterogeneity was detected in the first 4 
beats, immediately after transition from 5 Hz to 8 Hz (Fig. 5b,c). Switching back from 8 Hz to 5 Hz (at 40 s) also 
induced some APD heterogeneity while highlighting a slow return to the steady state APD (Fig. 5b,d).
Calcium Decay Mapping. Optical mapping is increasingly utilised to study calcium release patterns across 
myocardial tissue or cellular monolayers, in response to disease, genetic factors or drug administration19. The 
estimation of calcium decay constant (τ) is common in single cell studies. However, τ is not commonly mapped 
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across multicellular preparations28, likely due to lack of support for this function in available software platforms. 
We developed algorithms for calculation of CaT and τ maps, as shown in Fig. 6a,b. Importantly, CaT can be 
measured from various ‘activation times’ during upstroke (Supplementary Figs II and VI), allowing for assess-
ment of both calcium release and uptake (Fig. 6a inset). Moreover, τ can be fitted from any user-defined value 
(Fig. 6b inset). To test and validate algorithms developed for calculation of τ, mouse atria were loaded with Rhod-
2AM and paced at incremental frequencies (3-8.33-10-12.5 Hz). Software accurately calculated progressively 
shorter τ values at higher pacing frequencies (Fig. 6c,d, P < 0.0001 for all pacing frequencies compared to 3 Hz). 
Interestingly, higher pacing frequencies were associated with a reduction in τ heterogeneity (Fig. 6e, P = 0.0286 
and P = 0.0168 for 10 Hz and 12.5 Hz pacing respectively).
Alternans Analysis Module. Alternans are beat-to-beat 2-period oscillations in ion handling, electrical 
activity and hence mechanical contraction of the myocardium that can act as a precursor to conduction block and 
lethal arrhythmias29,30. We have developed a module within ElectroMap to detect and quantify alternans across 
tissue and cellular monolayers. Alternans module is capable of quantifying peak, duration, and release or load 
alternans (see Supplementary Fig. VIII for alternans definitions).
In Fig. 7 we demonstrate utility of the alternans module in detection and quantification of calcium alternans 
in a murine left atrium loaded with Rhod-2AM. The atrium was subjected to high frequency pacing of 12.5 Hz, 
initially leading to moderate alternans (Fig. 7a, blue CaTs) and then transitioning to more pronounced alternans 
(Fig. 7a, red CaTs). ElectroMap was used to generate maps allowing visualization and alternans quantification 
across the atrium (Fig. 7b,c). Alternans displayed clear spatial heterogeneity (Fig. 7b,c) with increased ‘CaT Peak 
Alternans’ correlating with changes in diastolic calcium load (‘Load Alternans’), see Fig. 7c.
Figure 2. ElectroMap conduction velocity module quantification methods. (a) Vector methods applied to 
murine atria. Top panel: multi-vector method, with local conduction vectors (arrows) calculated across the 
tissue. Lower panel: single velocity method, where conduction speed is measured along the vector (arrow) 
connecting two points. (b) Activation map represented in 3D with x,y pixel positions and activation time 
on z-axis. Upper inset demonstrates calculation of one local vector from a 5 × 5 pixel region by fitting of a 
polynomial surface (f(x,y)) to measured activation times (t(x,y)). Lower inset shows calculation of single vector 
velocity from activation time difference (Δt) and distance (r) between two selected points. (c) Activation of the 
murine atria at 20% (act20), 50% (act50), and 90% (act90), total activation. (d) The associated activation curve, 
with act20, act50 and act90 highlighted.
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Figure 3. Validation of conduction velocity quantification methods using model datasets. (a) Model 
conduction datasets exhibiting isotropic conduction (i), anisotropic conduction (ii) and isotropic conduction 
with a 2:1 conduction block in lower right region (iii). (b–d) Measured conduction velocities (CV) from 
isotropic conduction model datasets spanning 10 to 100 cm/s using ElectroMap. (b) CV is measured using a 
single vector from centre of sample (black) and from edge of sample (pink). (c) multi-vector method is used 
with windows sizes of 3 × 3 (green), 5 × 5 (red) and 10 × 10 (blue) pixels. CV is then measured as mean of the 
magnitude of all local vectors calculated, with error bars representing the standard deviation of the mean. (d) 
Activation curve method with act50 (time to 50% activation) used to quantify conduction. (e–g) Three CV 
quantification methods applied to model datasets with isotropic, anisotropic and conduction block present 
conduction. In all three cases, fastest model conduction was 50 cm/s. (e) Change in measured CV as a function 
of angle using single vector method from centre of tissue. (f) Distribution of local vector magnitude measured 
by multi-vector method (5 × 5 pixel window) in the three model datasets. (g) Activation curves from the model 
datasets. (h) Example activation maps from unfiltered model datasets with isotropic conduction of 50 cm/s, 
but with 10% and 30% signal noise. (i) Measured CV using multi-vector method (5 × 5 pixel window) from 
unfiltered (Black), temporally filtered (Savitzky-Golay, Blue), Spatially filtered (3 × 3 Gaussian, Green) and 10 
beat ensemble averaged (Red) model datasets at increasing noise levels, n = 5 at each noise level.
www.nature.com/scientificreports/
7Scientific RepoRts |          (2019) 9:1389  | https://doi.org/10.1038/s41598-018-38263-2
Human Optical Mapping and Electrogram Recordings. ElectroMap’s utility extends to human tissue, 
see Fig. 8a for optical mapping of human atrial appendages. We also looked to test whether ElectroMap can be 
applied to analysis of clinically relevant mapping technologies. Right atrial virtual electrograms from a patient 
during sinus rhythm and AF were recorded and analysed after QRST subtraction22. During sinus rhythm, the 
spread of activation was calculated from the timing of dV/dtmin in each electrogram, generating an activation map 
(Fig. 8b). ElectroMap clearly identified higher DF components (Fig. 8c) during AF in the physiological range of 
4–10 Hz (DF range can be set within ElectroMap’s interface). Additionally, marked phase discontinuities (Fig. 8d 
and Supplementary Video III) are observed in the electrogram recordings during AF. These findings are con-
firmed using previously published algorithms22 with similar areas of high dominant frequency and discontinuous 
phase behaviour identified (Fig. 8e,f).
Additional Features. ElectroMap analysis options further extend to measure diastolic interval (DI) and 
time to peak. DI is measured from APD90 to the following activation time, which can be difficult to quantify in 
low SNR samples on a single beat. To validate the DI function, guinea pig hearts were loaded with Di-8-ANEPPS 
and pacing cycle length was decreased in 10 ms intervals from 170 ms to 110 ms. Ensemble averaging of 10 beat 
segments was used to produce an ‘average beat diastolic interval’, with improved SNR, and DI mapping function 
was validated by plotting DI-APD restitution curves (Supplementary Fig. VIII). Both APD50 and DI decrease 
more rapidly at higher pacing frequencies as previously demonstrated31.
Optogenetic excitation and pacing via light pulses in cardiac tissue expressing light sensitive ion channels is 
a novel research tool32,33 and may even be used for cardiac pacing in patients34. However, introduction of large 
amplitude light pulses will distort optical mapping images and thus preclude processing and analysis of such 
data. To this end, ElectroMap integrates a pacing artefact removal algorithm (Supplementary Fig. IX), which can 
identify and correct for light-pacing peaks, thereby allowing processing and analysis of previously obscured data.
Discussion
This work presents the development and validation of a novel open-source software for analysing and mapping 
optical and electrical signals. We demonstrate the compatibility of ElectroMap with a variety of camera types, spe-
cies and experimental models. Key features include comprehensive measurement, analysis and mapping of global 
and regional conduction, versatile signal segmentation and semi-automated high-throughput analysis of action 
potential and its spatial and temporal (beat-to-beat) variations, calcium transients, and cardiac alternans. Using 
model and real data, we demonstrate the application of ElectroMap for analysis, measurement and mapping of 
basic and complex electrophysiology and its utility in dissecting pro-arrhythmic mechanisms in vitro and in vivo.
ElectroMap is built on years of international research and development in optical mapping processing and 
analysis, described in many excellent papers and reviews6,14,15,18,35,36. Algorithms that ElectroMap relies on have 
previously been validated against monophasic and transmembrane potentials in murine atria15. Further valida-
tion performed against established open-source (Rhythm14) and commercially available software (Optiq, Cairn 
Research, UK) yielded similar APD values and activation maps (Supplementary Fig. X). To the best of our knowl-
edge, this is the first such comparison of commonly used analysis algorithms, which should help instil confidence 
Figure 4. Validation of conduction velocity quantification methods in murine atria. (a) Activation maps from 
murine atria at 3 Hz and 10 Hz pacing (i), and during normoxia and hypoxia (ii). (b) Pacing at 10 Hz slows CV, 
measured using multi-vector method. (c) Representative activation curve showing prolongation of activation 
at 10 Hz vs 3 Hz pacing. (d) Pacing at 10 Hz slows CV, measured by time to 50% activation (act50). (e) CV 
slowing induced by hypoxia, measured using multi-vector method. (f) Representative activation curve showing 
prolongation of activation curve by hypoxia. (g) Hypoxia slows CV, measured by time to 50% activation (act50). 
Grouped data displayed as mean ± standard error, n = 8, *P < 0.05 by paired t-test.
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in interpretation of data generated thus far. Importantly, ElectroMap provides further functionalities and outputs, 
not widely available currently, including ensemble averaging, multiple CV methodologies, automatic frequency 
detection, signal segmentation, alternans analysis and decay constant mapping. The use of ElectroMap extends 
beyond optical mapping, allowing for its application in clinical settings with electrogram array data.
Robust validation studies performed using both model and experimental data demonstrate ElectroMap’s util-
ity for accurately quantifying key parameters of electrical function and calcium release across cardiac tissue. CV 
quantification in model data with noise verified that processing using ElectroMap allows accurate parameter 
quantification. In this case, ensemble averaging proved the most effective processing strategy due to the ran-
domness of the noise and the underlying identical morphology of all simulated action potentials. In other cir-
cumstances, (e.g. beat-to-beat variations) ensemble averaging of signals should be avoided, necessitating distinct 
processing strategies such as spatial filtering, temporal filtering and baseline correction which are all employable 
using ElectroMap.
Additionally, we demonstrate that improved processing speeds with automatic or user defined signal segmen-
tation enable more complex and computationally challenging analyses; e.g. beat-to-beat variations in APD or 
regional differences in calcium decay. Indeed, we demonstrate that using ElectroMap, rapid and straightforward 
analysis of long experimental datasets can reveal acute periods of pro-arrhythmic EP behaviour throughout the 
entire guinea pig myocardium (Fig. 5). Such analysis would otherwise be missed by ensemble averaging of multi-
ple beats or analysis of a single beat. ElectroMap, in contrast, provides rapid analysis of these complex EP parame-
ters and exports to video and spreadsheet formats that facilitate interpretation of the observed patterns. This may 
be of particular importance when examining the pathophysiological effects of rapid changes in heart rate and/
or immediate and prolonged responses to stimuli such as adrenaline or acute ischaemia. With improving SNR 
through better cameras and dyes, there is an increasing demand for beat-to-beat analysis of mapping data37,38. We 
Figure 5. Beat to beat analysis of whole guinea pig heart. (a) Tissue averaged fluorescent signal from voltage 
dye loaded guinea pig heart across 70 s experiment. (b) Graph of whole heart beat-to-beat changes in mean 
APD50. (c) Raw trace and whole heart APD50 maps prior to (beats 47 & 48) and immediately after (beats 49–
52) pacing frequency increase from 5 Hz to 8 Hz (blue in A and B). (d) Raw trace and whole heart APD50 maps 
prior to (beats 300 & 301) and immediately after (beats 302–305) pacing frequency return to 5 Hz.
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anticipate that ElectroMap’s ability to achieve such analysis in a high-throughput semi-automated manner will 
prove valuable for preclinical and clinical researchers.
The ability to simultaneously use three CV quantification methods is a key feature of ElectroMap. This is 
essential due to inherent limitations of each individual methodology for analysis of cardiac CV18,24. Here, we 
demonstrate that single vector method can suffer from significant user-generated overestimation of CV (see 
Supplementary Fig. IVA). More automated approaches have been proposed, such as that of Doshi et al.39 whereby 
single vector quantification is limited to areas where activation time linearly increases. Within ElectroMap’s con-
duction module, we have looked to overcome and highlight difficulties with the single vector method via an auto-
matic angular sweep of measured CV from a user chosen point, as in Fig. 3e and Supplementary Fig. IVA. This 
approach reveals inherent variability that stems from user-defined propagation direction. ElectroMap automat-
ically identifies the slowest conduction direction, which, in normal circumstances, will be parallel to wavefront 
propagation. The angular sweep additionally allows straightforward identification of longitudinal and transverse 
CVs40,41.
Application of multi-vector method reduces the likelihood of user-introduced errors but does not eliminate 
them completely. Simulation studies by Linnenbank et al.18 for instance demonstrate that despite increased auto-
mation, multi-vector methods can introduce systematic errors in CV quantification. The successful use of the 
method requires minimum criteria to be met in terms of grid size, local region size and angular binning for iden-
tification of propagation directions. Another problem can stem from inability to fit local vectors to some areas 
of the tissue. For example, activation definitions that are intrinsically limited to sampling rate (such as upstroke) 
can result in local regions where measured activation time is the same throughout. In such circumstances, mean-
ingful surface fit (e.g. Fig. 2b) or other methods for describing local activation such as finite difference analysis42, 
are not achievable24. This can be particularly problematic in small tissue samples, like isolated murine left atria, 
or in tissues exhibiting fast conduction and/or wavebreak. Viable solutions to this issue include interpolation of 
data between sampling points or use of alternative activation definitions such as depolarisation midpoint (see 
Supplementary Fig. II and IV). However, this relies on accurate signal interpolation, not always achievable in 
practice43. Epicardial conduction velocity quantification can also be complicated by multiple breakthroughs in 
the endocardium leading to inaccurate CV estimation during complex arrhythmias44 or in the absence of epicar-
dial pacing. In conclusion, there is no universally applicable activation measure suited for every optical mapping 
experiment, further validating the need for integration of multiple activation and CV quantification methodolo-
gies within ElectroMap.
ElectroMap incorporates a novel activation curve method of conduction analysis. This method allows 
users to quantify the time taken to activate a defined tissue percentage or study the whole activation curve. The 
Figure 6. Calcium analysis and decay constant validation. (a) CaT50 map from murine atrium as measured 
from time of maximum upstroke velocity to 50% decay, illustrated in red in region of interest signal 
(CaT50upstroke). Also shown is the measurement of CaT50 from peak amplitude in region of interest (blue, 
CaT50peak map in Supplementary Fig. VA). (b) Map of decay constant, τ, from the same atrium. Map shows 
calculation of τ by fitting of exponential decay points between 30% and 90% decay from peak (τ30–90), illustrated 
for the regional signal in blue. Also shown is calculation of τ between 10% decay and baseline (red, τ10-BL map 
in Supplementary Fig. VD). (c) Representative τ maps (τ30–90) from murine left atria as pacing frequency is 
increased. (d) Data showing shortening of mean τ across the atria with increased pacing frequency. (e) Data 
showing decrease of τ heterogeneity (measured as standard deviation of mean τ across individual atria) across 
the atria with increased pacing frequency. Data displayed as mean ± standard error, n = 5. P < 0.05, One-Way 
ANOVA followed by Bonferroni multiple comparison test against 3 Hz pacing.
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methodology is less susceptible to user bias or to sparsity of local vectors in areas of rapid conduction as it does 
not rely on user input or vector calculation. Furthermore, activation time can be normalized to tissue size, yield-
ing an activation constant in units such as ms/mm2. This extends the use of the activation constant to studies 
where tissue morphology may be altered, such as in hypertrophy or genotype dependent differences in cardiac 
structure. However, activation constant only provides a summarised measure of activation, thus a combination 
of analysis methods may be required for robust interrogation of cardiac conduction. Additionally, despite the 
various CV methods within ElectroMap, conduction analysis can remain challenging if the underlying activation 
pattern is heterogeneous, often observed in arrhythmic tissue and cultured cardiac monolayers45. The ‘Ccoffinn’ 
method of Tomek et al.24 combines sophisticated image processing techniques with novel wavefront tracking 
algorithms and can potentially overcome heterogeneity issues24.
Defining activation times for APD and CaT duration mapping is an important but complex and often poorly 
understood analysis option. Different studies utilize distinct features of the upstroke to define activation, includ-
ing dF/dtmax (upstroke)44, d2F/dt2max (start)46, depolarization midpoint47 and peak8. Similarly, time of repolari-
sation/decay can be measured at a defined repolarisation percentage15,48, dF/dtmin (downstroke) or d2F/dt2max36. 
The parameters best suited for duration measurement will depend on experimental model, signal quality and 
experimental question. We have integrated all of these user-selectable definitions within ElectroMap for both 
APD (Supplementary Fig. II) and CaT mapping (Fig. 6a and Supplementary Fig. VI).
Similarly, τ calculations can be customised in ElectroMap’s interface to calculate decay constant for any 
user-defined segment of the calcium reuptake. This permits analysis of cytosolic or SR23 calcium handling kinet-
ics in different animal species and cells. For example, note the regional discrepancy between CaT50 and τ atrial 
maps in Fig. 6a,b. This contrast results from the definition in CaT50 used, i.e. time from upstroke to 50% decay 
(CaT50upstroke). CaT50upstroke is a measure of both the release and reuptake of the cytosolic calcium. In contrast, 
τ depends only on reuptake kinetics, and so is unaffected by the changes in calcium release. By measuring CaT 
Figure 7. Alternans module. (a) Tissue averaged fluorescent signal from calcium dye loaded mouse atrium 
paced at 12.5 Hz, showing distinct alternans behaviour at 0.5–3 s (blue, moderate alternans), and 4–6.5 s (red, 
large alternans). (b) Representative signals and time averaged alternans maps from tissue during moderate 
alternans behaviour. Four maps shown correspond to the four measures of alternans available in ElectroMap 
(see methods and Supplementary Fig. VI). (c) Maps during period of large alternans (4–6.5 s) show increase in 
alternans amplitude, and clear spatial discordance.
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from peak (CaT50peak), the CaT50 and τ values become more similar across the atria (Supplementary Fig. VI). 
Deciphering pathophysiological relevance of these observations is not within the remit of this manuscript. 
However, we predict the user-defined tools for comprehensive measurement of vital duration and relaxation 
parameters that ElectroMap provides will aid understanding of cardiac pathophysiology.
The utility of processing and analysis algorithms in ElectroMap can extend beyond optical mapping. Here, we 
show analysis of in vivo virtual unipolar electrogram recordings from human right atrium (Fig. 8b–d). Despite 
the contrasting waveforms compared to optical mapping, by analysing the timing of dV/dtmin in electrogram 
recordings, ElectroMap is able to accurately calculate local activation times. Beyond its clinical utility, access to 
analyses such as dominant frequency and phase mapping, allowing mapping the site of triggered activity during 
arrhythmia (Fig. 8c,d), can aid the translation of experimental data10,49. These capabilities of ElectroMap require 
further systematic validation against a range of clinically used platforms, however current outputs are compara-
ble to previous published analysis of similar datasets22, see Fig. 8c–f. Implementation of other analysis options 
available within ElectroMap such as beat-to-beat segmentation, CV quantification and alternans detection and 
quantification hold immense potential for the analysis of electrogram data.
ElectroMap provides a robustly validated open-source flexible tool for processing and analysis of optical map-
ping data. We anticipate ElectroMap to facilitate increased uptake of optical mapping in cardiac electrophysiol-
ogy. Furthermore, application of novel data analysis strategies developed here will further our understanding of 
Figure 8. Human atrial optical and electrogram mapping analysis. (a) Activation map and example signals 
generated from human left atrial appendage stained with voltage sensitive dye. (b) Activation map and 
example signals generated from human right atrial in vivo electrogram array recordings. Labels refer to closest 
anatomical structure on 2D map - IVC and SVC: Inferior and Superior Vena Cava, CSO – Coronary Sinus 
Ostium, Fossa - Fossa Ovalis. (c) Dominant Frequency analysis between 4 and 10 Hz, showing localized area 
of increased frequency during AF. (d) Phase maps at 3 time points during sinus rhythm and AF. Synchronised 
phase behaviour during sinus rhythm is not replicated during AF. The displayed frames are taken from phase 
mapping over 30 s, Supplementary Video II. (e) Dominant Frequency analysis and (f) Phase maps at 3 time 
points during sinus rhythm and AF performed using previously published algorithms of similar datasets22.
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the mechanisms underpinning lethal arrhythmia. The application of ElectroMap extends beyond optical map-
ping. Here, we have demonstrated that ElectroMap can also be used in the analysis of clinical electrogram-based 
mapping data. Moreover, application of high-throughput CV quantification methodologies can be applied to 
drug-screening pipelines for cardiotoxic effects in cell monolayers. There is scope to broaden the existing func-
tions of ElectroMap, for example, by introducing dual-analysis of simultaneous voltage and calcium recordings 
and implementing computational approaches to overcome motion artefacts50. Furthermore, increases in compu-
tational efficiency through more sophisticated computational techniques, such as parallel processing, would allow 
for faster data processing and could eventually facilitate in-acquisition analysis.
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3.2 Additional material
The following sections detail investigations into ensemble averaging, baseline
correction and local vector calculation that were conducted as part of developing
the software.
3.3 Testing the efficacy of ensemble averaging in optical
mapping
Misapplication of spatial or temporal filtering methods can unphysiologically alter
optical recorded cardiac signals. An alternative solution to direct filtering is the
use of ensemble or multi-beat averaging, where the cyclic nature of cardiac
rhythm is utilised to create an ‘average’ waveform from several successive action
potentials or calcium transients, Figure 3.1A. As pacing cycle length is known,
signals can be time matched by stacking fluorescent values at time points
separated by the cycle length [1]. This methodology however relies on pacing
frequency being known. Methods based on the measured signals, such as the
tissue averaged optical signal, are advantageous as they do not rely on prior
knowledge of the pacing protocol, can to some extent adapt to physiological
pacing and imaging changes, and can be combined with automatic frequency
detection algorithms.
The successful use of ensemble averaging relies on accurate signal alignment
and temporal stability of the signal. Therefore, to verify the efficacy of ensemble
averaging and test different alignment methods, two methods of ensemble
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Figure 3.1: Ensemble averaging techniques. A) Example application of the
i) Window and ii) Peak techniques for multi-beat averaging. B) Signal to noise
ratio (measured as ratio peak amplitude and root mean square of baseline
fluorescence) as a function of number of beats averaged. C) Mean APD50
as a function of ensemble averaging technique and number of beats averaged.
D) Comparison of inter-sample variability compared to the mean in measured
APD50 at 10 and 100 averaged beats. E) Mean CV as a function of ensemble
averaging technique and number of beats averaged.
averaging were compared both in effectiveness of reducing noise in optical
signals and recovering important EP parameters such as APD in isolated mouse
left atria loaded with Di-4-ANEPPS (see section 2). The two methods were
(Figure 3.1A) ‘Window’: known pacing frequency used to calculate time point to
be averaged which are separated by constant cycle lengths [1], and ‘Peak’:
peaks in the tissue averaged optical voltage signal were automatically identified
and used for reference to calculate pacing frequency and time points to be
matched. No pre- or post-processing was applied other than ensemble
averaging. APD50 was calculated as time between maximum upstroke velocity
and 50% repolarisation. CV was calculated using the Bayly multi-vector method
from activation maps generated using the depolarisation midpoint [2], [3].
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Figure 3.1B demonstrates that both methods similarly increased peak SNR to
the same extent dependent on number of beats averaged in mouse atria (n=6).
However, when calculating APD50, there was some evidence of differences
between the two methods at lower numbers of averaged beats, but no significant
difference in the measured APD50 are present as the number of beats averaged
increases, Figure 3.1C. For example, when 10 beats were averaged by the
window method, AP50 was 11.4±0.86ms compared with 10.75±0.34ms using
the automatic peak method (P=0.50). At 50 beat averaging, APD50 is
9.44±0.26ms and 9.43±0.35ms respectively (P=0.97).
Notably however, there is a greater divergence in inter-sample measurements
(as measured as deviation from the mean) of APD50 when using the window
compared to the peak method at low numbers of averaged beats, Figure 3.1D,
which is not the case as more beats are averaged. With 10 beat averaging, the
window method results in an inter-sample variability of 1.75±0.35ms, compared
to 0.68±0.16ms with the peak method (P=0.043). This suggests a greater
number of action potentials need to be averaged using the window method to
accurately recover the waveform. CV measurements are the same by both
methods irrespective of number of beats averaged, Figure 3.1E. These results
suggest that peak alignment was a more effective method, and was hence
decided as the default method of alignment for ensemble averaging. Of course,
an important constraint of ensemble averaging will be a loss of beat-to-beat
heterogeneity, which can preclude analysis of important phenomena such as
alternans.
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3.3.1 Ensemble averaging for improved optical signal quality
in mouse left atria
To further test the utility of ensemble averaging for use in optically mapped
mouse atria, a simple model of the mouse atrial action potential and conduction
(see appendix A.1.3) was used to produce model datasets with progressively
longer APD50 values (6-14ms), Figure 3.2A, and confirm the accuracy of APD
measurement algorithms, Figure 3.2B. APD50 was then set to 10ms and
Gaussian noise introduced to these datasets. As expected, increasing Gaussian
noise decreased the ability to accurately measure APD from a single beat
(Figure 3.2Ci), and increased measurement heterogeneity (Figure 3.2Cii).
Ensemble averaging of 10 beats was then applied to the model dataset, while also
independently applying spatial filtering (3x3 Gaussian filter, standard deviation =
1.5) and temporal filtering (3rd order Savitzky-Golay filter, 11ms length). Temporal
filtering did not improve ability to measure APD but did reduce measurement
heterogeneity within the sample (Figure 3.2C). Both spatial filtering and 10 beat
ensemble averaging substantially improved APD measurement accuracy (Figure
3.2C).
In independent experiments, regional action potential morphology heterogeneity
was introduced to simulated datasets as an area of prolonged APD (Figure 3.2D)
and APD gradient (Figure 3.2E). In the ideal, no noise case, regional differences
are accurately identified, which are masked at 30% noise. However, by 10 beat
ensemble averaging, these differences can still be clearly identified (Figure 3.2D
and E).
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Figure 3.2: Action potential duration (APD) measurement validation and
ensemble averaging model testing A) Model action potentials with varying
duration. B) ElectroMap measured APD50 from model data with set APD50
spanning 6 to 14ms. C) Absolute change in APD50 measurement compared
to 0% noise (i) and APD50 heterogeneity (ii) at increase noise levels for
unfiltered (Black), temporally filtered (Savitzky-Golay, Blue), Spatially filtered (3x3
Gaussian, Green) and 10 beat ensemble averaged (Red) data, n=5 at all noise
levels. D) Model dataset with area of prolonged APD measured at 0% noise,
30% noise from a single beat and 30% noise with 10 beat ensemble average.
E) Similar to D), but with a model dataset exhibiting an APD gradient across the
tissue.
To further test the utility of ensemble averaging in real optical mapping datasets,
mouse left atria (n=13) were paced at 3Hz and 10Hz pacing frequency. An
increase in pacing frequency is expected to shorten action potential due to
cardiac restitution dynamics [4], [5]. As with the model data, ensemble averaging
of 10 beats is observed to improve signal quality, here quantified as signal to
noise ratio (SNR), Figure 3.3A-C. Noise was defined as the standard deviation of
the baseline signal and compared to the amplitude. The increase in SNR
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correlates to a reduction in measurement heterogeneity across the tissue, and
simultaneously a reduction in the number of pixels in which analysis of APD was
not possible (Figure 3.3D). Furthermore, when analysing a single beat, there is
no difference between measured APD50 values at the respective pacing
frequencies Figure 3.3E. In contrast, when ensemble averaging is applied, an
expected decrease in APD50 at 10Hz pacing is observed, Figure 3.3E.
These results suggest ensemble averaging is an effective denoising technique in
this experimental setup. It is important to note however that multi-beat averaging
relies on the assumption that action potential (AP) morphology is consistent
across several cardiac cycles. There are however a number of physiological and
pathophysiological conditions in which action potentials morphology is known to
alter between beats, for example alternans [6] and other forms of beat-to-beat
heterogeneity [7]. In these situations, ensemble averaging may mask important
and potentially pro-arrhythmic periods of temporal heterogeneity. It was
observed in model studies that spatial filtering is as efficacious for denoising as
ensemble averaging. It therefore may be more appropriate for certain studies,
although it also has limitations with respect to possibly masking of local spatial
heterogeneity [8].
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Figure 3.3: Ensemble averaging to resolve action potential duration (APD)
changes. A) APD50 map and example single pixel signal from single beat optical
action potentials. B) APD50 map and example single pixel signal from optical
action potentials generated by ensemble averaging of 10 successive beats (peak
method). C) SNR of single beat compared to 10 beat averaged signals. D) APD50
heterogeneity (i) and number of measurement failures (ii) as a function of SNR for
single beat and 10 beat averaged APD50 maps. E) APD50 at 3 and 10 Hz pacing
frequency, as measured from single beat and 10 beat maps. ****P<0.0001
3.4 Comparison of local conduction velocity vector
quantification methods
There are multiple methodologies to compute cardiac CV from optical mapping
derived activation maps. The multi-vector method, where conduction is quantified
and averaged across an activation map, is widely used as it analyses conduction
across whole tissues, rather than along single paths as occurs with single vector
methods [9]. This makes multi-vector methods less susceptible to user bias than
single vector methods and allows analysis of conduction heterogeneity. There
however can persist systematic errors in CV quantification [10].
To perform multi-vector conduction analysis, local CV vectors (CVlocal), need to
be quantified across activation maps. To achieve this, the activation maps are
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segmented into local areas of n x n pixels, and conduction speed and direction
quantified as CVlocal.
A method to quantify CVlocal is the polynomial surface method developed by Bayly
et al, originally proposed for use in epicardial electrode mapping [3]. For each of
the local regions, a polynomial surface, T(x,y), is fitted using least squares fitting
that describes the relationship between activation time, t, and spatial position
(x,y), where T(x,y) is of the form,
T(x, y) = ax2 + by2 + cxy + dx + ey + f. (3.1)








where Tx = ∂x/∂T and Ty = ∂y/∂T are the ’conduction gradients’ in the x and
y direction respectively, and i and j are unit vector directions. This procedure
therefore computes both a magnitude and direction of conduction in each local
region.
However, the need to fit polynomial surfaces across whole tissue activation maps
can make this a computationally intensive procedure. Additionally, several factors
may influence results, including the method for surface approximation. In contrast,
the finite difference method represents a simpler technique to approximate local
conduction [11], [12]. Here, the activation time difference between the pixel of
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interest (t(x,y)), and the difference between that and its nearest neighbour pixels
(t(x±1,y) and t(x,y±1)) can be used to measure the conduction gradients as
Tx =
t(x + 1, y) – t(x – 1, y)
2d
i, Ty =
t(x, y + 1) – t(x, y – 1)
2d
j (3.3)
where d is the interpixel distance, i is the unit vector in x direction and j is the
unit vector in y direction. The local conduction can then be quantified as in
equation 3.2. Additionally, the underlying formulae underpinning the finite
difference method (equation 3.2 and 3.3) can be extended to calculate local
conduction gradients from more pixel sites than simply nearest neighbours
considered here, resulting in similar versatility in ‘local’ area size as possible with
the polynomial method. This was achieved by modification of equation 3.3 for nth













t(x, y + n) – t(x, y – n)
2nd
j (3.4)
The two methods for calculating CVlocal were then compared using model
datasets to test their accuracy in ideal, no noise, cases and robustness to
increasing levels of noise. Polynomial and finite difference methodologies were
additionally utilised to analyse experimental datasets of voltage dye optically
mapped mouse left atria subjected to hypoxic conditions, expected to slow
conduction [13]. Magnitude and directionality of conduction, alongside
computation time, were compared. Model datasets underwent no
pre-processing, while mouse atrial datasets were pre-processed as previously
described (3x3 gaussian spatial filter, ensemble averaging of final 20 beats).
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3.4.1 Finite difference and polynomial surface comparison in
model datasets
To first confirm the efficacy of the two methods, model datasets of isotropic
conduction spanning CVs of 10 to 100cm/s were produced (see Appendix
A.1.3). Note: As these comparisons focused on local velocity measurement,
analysis was restricted to isotropic conduction for simplicity as macroscopic
variations (such as anisotropy) are less likely to influence calculations from small
activation regions. Both methods were applied with window sizes of 3x3, 5x5
and 7x7 pixels. Figure 3.4A demonstrates that in the ideal no noise case, both
methods can accurately quantify conduction, with a linear relationship between
model and measured CV. However, the finite difference method does report
more heterogeneity in CV measurements compared to the polynomial method,
Figure 3.4B. In these models, conduction is homogenous across the tissue,
suggesting that the finite difference methodology is more susceptible to errors
induced due to imprecise activation times which arise from finite sampling rates
and pixel sizes in optical mapped datasets.
To investigate the effects of noise, CV was set at 50cm/s and increasing levels of
Gaussian noise, with standard deviation of up to 75% of the signal amplitude, was
added to the datasets. Due to the pseudorandom nature of the noise addition, this
procedure was repeated five times at each CV (n=5). As expected, both methods
become less accurate as noise is increased to very large levels (>40%), Figure
3.5. Noise levels in experimental datasets were also quantified by comparing
the maximum of the signal amplitude to the standard deviation of the baseline
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Figure 3.4: Polynomial and finite difference conduction velocity (CV)
measurement in ideal, no noise, datasets A) Measured CV as a function of
model conduction velocity using the polynomial (black) and finite difference (grey)
methods for calculating local CV at window size of i)3x3, ii)5x5 and iii)7x7 pixels.
B) Measured CV heterogeneity as a function of model conduction velocity using
the polynomial (black) and finite difference (grey) methods for calculating local CV
at window size of i)3x3, ii)5x5 and iii)7x7 pixels
(i.e. in an analogous manner to how noise was simulated in the model datasets).
Experimental noise levels ranged from 9 to 19%, as shown in the blue shaded
areas in Figure 3.5. At these noise levels, the polynomial method is more accurate
than the finite difference method across the window sizes tested.
3.4.2 Finite difference and polynomial surface comparison in
experimental datasets
To compare the two methods for measuring local vectors, conduction was
quantified from Di-4-ANEPPS loaded mouse left atria (n=14). These
experiments were performed using the methods described in section 2 by Simon
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Figure 3.5: Polynomial and finite difference conduction velocity
measurement accuracy as a function of signal noise A) Measured CV as a
function of signal noise in model of isotropic conduction with conduction velocity
50cm/s using the polynomial (black) and finite difference (grey) methods for
calculating local CV at window size of i)3x3, ii)5x5 and iii)7x7 pixels.
Wells, and not by the author of this thesis. Activation maps were generated for
each atrium by measuring the time of depolarisation midpoint at 10Hz pacing
under normoxic (95%O2/5%CO2) and hypoxic (95%N2/5%CO2) conditions. CV
was then quantified from ‘local’ regions of 3x3 pixels of allow direct comparison
between the polynomial and finite difference methods. Mean measurements
showed a small difference in measured CV (Figure 3.6A Polynomial =
51.8±2.8cm/s, finite difference = 54.25±2.8cm/s, P=0.027) between the two
methods. Additionally, the finite difference method resulted in greater CV
heterogeneity, measured as standard deviation from the mean in each atria
(Figure 3.6B, polynomial = 21.3±1.6cm/s, finite difference = 32.9±2.4cm/s,
P<0.0001).
One of the benefits of the multi-vector methods is the automatic directional
information that can be simultaneously quantified alongside CV from the angular
direction of the local vectors. Here, it is observed there is no difference between
the methods in terms of mean direction of conduction (Figure 3.6C) or angular
heterogeneity (Figure 3.6D). The finite difference method is less computationally
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Figure 3.6: Comparison of polynomial and finite difference multi-vector
conduction velocity (CV) quantification methods A) Mouse left atrial mean CV
as measured using polynomial and finite difference method. B) CV heterogeneity
(measured as standard deviation of the mean) as quantified by the two methods.
C) Mean propagation direction as quantified using polynomial and finite difference
method. D) Angular heterogeneity (measured as standard deviation of the mean)
as quantified by the two methods. E) Computation time to quantify CV by the two
methods. F) Mean CV under normoxic and hypoxic conditions at 3Hz pacing as
quantified by the polynomial (i) and finite difference methods (ii). n=14, *p<0.05,
*** p<0.01, ***p<0.0001.
intensive than the polynomial method, calculating the same number of local
vectors across the activation maps in 31.6±1.8% of time taken using the
polynomial method (Figure 3.6E) and importantly, both methods successfully
measured CV slowing induced by hypoxia (Figure 3.6F).
3.4.3 Discussion and conclusion on local conduction velocity
vector quantification methods
As shown in Figure 3.5A, the polynomial method is more accurate in quantifying
conduction from activation maps generated from signals with similar noise levels
as observed in experimental recordings. Hence, it is used as the default
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conduction analysis method in the ElectroMap software and for CV quantification
in this thesis. Despite this, and the discrepancies in mean CV and increased
heterogeneity, the simpler implementation of the finite difference method makes
it an attractive alternative to the polynomial method. Automatically calculated
conduction directionality (Figure 3.6C-D) remains consistent between the two
methods and changes in CV are successfully resolved (Figure 3,6F). Crucially,
this is achieved at much shorter timescales (Figure 3.6E) than when using the
polynomial method, showing the finite difference method could be applicable to
studies such as single beat investigation of conduction over long experimental
timescales.
3.5 Testing of baseline correction methods
Polynomial approaches have been suggested as methods to reduce
non-physiological changes in fluorescent signal baselines from optical signals
[14]. However, previous studies have suggested that linear top hat filtering may
be a more robust method for baseline correction [15]. Here, a structuring
element of given length is utilised so that changes with a time period less than
the kernel length are removed [15].
To test the efficacy of top-hat baseline correction compared to polynomial
methods, 17 signals from voltage optical mapping datasets of mouse left atria
were baseline corrected by both methods (including 4th and 11th degree
polynomials). Top hat filter length was 100ms. Successful baseline correction
was quantified as root mean square error (RMSE) compared to an ‘ideal’ flat
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Figure 3.7: Baseline correction testing. A) Root mean square error of optical
voltage signal baselines (n=17) against an ideal flat baseline after 4th degree
and 11th degree polynomial and top-hat filtering baseline correction. B) Example
of baseline detection (red) using 11th degree polynomial and top-hat filtering in
an optical voltage signal with a varying baseline (long timescale) and a short
timescale artefact.
baseline during diastolic periods, with lower RMSE representing better baseline
correction. This demonstrated that top-hat filtering outperformed 4th degree
polynomial filters (P=0.0472, Figure 3.7A) and, although not significantly
outperforming the 11th degree polynomial method on RMSE measure
(P=0.1688, Figure 3.7A), was more adept in detecting sharp events such as
bubble artefacts (Figure 3.7B).
To further test efficacy of top-hat method, baseline decay was introduced to
simulated data with a sinusoidally changing function with period of 1000 frames
(1013ms) and compared to a similar dataset on a flat baseline. 10% noise was
also added to both datasets, to match noise levels observed in experimental
data. Application of a top-hat filter with a length of 100 frames (101.3ms)
accurately identified and corrected for the baseline shift (Figure 3.8A), resulting
in similar activation patterns and action potential morphologies values (Figure
3.8B-C).
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Figure 3.8: Baseline correction of simulated data. A) Example trace from
dataset where baseline drift has been artificially added. The baseline has then
been detected and then corrected for using top-hat correction method within
ElectroMap. B) Activation maps generated from simulated data with flat baseline
(black) and baseline corrected data (red) as shown in A. C) Example simulated
action potentials from the two datasets, post baseline removal.
3.6 Chapter summary
In this chapter, the development, application and use of an MATLAB based
software, ElectroMap, for analysis of optical mapping data has been presented.
Key developments within the software included automated pacing cycle length
detection and standalone modules for analysis of pro arrhythmic phenomena
including conduction changes and alternans. Algorithms were tested in silico
datasets, mouse and guinea pig optical mapping datasets.
This software package has been used for all analysis of optical mapping data
presented in this thesis, unless stated otherwise.
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Chapter 4
Optical mapping of optogenetic models
This chapter describes work undertaken on combination of optical mapping of
cardiac samples with optogenetic manipulation. Optogenetics refers to the use
of genetically encoded photosensitive ion channels or pumps to allow optical
control of tissue excitability, including initiation, suppression and modulation of
electrical activity of cardiac tissue. Likewise, fluorescent indicators can also be
genetically encoded. Combination of optogenetic techniques with optical
mapping gives rise to ’all-optical’ electrophysiology, allowing precise optogenetic
actuation of cardiac tissue with high spatio-temporal resolution imaging of action
potential and calcium transient morphology and conduction patterns. This
makes all-optical experiments a unique and powerful research platform.
The presented work consists of two published articles. The first (section 4.1) is a
technical review of combined optogenetic and optical mapping systems. With the
necessity of multiple light paths in all-optical setups, the combination of optical
mapping and optogenetics is not straightforward. Therefore, a thorough review of
current techniques to achieve such a setup was undertaken.
The second article (section 4.2) presents optical mapping analysis of mouse
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sinoatrial nodal preparations which cell specifically express channelrhodopsin2,
a light sensitive cation channel. These preparations are shown to be robustly
paced by blue light. Using optical mapping of voltage and calcium sensitive
dyes, we were able to thoroughly analyse the electrical behaviour of these
preparations both in intrinsic and optical pacing conditions, including activation
dynamics and calcium transient morphology.
Analysis was conducted using the ElectroMap software (Chapter 3) making use
of several of the features in the software. Conduction module was utilised to
thoroughly probe the effects of optical pacing on the activation dynamics within
the sinoatrial nodal preparations, including identification of earliest activation
time, tissue activation curve analysis, conduction velocity quantification, and
directionality analysis. Waveform morphology was applied to study calcium
transient rise times and duration, while frame removal options where employed
to remove optical pacing artefacts. Hence, development of the software made
previously difficult to apply analyses routinely employable.
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4.1 Cardiac Optogenetics and Optical Mapping –
Overcoming Spectral Congestion in All-Optical Cardiac
Electrophysiology
Publication 2.
This review article was originally published in Frontiers in Physiology.
Cardiac Optogenetics and Optical Mapping – Overcoming Spectral Congestion in
All-Optical Cardiac Electrophysiology (Review). C O’Shea, A P Holmes, J Winter,
J Correia, X Ou, R Dong, S C He, P Kirchhof, L Fabritz, K Rajpoot, D Pavlovic.
Front. Physiol. 10:182, 1-14, 2019
Author contributions in publication 2
I conducted the literature review, wrote the manuscript and produced the figures.
The primary manuscript was then reviewed and edited by all authors.
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Optogenetic control of the heart is an emergent technology that offers unparalleled
spatio-temporal control of cardiac dynamics via light-sensitive ion pumps and channels
(opsins). This fast-evolving technique holds broad scope in both clinical and basic
research setting. Combination of optogenetics with optical mapping of voltage or
calcium fluorescent probes facilitates ‘all-optical’ electrophysiology, allowing precise
optogenetic actuation of cardiac tissue with high spatio-temporal resolution imaging
of action potential and calcium transient morphology and conduction patterns. In
this review, we provide a synopsis of optogenetics and discuss in detail its use
and compatibility with optical interrogation of cardiac electrophysiology. We briefly
discuss the benefits of all-optical cardiac control and electrophysiological interrogation
compared to traditional techniques, and describe mechanisms, unique features and
limitations of optically induced cardiac control. In particular, we focus on state-of-the-art
setup design, challenges in light delivery and filtering, and compatibility of opsins with
fluorescent reporters used in optical mapping. The interaction of cardiac tissue with light,
and physical and computational approaches to overcome the ‘spectral congestion’ that
arises from the combination of optogenetics and optical mapping are discussed. Finally,
we summarize recent preclinical work applications of combined cardiac optogenetics
and optical mapping approach.
Keywords: optogenetic, optical mapping, fluorescence, cardiac, action potential, calcium, conduction (action
potential), arrhythmias
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INTRODUCTION
Over the past 30 years high resolution camera technologies and
development of several potentiometric and intracellular calcium
sensors has led to optical mapping becoming a valuable tool in
cardiac research (Salama et al., 1987; Boukens and Efimov, 2014).
Electrical conduction, action potential and calcium transient
morphology can be directly measured, quantified, and tracked
across multicellular cardiac preparations in high spatio-temporal
resolution, unparalleled by traditional electrode techniques
(Herron et al., 2012; Yu et al., 2014). Optical mapping has
hence played a pivotal role in cardiac research, providing several
insights into physiology and pathophysiology of the heart (Jalife,
2003; Myles et al., 2012; Syeda et al., 2016; Winter et al., 2018).
Conversely, optogenetics shifts light to an actuator role to
control and tune EP behavior through genetically introducing
photosensitive ion channels and pumps (opsins), able to
depolarize and hyperpolarize excitable cells. This emergent
technology, with its foundations in neuroscience, is now
increasingly exploited by heart researchers. Optogenetic pacing
of cardiac preparations has now been reported in several
experimental models (Park et al., 2014; Vogt et al., 2015;
Zhu et al., 2016; Nyns et al., 2017). Beyond rhythm control,
optogenetics has been used to terminate arrhythmias in both
ex vivo and in vivo rodent hearts (Bruegmann et al., 2016,
2018; Nyns et al., 2017), suppress and manipulate rotors in
cardiomyocyte monolayers (Feola et al., 2017; Watanabe et al.,
2017) and elucidate the function of both cardiomyocyte (Wang
et al., 2017) and non-cardiomyocyte (Hulsmans et al., 2017)
cellular subpopulations in the heart. Hence, optogenetics presents
a pivotal emergent technology for basic research, while some of its
unique features make it a potentially transformative clinical tool
for both pacing and arrhythmia termination.
Combination of optogenetics with optical imaging of cellular
monolayers and whole hearts allows ‘all-optical’ cardiac EP
investigation (Figure 1); an approach that has seen growing
application in cardiac research (Entcheva, 2013; Nussinovitch
and Gepstein, 2015b; Entcheva and Bub, 2016). Owing to
contactless operation and high spatio-temporal resolution, all-
optical systems are uniquely capable of high throughput control
and study of complex phenomena that can arise in excitable
media. High spatio-temporal understanding of cardiac behavior
in response to optical actuation, aside from providing an
invaluable research tool, is also vital if optogenetics is to transition
to clinical utility.
The requirement and employment of all-optical approach has
been expansively presented in recent reviews (Entcheva and Bub,
2016; Crocini et al., 2017). In the present article, we discuss
the basic tools of optogenetics (opsins), and optical mapping
(voltage and calcium sensors). We focus on their dual use in
all-optical setups, including their mechanisms of action, delivery
to cardiac tissue, spectral compatibility and highlight technical
considerations and advances that have made all-optical systems
practical. Additionally, benefits of all-optical cardiac control
and EP interrogation when compared to traditional contact
techniques are discussed, and we highlight recent applications of
combined cardiac optogenetics and optical mapping approaches.
TOOLS OF OPTOGENETICS – OPSINS
The development of optogenetics as a valuable research tool
stems from the discovery and cloning of microbial opsins that
behave as light-gated ionic channels in the early to mid-2000s –
Channelrhodopsins (Nagel et al., 2003, 2005; Boyden et al.,
2005). In particular Channelrhodopsin2 (ChR2), and variants
thereof, is by far the most utilized opsin in optogenetics. On
excitation by blue light (∼470 nm) of threshold irradiance, ChR2
opens as its covalently bound photosensitive chromophore, all-
trans retinal, isomerizes (Nagel et al., 2003). The opening of
the channel allows ions, including Na+, to cross the cellular
membrane, as occurs in phase 0 of the action potential, initiating
depolarization. Hence, cells expressing ChR2 can be effectively
stimulated with blue light, initiating and/or prolonging the action
potential (Figure 2A). As well as being light sensitive, ChR2 also
acts in a voltage dependent manner, with decreasing conductance
at more positive membrane potentials and a reversal potential
near 0mV (Lin, 2010; Park et al., 2014).
Enhancement of the native properties of ChR2 is vital for
the future use of optogenetics in cardiac tissue, due to relatively
small currents generated by wild type ChR2 (steady state current
∼0.25 nA) and large absorption and scattering of visible light
by biological chromophores. This limits optical penetration
depth, preventing transmural opsin activation from deep tissue.
Deep activation would be advantageous for synchronous cardiac
activation and has been demonstrated as an important factor
in successful re-entry termination (Karathanos et al., 2016;
Watanabe et al., 2017). One possible method to realize deep
tissue activation is red-shifting of the excitation window toward
the ‘biological window’ of 650–1350 nm, where the extinction
coeÿcient of biological tissue is greatly reduced (Smith et al.,
2009). Light in this wavelength range can penetrate a few
centimeters into the cardiac tissue and thus more light can
reach and activate deep tissue opsins. Furthermore, decreasing
the threshold irradiance required for photocurrent activation
and/or increasing channel conductance or opening times, can
aid deep tissue activation and reduce energy requirements in
optogenetic applications.
Hence, since its isolation and cloning, ChR2 has undergone
several alterations including variants with enhanced conductance
[ChR2-H134R (Nagel et al., 2005), ChR2-T159C (Berndt
et al., 2011), ChR2-XXL (Dawydow et al., 2014)], Ca2+
permeability [CatCh (Kleinlogel et al., 2011)] and red shifted
spectral properties [ReaChR (Lin et al., 2013)]. Additionally,
channelrhodopsins separate from ChR2 have been cloned from
distinct algae species and subsequently optimized [CheRiff
(Hochbaum et al., 2014)], while chimeras of ChR1 and ChR2
have also demonstrated enhanced photocurrents [ChIEF (Lin
et al., 2009)]. These developments have led to a plethora of
available depolarizing opsins with diverse spectral and kinetic
properties (Schneider et al., 2015). Equally, it has been shown
how exogenously supplemented all-trans retinal can significantly
increase light sensitivity of ChR2, although concentration
dependent cytotoxic effects were also observed (Yu et al., 2015).
An important factor in enhancing the photocurrent of native
Channelrhodopsins is the effects mutagenesis can have on the
Frontiers in Physiology | www.frontiersin.org 2 March 2019 | Volume 10 | Article 182
fphys-10-00182 March 5, 2019 Time: 18:21 # 3
O’Shea et al. Cardiac Optogenetics and Optical Mapping
FIGURE 1 | All-optical electrophysiology. Cardiac preparations treated with opsins and sensors allow simultaneous optically driven control of the heart (pacing or
modulation of the action potential) and optical recording of action potential or calcium handling across the myocardium.
photocycle kinetics. By prolonging channel opening times after
the cessation of light activation, light sensitivity can be improved
by a short pulse leading to a long-lasting photocurrent, e.g.,
ChR2-D156A which exhibits a dark off time of > 150 s (Bamann
et al., 2010). However, significant slowing of the channel kinetics
is detrimental to dynamic initiation and control of membrane
perturbation. Therefore, the channelrhodopsins that have found
most use in all optical setups (ChR2-H134R, CatCh, ReaChR,
and CheRiff) are those whose enhanced photocurrents have been
achieved with only moderate prolongation compared to wild type
ChR2, which exhibits on and off time constants of ∼0.2 and
∼10 ms respectively (Nagel et al., 2003).
Aside from depolarizing Channelrhodopsins, hyperpolarizing
opsin pumps include halorhodopsin Cl− pumps (e.g., eNpHR3.0)
and bacteriorhodopsin proton pumps (e.g., Arch and ArchT)
(Kandori, 2015). Hyperpolarizing opsins allow selective
suppression and shortening of action potentials (Figure 2B),
and have been utilized for applications such as suppressing
in vivo cardiac motion for high resolution imaging in
zebrafish (Mickoleit et al., 2014). Thanks to distinct absorption
characteristics in comparison with ChR2, a cardiac preparation
expressing both depolarizing and hyperpolarizing opsins can be
selectively stimulated and silenced simply by tuning illumination
wavelength, thereby allowing comprehensive control of the
action potential. While opsins can be expressed independently,
gene-fusion enables formation of protein complexes such as
ChR2-ArchT, allowing co-localization and bi-directional control
of membrane voltage with one protein complex (Nussinovitch
et al., 2014; Streit and Kleinlogel, 2018).
Hyperpolarizing pumps suffer from restricted photocurrent
as one ion is transported per absorbed photon (Berndt et al.,
2011). Anion channelrhodopsins (ACRs), with the potential
for enhanced conductance driven instead by electrochemical
gradients, were first realized by mutation of channelrhodopsins
to infer Cl− conductance, although with some remaining cationic
conductance and slowing of the channel kinetics (Berndt et al.,
2014; Wietek et al., 2014). Subsequently, naturally occurring
ACRs with reduced cationic conductance have been discovered
and cloned (Govorunova et al., 2015). Preliminary studies
indicate that reduced light intensities are required to optically
induce hyper- and repolarizing currents in cardiomyocytes using
these novel ACRs, compared to pumps (Govorunova et al., 2016).
Greater structural and functional understanding of both natural
(Kim et al., 2018) and designed (Kato et al., 2018) ACRs promises
further optimization of inhibitory channels.
Prolonged use and activation of inhibitory pumps or channels
based on conductance of H+ or Cl− can detrimentally alter
intracellular ionic concentrations (Alfonsa et al., 2015; Bernal
Sierra et al., 2018). One promising avenue to potentially
circumvent this limitation is the development of tools which
more closely mimic the resting and repolarization mechanisms
of excitable cells via light activated K+ conductance. Several
approaches have now been tested, including recently published
PAC-K constructs which combine a cAMP-gated K+ channel
with photo-activated nucleotidyl cyclase, allowing optical
silencing of cardiomyocyte (and neuron) activity (Bernal Sierra
et al., 2018). These constructs, however, do not currently allow
for fast responsive control of membrane potential, eliciting
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FIGURE 2 | Optogenetic control of the cardiac action potential. (A) Opsins such as channelrhodopsins, by conducting cations such as H+, Na+, K+, Ca2+ on light
activation, can depolarize the cell membrane and hence initiate or prolong the cardiac action potential. (B) Hyperpolarizing opsins such as Halorhodopsins (Cl−
pumps), Bacteriorhodopsins (H+ pumps) and Anion Channelrhodopsins (I−, Br−, Cl−, F− channels) can shorten or completely suppress the action potential.
hyperpolarization lasting minimally for 100 ms, preventing
dynamic control during the action potential.
Delivery of Opsins in Cardiac Tissue
Optogenetic control requires reliable, rapidly responsive, and
reversible generation of depolarizing and hyperpolarizing
currents by the expression of the light gated ionic transport
proteins. The first barrier to achieving cardiac optogenetic
perturbation therefore is effective delivery and expression of
desired opsins in cardiac preparations. Pioneering cardiac
optogenetic studies in 2010 transgenically expressed ChR2 in
zebrafish (Arrenberg et al., 2010) and mouse (Bruegmann et al.,
2010). ChR2 expressing mouse lines remain prevalent (Quiñonez
Uribe et al., 2018) and interventions such as Cre recombinase
allow powerful research strategies (Wang et al., 2017).
However, requirement for transgenic expression of opsins
is costly, time-consuming and limits clinical application of
optogenetics (Knollmann, 2010). Therefore, other techniques
have been explored exploiting tandem-cell-unit (Jia et al., 2011)
and viral (Abilez et al., 2011; Vogt et al., 2015) delivery of
ChR2 and other opsins. Tandem-cell-unit delivery centers on
the concept where previously non-excitable cells, transfected
to express ChR2, are grafted into cardiomyocyte preparations.
The cells couple to the cardiomyocytes via gap junctional
proteins and act as ‘sparks,’ initiating depolarization of coupled
cardiomyocytes on light stimulation (Jia et al., 2011).
In viral delivery, opsin genes are encoded in lentiviruses,
adenoviruses, or adeno-associated viruses (AAV). Viral methods
allow for tissue or cell selectivity, depending on the promoter
used, and can be directly injected to realize light excitability.
Importantly for future clinical utility of optogenetics, there is
increasing evidence that AAVs can be safely and eÿc aciously
used in the heart (Bera and Sen, 2017) and systemic viral delivery
can be used to promote cardiac specific ChR2 expression in vivo
(Ambrosi et al., 2019). In wild type mice for example, AAV
injection has shown to result in stable and long lasting ventricular
(Vogt et al., 2015; Bruegmann et al., 2016) and atrial (Bruegmann
et al., 2018) expression of ChR2. However, transfection rates and
consequently optical sensitivity remain variable between treated
hearts, and there is some evidence of chamber discrepancies
with atrial transfection rates lower than ventricular (Vogt et al.,
2015; Bruegmann et al., 2016, 2018). Hence, extensive effort is
ongoing to realize the most effective method to introduce optical
excitability to cardiac tissue (Ambrosi et al., 2015).
Reports that high-level expression of lentiviral-delivered ChR2
in NRVMs is associated with cytotoxicity also need to be carefully
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considered if translational potential of this technology is to
be fully realized. The mechanisms underpinning cytotoxicity
are unclear, with Ca2+ overload and membrane damage being
implicated (Li et al., 2017). Further work on mechanistic insight
into cytotoxicity is required to ensure safe use of ChR2 and other
opsins in cardiac optogenetics.
OPTICAL VOLTAGE AND CALCIUM
SENSORS
Synthetic Sensors
A range of sensors are utilized in optical mapping to image
transmembrane voltage, as well fluctuations in cytosolic
and sarcoplasmic reticulum Ca2+ concentrations (Broyles
et al., 2018). Synthetic sensors are small molecules that
are most commonly introduced to ex vivo hearts via
Langendorff perfusion, or via superfusion to both in vitro
and ex vivo preparations.
The most popular voltage sensors are ‘fast’ synthetic styryl
sensors, such as di-4-ANEPPS and rh-237, which embed within
the plasma membrane, Figure 1. As the transmembrane voltage
changes, for example during the cardiac action potential, these
sensors exhibit fast responding (femto- to picosecond) spectrally
shifted fluorescent output due to shifts in charge state and hence
dipole energy levels (electrochromism) (Loew et al., 1978; Miller,
2016). Longpass filtering the emitted fluorescence beyond the
emission spectra maximum therefore allows recording of optical
signals exhibiting fluorescence intensity proportional to cellular
membrane voltage changes, i.e., optical action potentials (OAP)
(Herron et al., 2012).
On the other hand, intracellular Ca2+ sensors such as rhod-
2AM are designed to internalize within the cell, Figure 1.
They are commonly esterified to neutralize the charge, aiding
intracellular uptake. The ester is then enzymatically cleaved once
in the cell, leaving behind a Ca2+ chelator and a fluorophore. As
Ca2+ is chelated, fluorescence output increases, and subsequently
decreases upon dissociation, reporting the changing [Ca2+] in
the intracellular space where the sensor localizes, either in the
cytosol or sarcoplasmic reticulum (Jaimes et al., 2016).
Genetically Encoded Sensors
Alternatively to small molecule synthetic sensors, voltage and
calcium responsive protein sensors can be genetically encoded to
achieve cell specific indicator expression (Liao et al., 2015; Quinn
et al., 2016). These are collectively termed genetically encoded
voltages/calcium indicators (GEVIs/GECIs), constructed by
the fusion of voltage/Ca2+ sensitive and fluorescent proteins
(Scanziani and Häusser, 2009). Genetic indicators can be used
to independently measure voltage or Ca2+, but can also be
fused to create dual voltage-calcium constructs such as CaViar
(Hou et al., 2014) which combines QuasAr2 (GEVI) with
GCaMP6f (GECI). Furthermore, co-expressed indicator and
actuator pairs offer a unique ability to provide all-genetic, all-
optical electrophysiological study (Chang et al., 2017). The
“Optopatch” platform for example combines genetic indicators
with CheRiff and has been utilized both in establishing all-optical
mouse lines and as a high throughput cardiotoxicity screening
platform for all-optical pacing with simultaneous voltage and
intracellular calcium measurement (Hochbaum et al., 2014;
Dempsey et al., 2016; Björk et al., 2017).
Synthetic vs. Genetically Encoded
Sensors
Genetic indicators rely on conformational changes to directly
alter their fluorescence response or via eliciting processes such
as Forster resonance energy transfer (FRET). Consequently,
compared to the ‘fast’ small-molecule sensors, an important
limiting factor of current genetically encoded indicators is their
response times which are typically in the order of milliseconds
(Kaestner et al., 2015). This can prove problematic when
measuring the sub millisecond phenomena involved in cardiac
depolarization, repolarization and calcium handling (Koopman
et al., 2017). Indeed, OAPs recorded by genetic indicators exhibit
a significantly altered morphology compared to simultaneously
measured OAPs using syntenic sensors (Shinnawi et al., 2015).
Coupled to this, the relatively straightforward application to
ex vivo and in vitro preparations makes synthetic sensors more
commonly utilized in optical mapping studies (Herron et al.,
2012), and to date the pioneering all-optical setups (Table 1).
Synthetic sensors will non-specifically stain all the cell
subpopulations in cardiac preparations. In contrast, genetic
sensors can be successfully utilized in vivo and in vitro to
cell specifically stain cardiomyocytes (or other cell types) (Hou
et al., 2014; Dempsey et al., 2016). They hence allow long-
term, cell specific, imaging of electrical and calcium activity,
currently not possible with synthetic sensors. Furthermore,
synthetic sensors suffer from internalization, phototoxicity and
cytotoxicity making them only suitable for short-term imaging
of cardiac preparations (Kaestner et al., 2015). The extent
to which synthetic sensors exhibit toxicity is dependent on
study specific parameters including experimental model, sensors
concentration and illumination protocols. For example, di-4-
ANBDQBS has been shown to exhibit little phototoxicity even
at high illumination intensities (Kanaporis, 2012). In this case,
the sensor was loaded into guinea pig ventricular preparations
and illumination time was restricted to 1 min. In other studies,
continuous illumination of di-4-ANBDQBS for 10 min showed
significant phototoxic effects compared to a genetic sensor
in both human induced pluripotent stem cell cardiomyocyte
monolayers (Shaheen et al., 2018), and single cells (Streit and
Kleinlogel, 2018). Thus, both of these studies suggest that despite
their slower response kinetics, GEVIS and GECIs are valuable
tools not only for in vivo study but also in situations where
phototoxic effects are prominent, such as cellular monolayers
and single cells (Fast and Kléber, 1994; Broyles et al., 2018;
Streit and Kleinlogel, 2018).
DESIGNING AN ALL-OPTICAL SETUP
The development of a successful all-optical system relies on
a number of key features, unique when compared to single
purpose, single cell, optical mapping or optogenetic setups.
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Light must be delivered to both the opsins and the voltage or
calcium sensors, demanding distinct illumination characteristics.
The possibility of illumination crossover necessitates careful
consideration of sensors, actuators and filtering requirements.
Table 1 summaries opsin-sensors combinations that allow
stimulation of optical actuation, control and imaging in pivotal
all-optical studies.
Opsin and Sensor Compatibility
For an all-optical system, the compatibility of opsins with voltage
and Ca2+ sensors is paramount, as spectral overlap will result in
unwanted crosstalk and perturbation of the cellular membrane.
For example, the absorption spectra of the most commonly used
synthetic voltage sensor di-4-ANEPPS (excitation peak = 475nm)
overlaps with that of ChR2, Figure 3. Therefore, excitation
of di-4-ANEPPS to optically measure voltage can also excite
ChR2, perturbing the membrane potential (Park et al., 2014).
With this spectral congestion in mind, it is not surprising
that the pioneering all-optical setups imaging Ca2+ routinely
used rhod-4AM (Jia et al., 2011), which exhibit less spectral
overlap with ChR2.
The use of opsins or sensors with red-shifted absorption
profiles is the most common solution to spectral congestion. In
general, it is easier for an all-optical system to utilize a red-shifted
sensor, as the further red-shift of fluorescence emission can
then be simply long-pass or band-pass filtered before imaging.
Pittsburgh I (PGH1) is a potentiometric sensor whose absorption
and emission spectra are far red shifted in comparison to di-
4-ANEPPS, with an excitation and emission peak of 608 and
880 nm respectively (in EtOH) (Salama et al., 2005). It was hence
the first sensor used in an all-optical manner with concurrent
opsin excitation and voltage mapping (Park et al., 2014). By
allowing opsin excitation with simultaneous voltage mapping,
this system demonstrated how optogenetics can be used to not
only pace cardiac tissue but crucially also prolong the action
potential by ChR2 excitation during repolarization, a potential
FIGURE 3 | Excitation spectra of the depolarizing opsin ChR2-H134 and
voltage sensitive sensors di-4-ANEPPS and di-4-ANBDQBS. Significant
overlap exists between the excitation spectra of ChR2 and di-4-ANEPPS,
preventing imaging of di-4-ANEPPS without perturbing the membrane
potential of ChR2 expressing cells. However, the red-shifted spectra of
di-4-ANBDQBS does allow for excitation without simultaneous
activation of ChR2.
therapeutic approach (Karathanos et al., 2014), or silence activity
by eNpHR3.0 driven hyperpolarization (Park et al., 2014).
Alongside PGH1, there are red-shifted variants of di-4-
ANEPPS. They include di-4-ANBDQPQ and di-4-ANBDQBS,
which share the same basic structure as di-4-ANEPPS but with
a distinct chromophore and longer linker sizes. The result is red-
shifted absorption and emission spectra, both effectively excited
between 500 and 700 nm (Figure 3) and imaged from 700
to 900 nm (Matiukas et al., 2007). They are hence spectrally
distinct from ChR2. Additionally, ‘blue-shifted’ opsins are being
developed (Lam et al., 2017) which may help avoid spectral
overlap, however, their use may be limited by tissue damage and
penetration depth.
PGH1, di-4-ANBDQPQ, di-4-ANBDQBS and rh-1691 have
all been successfully used in all-optical setups due to their
favorable spectral properties. Table 1 lists potentiometric and
calcium sensors used concurrently with optogenetic control
and gives examples of illumination and filter setups (discussed
in more detail later) that have been employed to minimize
actuator-sensor crosstalk. Despite spectral overlap, sensors such
as di-4-ANEPPS and GCaMP based calcium indicators have
also been used in all-optical setups. However, dual-excitation,
and fluorescence baseline shifts on pulse excitation, result in
the requirement for spatial separation between excitation and
emission areas, or need for extensive pre- and post-acquisition
filtering (Dempsey et al., 2016; Li et al., 2017; Wang et al., 2017).
Illumination Sources
For optical mapping, sensor excitation is most commonly
achieved using LEDs which benefit from narrow wavelength
spectra, long operational lifetimes and low heat emission
(Beacher, 2008), though Tungsten-Halogen lamps,
Mercury/Xeon arc lamps and lasers are also used. Illumination
source is chosen based on a number of characteristics, including
wavelength and power. However, illumination of the sample
in terms of spatial and temporal homogeneity is of paramount
importance for successful optical mapping. In contrast, optical
actuation in optogenetics routinely requires impulse-like signals
(temporal inhomogeneity) delivered to a specific area of the
sample (spatial inhomogeneity). Additionality, a number of
studies have demonstrated the importance of patterned light
delivery to drive conduction dynamics and realize effective
arrhythmia termination (Burton et al., 2015; Crocini et al.,
2016; Feola et al., 2017). Therefore liquid crystal (Schmieder
et al., 2017) and digital micromirror device (DMD) spatial light
modulation coupled to an illumination source such as an LED,
able to uniquely deliver synchronous patterned illumination,
have been extensively used in cardiac optogenetics from its
infancy (Arrenberg et al., 2010). DMDs utilize several hundred
thousand or millions of hinged micrometer sized mirrors to
deliver illumination patterns with high spatial resolution, an
ability that has been key to several optogenetic based discoveries
(Scardigli et al., 2018).
Furthermore, fiber-optic coupled LED (Prando et al., 2018)
and laser-based approaches have been utilized. This has partially
been driven by the potential to incorporate illuminating fibers
in clinically used tools for precise spatial illumination in vivo
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(Klimas and Entcheva, 2014). Devices incorporating micro LED
illumination with photodetectors have also been developed
(Xu et al., 2014), and further optimization of such unique
light delivery strategies is crucial if latent clinical benefits of
optogenetics are to be realized.
Optical Filtering
The use of compatible opsins and sensors to avoid spectral
overlap has already been discussed. However, optical filtering
is still crucial in effective excitation and imaging of samples,
especially when considering the multiple light paths necessary
in the majority of all-optical setups. Single wavelength filters
utilized in all-optical setups can be broadly characterized as
(i) Bandpass filters (ii) Long- or shortpass filters, and (iii)
Dichroic mirrors/beam splitters (Figure 4). An idealized single
wavelength bandpass filter (Figure 4A) absorbs wavelengths
outside a defined window, characterized by a central wavelength
(CWL) and full width half maximum (FWHM). A common use
of bandpass filters in all optical setups is excitation filtering,
where illumination light is filtered before reaching a sample to
narrow spectral bandwidth with a relatively small FWHM filter.
This helps avoid interference with other sensors or actuators
(Jaimes et al., 2016). For example, an effective excitation filter for
red shifted voltage sensor di-4-ANBDQPQ may be a 640/40 nm
(CWL/FWHM) bandpass filter (Scardigli et al., 2018), placed
between the illumination source and sample.
Longpass filters (Figure 4B) will absorb light with a
wavelength below the CWL but will transmit light above this
threshold (with the opposite holding for a shortpass filter with the
same CWL). They therefore do not have an associated FWHM
and are most used as emission filters, absorbing excitation
light wavelengths while conserving the red-shifted fluorescence
emission (Park et al., 2014). In conjunction with removing
excitation light, longpass filtering is also necessary to effectively
measure voltage dependent signals that arise from spectral shift,
e.g., the electrochromic based indicators previously discussed,
as the fluorescence must be imaged away from the emission
maxima. Bandpass filters with red-shifted CWL compared to
excitation wavelengths (and emission maxima if required) can
also be used for emission filtering, i.e., between the sample
and imaging device. For an effective emission bandpass filter,
however, a large FWHM is often desirable to maximize the
photon count at the imaging device, assuming absorbance of
excitation light is maintained (Scardigli et al., 2018). Table 1
summaries excitation and emission filtering setups that have been
implemented in all-optical setups encompassing both voltage and
calcium indicators.
Bandpass and longpass filters interact with light by either
absorbing or transmitting depending on wavelength. Dichroic
mirrors (or beam splitters), however, reflect certain wavelengths
of light. An idealized longpass dichroic mirror for example
(Figure 4C) transmits light with wavelength above the CWL
and reflects (often at an angle of incidence of 45o) wavelengths
below this cut off. Therefore, aside from basic filtering that is also
possible to achieve with longpass and bandpass filters, dichroic
mirrors can be used for important functions such as directing
light paths (Scardigli et al., 2018) and splitting emission in dual
sensor setups to either separate cameras or sections of a single
imaging chip (Dempsey et al., 2016; Wang et al., 2017). The filters
outlined in Figure 4 are known as single wavelength or single
band filters, with one characterizing CWL. In contrast, multiband
filters are characterized by multiple transmission wavelength
regions. They have hence found particular utility in dual optical
mapping setups to simultaneously filter voltage and calcium
emission signals (Wang et al., 2015).
Removing Spectral Deconvolution
Requirement
Problems with spectral overlap can be circumvented by utilizing
optical imaging techniques that are not reliant on fluorescent
sensors, i.e., do not require illumination. On initiation of
the action potential, excitable cells exhibit changing light
FIGURE 4 | Example effect of idealized optical filters on ‘white’ light. Arrows indicate path of light with indicated spectra pre and post filtering. (A) Bandpass filter. All
wavelengths of light, other than those within the transmission window are absorbed. (B) Longpass filter. Light with wavelengths above the central wavelength (CWL)
are transmitted, and all other wavelengths are absorbed. (C) Dichroic mirror. As with the longpass filter, light with wavelengths above the CWL are transmitted. Light
with wavelengths below the CWL is reflected at an angle of incidence, commonly 45
◦
.
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scattering properties, changing contrast (Cohen et al., 1972).
However, with well-thought out setup design such as contrast
enhancing off-axis illumination, the optical changes of the
cell have shown to be a useful (although limited) substitute
to direct sensor imaging of transmembrane voltage (Burton
et al., 2015). Although parameters such as action potential
morphology cannot be accurately recovered, sensor free imaging
allows non-invasive tracking of excitation waves through cellular
monolayers, and simple integration with optogenetic actuators
(Burton et al., 2015). More recently, there has been development
of bioluminescent, rather than fluorescent GEVIs such as the
FRET based LOTUS-V (Inagaki et al., 2017). As bioluminescent
output is stimulated chemically by treatment with a substrate
such as Furimazine rather than optically, no illumination is
required. This avoids the need for spectral separation between
any excitation light and actuators present and facilitates long-
term voltage imaging. When expressed in human induced
pluripotent stem cell cardiomyocytes, LOTUS-V has been shown
to deliver comparable, action potential signals to the synthetic
sensor di-8-ANEPPS, although values such as action potential
duration were prolonged due to the slower response kinetics
(milliseconds) of the FRET response compared to the ‘fast’
synthetic sensors (Inagaki et al., 2017). The use of bioluminescent
sensors in all-optical setups may therefore provide an attractive
alternative to fluorescent GEVIs.
Additionally, novel non-genetic techniques for optical cardiac
excitation based on graphene substrates (Savchenko et al., 2018),
x-ray and ultrasound activated nanoparticles (Berry et al., 2015),
or infrared induced temperature gradients (McPheeters et al.,
2017) can act as a solution to spectral overlap and to realize deep
tissue activation. These optical pacing strategies, however, do not
share some of the unique advantages that genetically induced
optical de- and hyperpolarization allows, most prominently
precise control over wave dynamics or cell-specific activation.
Imaging
As with many other areas of the life sciences, cardiac optical
mapping has benefitted from continued advancement of camera
technology. Photodiode arrays (PDAs) were utilized in the
early optical mapping experiments that moved beyond single
photomultiplier tubes (Salama et al., 1987). PDAs benefit from
a large dynamic range (as the PDA is made up of large individual
diodes) and enhanced sampling rates. Low fractional changes in
sensor fluorescence and the sub millisecond dynamics of cardiac
electrical activity make these invaluable features for successful
optical mapping (Efimov and Salama, 2012).
However, due to the physical arrangement of individual
diodes, the maximal spatial resolution of a PDA is more limited
compared to charge-coupled device (CCD) and complementary
metal oxide semiconductor (CMOS) cameras. In modern setups
therefore, CCD and CMOS cameras dominate (Gloschat et al.,
2018; Wen et al., 2018). Developments such as electron-
multiplication in CCD cameras, and 2nd generation back
illuminated ‘scientific’ CMOS cameras have helped improve
dynamic ranges and noise levels of these cameras, while
enhanced compatibility with standard computer interfaces such
as USB-3 help alleviate previously prohibitive costs (Boukens
and Efimov, 2014). Crucially, these cameras offer much
higher spatial resolutions than possible with PDAs, capable of
capturing > 10,000 pixel images at kHz sampling rates (Yu et al.,
2017). The choice of imaging device for an all-optical setup
does not differ considerably from a traditional optical mapping
setup, and PDAs, CCD cameras and CMOS cameras have all
been successfully utilized. Another important consideration is
quantum eÿciency of imaging devices in the far-red to near
infrared wavelengths, if using red-shifted sensors.
Dual Voltage–Calcium All Optical Setups
Optical mapping of preparations dual loaded with both voltage
and calcium sensors offers unique insights into the interplay
between the cardiac action potential and Ca2+ handling (Myles
et al., 2012). Achieving dual voltage-calcium optical mapping
requires careful consideration of sensors spectra and filtering
requirements. Addition of optical actuation, with its unique
spectral, spatial, and temporal illumination requirements, further
complicates the setup. Therefore to date, optical setups utilizing
both voltage and calcium sensors have been shown to image the
two indicators separately or sequentially (Klimas et al., 2016). In
all-optical setups with simultaneous voltage-calcium imaging and
optical pacing, spatial separation was necessary between pacing
site and imaged area (Dempsey et al., 2016).
Computational Post-processing
In lieu of physical methods, computational methods can be
used to overcome the spectral congestion that arises from
optogenetic manipulation of optically mapped samples. However,
it is important to note that these do not overcome undesired
modulation of the membrane potential. A simple example is
automatic identification and removal of optical pacing peaks by
the application of several filters (Feola et al., 2017) or image
frame removal (O’Shea et al., 2019). This is an effective strategy
providing filtering/frame removal does not alter the fluorescence
signal properties at pertinent times, and so ideally requires
either temporal or spatial separation between pulsing peaks and
fluorescence output.
Light pulses, however, can be more prohibitive to optical
mapping analysis if pulses are applied during relevant phases of
the cardiac cycle. For example, when pulses of light are delivered
during the plateau and repolarization of the action potential,
despite optical filtering attempts to avoid crosstalk, blue and
green pulses can cause baseline shift in OAPs. As demonstrated
by Park et al. (2014), to compensate for this, ‘gap compensation’
modeling procedures can be implemented. Briefly, this involves
construction of a perturbation model of the optical emission
(Fbluepulse) like shown in Equation 1
















where Ffit is the model of a control action potential without
blue light illumination, A is a constant, t is time, tpulse is
start time of the light pulse, and τslow and τfast are decay
constants. The repolarization phase of the perturbed OAP
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therefore is modeled by least square fitting a bi-exponential
decay from the start of the blue light pulse allowing recovery
of the OAP during optogenetically induced action potential
prolongation (Park et al., 2014).
CONTACTLESS ACTUATION AND
ELECTROPHYSIOLOGY
Both in basic research and clinically, electrode-based techniques
for pacing and stimulation require direct or close contact to
cardiac tissue. Although extensively exploited and effective, these
actuation methods are not without limitation. The direct contact
between electrodes and tissue can promote electrochemical
reactions and reactive oxygen species formation. Conversely
in some situations, for example in cardioversion strategies
(Nyns et al., 2017) or in cardiomyocyte monolayers to improve
signal quality (Lapp et al., 2017), simultaneous activation
of the large areas is desired rather than at a single site. If
the activation region needs to be changed then electrodes
must be physically moved, limiting spatial flexibility and
throughput. From a clinical perspective, implantable pacemaker
and defibrillation devices are highly energy consuming, tissue
damaging, prone to post-implantation complications and
can cause psychological distress and reduced quality of life
(Bruegmann et al., 2016; Israelsson et al., 2018).
Optogenetic pacing therefore is one of a few biological
strategies being explored as a replacement for traditional
pacemaker devices (Rosen et al., 2011) but undoubtably
its most immediate beneficial quality is the ability realize
unique basic research possibilities. Optogenetic opsins can
be delivered to specific cell types (Hulsmans et al., 2017;
Wang et al., 2017), providing novel research strategies,
and promoting precise, repeatable and coordinated activation
patterns. Conversely, by changing illumination conditions or
the spatial arrangement of opsins expression, simultaneous
excitation/suppression of large areas can be achieved. This can
be applied in cellular monolayers, where concurrent activation
can enhance signal quality, or in cardioversion strategies to
terminate arrhythmias (Bruegmann et al., 2018). Contactless
actuation avoids tissue damage due to the lack of tissue-electrode
interface and can be realized in high-throughput applications
such as multi-well cellular assays, discussed in more detail
later (Klimas et al., 2016).
Optical mapping offers several clear advantages compared
to electrode recording techniques. The spatial resolution
achievable with optical mapping systems greatly outperforms
multi-electrode array mapping systems. Furthermore, optical
imaging can allow detailed, direct and multi-parameter
investigation of voltage and calcium dynamics, whereas electrode
techniques often make indirect measurements such as field
potentials, where signals can be corrupted by noise and can alter
significantly over time due to changes in electrode positioning
or the maintenance of contact. Therefore, despite some
notable disadvantages of optical study including requirement
of contraction uncouplers and inability to perform in vivo
experiments (Boukens and Efimov, 2014), optical mapping
techniques have seen growing use, even prior to transformative
capabilities of optical stimulation was made available. The
recent combination of actuation and measurement in all-optical
setups has therefore, in a relatively short timeframe, delivered
remarkable insights into optogenetic pacing (Nussinovitch
and Gepstein, 2015a), cell targeting (Wang et al., 2017) and
arrhythmia termination (Feola et al., 2017); advancing basic
understand and enhancing the prospect of future clinically
relevant optical therapies.
EFFECTS OF LIGHT PACING ON ACTION
POTENTIAL MORPHOLOGY AND
PROPAGATION
For further implementation of optogenetic technologies, detailed
understanding of whether optogenetic actuation affects cardiac
electrical signal morphology is required. All-optical systems
are uniquely advantageous for such investigations, as they are
able to report key EP signal parameters for comparison against
established techniques, while also providing high spatio-temporal
recording of cardiac activation (Entcheva and Bub, 2016).
Recent work using human stem cell-derived cardiomyocytes
expressing commercial optogenetic constructs OptoPatch and
CaViar have demonstrated that optogenetic modulation does
not significantly alter single cell electrophysiological properties
(Björk et al., 2017). Furthermore, optogenetic manipulation
of neonatal rat ventricular myocyte monolayers expressing
ChR2 indicate unaltered conduction velocity, action potential
duration and upstroke velocity compared to control cells,
using either optogenetic or electrical actuation (Li et al.,
2017). Computational insights have for the most part agreed
with experimental findings by showing similar action potential
morphologies and cell type dependent variability (Williams
and Entcheva, 2015). Nevertheless, fundamental differences in
electrical and optogenetic stimulation exist. Electrical current
injection is traditionally achieved with a rectangular pulse
delivered at short pulse widths of 2–10 ms (Myles et al., 2012;
Holmes et al., 2016). ChR2 photocurrent exhibits slower onset
kinetics, meaning longer pulse timescales can be required to reach
excitation threshold (Williams and Entcheva, 2015). The effects
of these stimulation differences on in vitro and in vivo cardiac
electrophysiology require further examination.
APPLICATIONS OF ALL OPTICAL
CARDIAC ELECTROPHYSIOLOGY
All-optical systems, in their relatively short period of existence,
have expanded our understanding of cardiac pathophysiology
thanks to their high spatio-temporal resolution and unique
ability for targeted tissue excitation. Indeed, by optically
mapping voltage in transgenic mice expressing ChR2,
threshold excitation and vulnerable areas for proarrhythmic
focal ectopic activity has been determined (Zaglia et al.,
2015). All-optical setups have allowed demonstration and
potential for utility of ChR2 mediated resynchronization
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(Nussinovitch and Gepstein, 2015a) and have crucially informed
the production of local rather than global areas of conduction
block using patterned illumination. The patterned illumination
shows similar success in arrhythmia termination but at
lower energy costs than global activation (Crocini et al.,
2016; Feola et al., 2017). However, whether optogenetic
approaches confer energy reduction benefits, over established
and effective electrode technologies requires detailed assessment
in future studies.
Previously, optical mapping of arrhythmia dynamics in whole
hearts has allowed mechanistically driven choice of patterned
illumination in an ‘open-loop’ fashion - information based
on previous recordings being used to dictate illumination
patterns. Although this proved similarly effective as global
illumination, there is reliance on consentient arrhythmia
dynamics between hearts (Crocini et al., 2016). However,
recent advancements including utilization of DMD illumination
technology and high-speed data recording have demonstrated
the potential of ‘closed-loop’ all-optical EP. Here, conduction
disorders such as atrioventricular block can be detected by
optical mapping and corrected by optical stimulation of
ChR2 in real time. Real-time intervention can also conversely
be used to setup and then study conduction abnormalities
such as re-entry. These abilities make ‘closed-loop’ systems
potentially vital going forward, allowing all-optical research
in experimental models that is tunable in a manner hitherto
only afforded by computational modeling, and at much
reduced timescales (Scardigli et al., 2018). Similarly, all-
optical control and output has shown the feasibility of
engineering bioelectric tissues capable of complex information
processing and in which all constituent parts are fully
characterized (McNamara et al., 2016).
A major avenue for use of all-optical setups is the delivery
of high-throughput platforms for cardiotoxicity screenings of
candidate drug compounds (Klimas et al., 2016; Streit and
Kleinlogel, 2018). These platforms are crucial in the context
of the comprehensive in vitro pro-arrhythmia assay (CiPA)
initiative – the recognition that cardiotoxicity screening should
not focus solely on hERG channel interactions and must
use experimental as well as computational methods (Fermini
et al., 2016). All-optical methods are distinctly suited to the
changing requirements of cardiotoxicity drug screening. As
highlighted, the lack of requirement for direct contact makes
optical actuation and optical recording much easier to scale to
high-throughput parallelized applications, crucial for screening
multiple drugs. As the reported voltage signals result from
the sum of all ionic currents, significant alterations in any
channel or pump function (not just hERG/IKr) in response
to a drug will be evident, while Ca2+ handling abnormalities
can also be screened with the use of appropriate sensors
(Dempsey et al., 2016; Klimas et al., 2016). If specific channels
warrant further investigation, all-optical methods can still be
utilized by expression of channels in cells otherwise void of
the ionic channels of interest (Streit and Kleinlogel, 2018),
and the scalability of optical methods means analysis of




Optogenetics is a technique that has developed into an immensely
useful tool in basic cardiac research with clear, though as of
yet unrealized, clinical potential (Entcheva, 2013). Fusion of
optogenetics with optical mapping has been made possible by the
substantial technical considerations and advances summarized in
this review. All-optical electrophysiology, and indeed the field
of cardiac optogenetics in general, however, remains a relatively
new technique with several opportunities to further advance our
understanding of electrical function in the heart.
Recent demonstration of ‘closed-loop’ all-optical investigation
opens up a plethora of exciting opportunities for application of
this exciting technology to key research questions, relevant in
health and disease. ‘Closed-loop’ all-optical investigation studies
could deliver faster, more physiologically relevant tools than even
the most sophisticated computational cardiac models.
In contrast to cardiac research, optogenetics is widespread
in neuroscience (Adamantidis, 2015). Effects on heart function
and coupling of neurons and cardiac cells are often measured
outcomes of neuromodulation. However, cardiac effects of
optical neuromodulation are potentially limited to simply
beating rate measurements (Nussinovitch and Gepstein, 2015b)
or monitored using traditional techniques, with only isolated
examples of optical mapping neuronal-cardiac effects (Dong
et al., 2016). The combination of optical neuromodulation
with all-optical cardiac electrophysiology could deliver
unique insights into control of the heart by the nervous
system (Wengrowski et al., 2015).
For optogenetic-based therapy to ever be realized in clinical
practice, several technological and biological advances need
to be implemented. These include novel methods for light
and gene delivery to in vivo cardiac tissue, wireless control
of implantable devices (Gagnon et al., 2017), and advanced
materials uniquely designed for use in bio-integrated electronic
circuits (Fang et al., 2016). However, regardless of future clinical
utility, implementation of optogenetics in all-optical imaging
systems has already proved a unique and transformative tool for
cardiac research and will continue to be used in the study of the
physiology and pathophysiology of the heart.
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Among the animal models for studying the molecular basis of atrial and sinoatrial node 
(SAN) biology and disease, the mouse is a widely used species due to its feasibility for 
genetic modifications in genes encoding ion channels or calcium handling and signaling 
proteins in the heart. It is therefore highly valuable to develop robust methodologies for 
studying SAN and atrial electrophysiological function in this species. Here, we describe 
a protocol for performing dual calcium-voltage optical mapping on mouse sinoatrial 
preparation (SAP), in combination with an optogenetic approach, for studying SAP 
membrane potential, intracellular Ca2+ transients, and pacemaker activity. The protocol 
includes the details for preparing the intact SAP, robust tissue dual-dye loading, light-
programmed pacing, and high-resolution optical mapping. Our protocol provides an 
example of use of the combination of optogenetic and optical mapping techniques for 
investigating SAP membrane potential and intracellular Ca2+ transients and pacemaker 
activity with high temporal and spatial resolution in specific cardiac tissues. Thus, our 
protocol provides a useful tool for studying SAP physiology and pathophysiology in mice.
Keywords: sinoatrial preparation, optogenetic pacing, optical mapping, murine heart, Ca2+ transient
INTRODUCTION
The heartbeat begins in the sinoatrial node (SAN) arising in a subset of nodal cells that display 
a spontaneous diastolic depolarization (Bleeker et  al., 1980). Unique to such automaticity of the 
SAN, pacemaker cells possess “membrane clock” contributions by several membrane currents 
including the funny current, If, carried by hyperpolarization-activated cyclic nucleotide-gated (HCN) 
channels. If is initiated specifically at the initial phase of the diastolic depolarization, following 
the deactivation of outward delayed rectifier K+ current, and triggering the activation of inward 
currents. Inward currents include Na+-dependent background current; the T- and L-type Ca2+ 
currents, ICaT and ICaL; and possibly, sustained inward current, Ist (Lei et  al., 2018). However, more 
recently, intracellular signaling involving the sarcoplasmic reticulum (SR) Ca2+ stores and the 
cellular cAMP levels and consequent phosphorylation of their signaling proteins have also been 
implicated in a “Ca2+ clock” contributing to diastolic depolarization (Lei et  al., 2018). Whereby, 
spontaneous RyR2-mediated Ca2+ release may enhance electrogenic effects of the Na+-Ca2+ exchanger 
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in late diastolic depolarization (Lei et al., 2018). These SR calcium 
release events may be  triggered by calcium-induced calcium 
release following the activation of CaV1.3 calcium channels (Torrente 
et  al., 2016). The relative importance of both the “membrane 
clock” and “Ca2+ clock” in pacemaker function remains controversial.
On the other hand, sinus node dysfunction (SND) associated 
with abnormal impulse formation or propagation in the SAN 
affects ≈1  in 600 cardiac patients aged >65  years and is 
responsible for ≈50% of the 1 million permanent pacemaker 
implants per year worldwide (de Marneffe et al., 1993). Although 
SND occurs most commonly in elderly patients in the absence 
of clinically apparent accompanying cardiac disease (de Marneffe 
et  al., 1993), its pathogenesis is unclear. The development of 
novel pharmacological therapies to cure these patients relies 
on the thorough understanding of both normal physiology 
and pathophysiology of the SAN and atria.
Among the animal models for studying the basic molecular 
mechanisms of the SAN and atrial biology and disease, mice 
are widely used due to their feasibility for modifications in 
the expression of different genes that encode ion channels or 
calcium handling proteins. It is therefore highly valuable to 
develop robust methodologies and techniques for studying SAN 
and atrial electrophysiological properties.
Recent advances in the technique of optogenetics provide an 
unprecedented opportunity for defining specific cell-type function 
in a highly complex multicellular system. The technique has 
enabled control over the activity of one specific cell type while 
leaving others unaltered, with high temporal resolution and cellular 
precision. Since the first demonstrations of utility in mammalian 
neurons in 2005 (Boyden et  al., 2005), optogenetics has spurred 
immense research activity in neuroscience and has extended to 
the cardiac field over the past few years (Entcheva, 2013; 
Nussinovitch and Gepstein, 2015; Boyle et al., 2018). We recently 
deployed a cell-type specific optogenetic approach to study the 
properties of Pnmt+ cell-derived cardiomyocytes in the murine 
heart (Wang et  al., 2017). Additionally, optical mapping using 
fluorescent dyes provides exciting opportunities for high spatio-
temporal study of cellular electrophysiological events, including 
Ca2+ dynamics of the heart (Wang et al., 2017; Wen et al., 2018). 
The combination of these two technologies therefore allows 
development of unprecedented platforms for studying physiological 
events (e.g., voltage and Ca2+ signals) in a selective manner at 
high spatio-temporal resolution (O’Shea et al., 2019b).
In this manuscript, we  describe a detailed protocol for the 
use of optogenetic and optical mapping techniques for 
investigating membrane potential and intracellular Ca2+ transients 
and pacemaker activity with high temporal and spatial resolution 
in sinoatrial preparations (SAPs). The protocol can be a powerful 
tool for studying SAP physiology and pathophysiology using 
the mouse as a model system.
METHODS AND MATERIALS
Animals
Pnmt-cre mice used in this study are as described previously 
(Wang et  al., 2017). Animals used were <6  months old. 
Pnmt-cre/ChR2 mice exhibit cell-type specific expression of ChR2 
by crossing B6.Cg-Gt (ROSA)26Sortm27.1(CAG-COP4H134R/tdTomato) Hze/J strain 
(Stock no. 012567, Jackson Labs) with a Cre transgenic strain 
under the control of a Pnmt promoter (Wang et  al., 2017). 
Channelrhodopsin 2 (ChR2) was specifically introduced into 
murine cells expressing the Phenylethanolamine n-methyltransferase 
(Pnmt) gene, which encodes for the enzyme responsible for 
conversion of noradrenaline to adrenaline. The murine model 
led to the identification of a distinctive class of Pnmt-expressing 
neuroendocrine cells and their descendants (i.e., Pnmt+ cell-derived 
cardiomyocytes) within the heart (Wang et  al., 2017).
All procedures have been approved by Institutional Animals 
Ethics Committees at Southwest Medical University, Luzhou, 
China or Department of Pharmacology at University of Oxford, 
UK and the national guidelines under which the institution 
operates. All mice used in this study were maintained in a 
pathogen-free facility at Southwest Medical University or 
University of Oxford. Mice were given ad libitum access to 
food and water. The authors confirm that they have taken all 
steps to minimize the animals’ pain and suffering.
Materials and Equipment
Table 1 shows the details of materials and buffers.
Figure 1 shows the optical imaging system for light stimulation 
of ChR2 light-sensitive channels and optical recording.
The tissues were paced through the activation of ChR2 light-
sensitive channels. This was achieved by the delivery of 470 nm 
blue light pulses (13–14 ms pulse width) generated by OptoFlash 
(Cairn Research, Faversham, UK). Pulses were triggered by a 
1,401 digitizer and Spike 2 software (Cambridge Electronic 
Design). Approximate blue light intensity was measured with 
a 818-ST2 Wand Detector connected to a 843-R power meter 
(both Newport Corporation, CA, USA), and we  estimate an 
average irradiance in our experiments of 0.1–0.3  mW/mm2 
based on an approximate distance of 1–2  cm between Sylgard 
and liquid light guide (Oriel instruments Model No. 77525).
TABLE 1 | Details of materials and buffers.
Chemical and catalogue reference Supplier







HEPES (W1122DO10) Sangon biological Shanghai, China
2,3-butanedione monoxime (BDM) (29297) Sigma-Aldrich
Blebbistatin (SLBV5564) Tocris Bioscience Minneapolis, 
MN, USA
Voltage-sensitive dye RH237 (1971387) Thermo Fisher Scientific, Waltham, 
MA, USA
Calcium indicator Rhod-2 AM (1890519) Invitrogen, Carlsbad, CA, USA
Dimethyl sulfoxide (DMSO) (RNBT7442) Sigma-Aldrich
Heparin Sodium (H51021209) Chengdu Haitong Pharmaceutical 
Co. Ltd. Chengdu, China
Avertin (2,2,2-tribromoethanol) Sigma-Aldrich Poole, Dorset, UK
Pluronic F127 (1899021) Invitrogen, Carlsbad, CA, USA
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Buffer Compositions
Physiological Salt Solution
Freshly prepared physiological salt solution (PSS) containing 
in mM: NaCl 119, NaHCO3 25, NaH2PO4 1.0, KCl 4.7, MgCl2 
1.2, CaCl2 1.35, and glucose 10; equilibrated with 95% O2/5% 
CO2 at 37°C, pH  =  7.35.
Dye Loading Solution
Calcium indicator Rhod-2 AM  (Invitrogen, Carlsbad, CA, 
USA) was dissolved in dimethyl sulfoxide (DMSO, Sigma-
Aldrich, St. Louis, MO, USA) to prepare a stock concentration 
of 10  mg/ml (8.9  mM). The voltage indicator stock was 
prepared by dissolving Di-4-ANBDQPQ (University of 
Connecticut Health Center) in ethanol to obtain a stock 
concentration of 29  mM. To avoid repeated freezing and 
thawing, both stocks were stored in 50  µl aliquots at −20°C. 
For working concentrations of Rhod-2 AM  dye loading 
solution, 15  µl Rhod-2 AM  stock solution was mixed with 
15  µl Pluronic F-127 (20% solution in DMSO, Invitrogen, 
Carlsbad, CA, USA) and then dissolved in 15 ml PSS (10 µM 
final concentration). Similarly, 5.2  µl of Di-4-ANBDQPQ 
stock was mixed with 15 µl Pluronic F-127 and then dissolved 
in 15  ml PSS to form a working concentration of Di-4-
ANBDQPQ dye loading solution (10 µM final concentration). 
The working dye loading solutions were prepared on the 
day of the experiment.
Blebbistatin Physiological Salt Solution
Excitation-contraction uncoupler blebbistatin (Invitrogen, 
Carlsbad, CA, USA) was dissolved in in DMSO (Sigma-Aldrich, 
St. Louis, MO, USA) to make up 10  mM stock solution. To 
avoid repeated freezing and thawing, aliquots of 15  µl were 
stored at −20°C. A 10  µl of 10  mM stock blebbistatin solution 
was added to 15  ml PSS to make blebbistatin PSS solution 
(10  µM final concentration).
Preparation and Equipment
 1. Dissection set-up includes stereomicroscope, dissection 
chamber filled with Sylgard gel, oxygenation device, LED 
light source, and surgical instruments.
 2. The optical mapping system was set up as detailed below:
A custom-designed system equipped with an EMCCD 
camera (Evolve 128, Photometrics, Tucson, AZ, USA) was 
used (see Figure 1). Two green (to excite Ca2+ sensitive 
dye Rhod-2 AM; a peak wavelength of 530  nm) and two 
red (to excite the voltage sensitive dye Di-4-ANBDQPQ; 
a peak wavelength of 627  nm) LED lights (Cairn Research, 
Faversham, UK) were placed around the imaging chamber 
so as to uniformly illuminate the SAP. The green LEDs (peak 
wavelength  =  530  nm) were fitted with excitation bandpass 
filters (S555/25X, Chroma Technology GmbH, Germany), 
and the red LEDs (peak wavelength  =  627  nm) were fitted 
with excitation bandpass filters (HQ640/50, Chroma 
Technology GmbH, Germany) to efficiently select optimal 
excitation wavelength range for Rhod-2 AM  and Di-4-
ANBDQPQ, respectively. A multi-bandpass emission filter 
(ET595/50  +  700LP, Chroma Technology GmbH, Germany) 
was placed in front of the camera lens to avoid bleed-through 
of the excitation light and to selectively let the fluorescence 
emission to pass through. CaT (calcium transient) and 
transmembrane potential (Vm) measurements were taken at 
high resolution (128  ×  128 pixels; pixel size 66  ×  66  µm) 
at a rate of 520 frames/s.
FIGURE 1 | The optical imaging system. Two green (a peak wavelength of 530 nm) and two red (a peak wavelength of 627 nm) LED lights (Cairn Research, 
Faversham, Kent, UK) were placed around the chamber so as to uniformly illuminate the SAP. The green LEDs were fitted with excitation bandpass filters (S555/25X, 
Chroma Technology GmbH, Germany), and the red LEDs were fitted with excitation bandpass filters (HQ640/50, Chroma Technology GmbH, Germany) to efficiently 
select the best excitation wavelength range for Rhod-2 AM and Di-4-ANBDQPQ, respectively. A multi-bandpass emission filter (ET595/50 + 700LP, Chroma 
Technology GmbH, Germany) was placed in front of the camera lens to avoid bleed-through of the excitation light and to selectively let the fluorescence emission 
pass through. A multi-stream light switcher (Cairn Research, Faversham, Kent, UK) was set up to automatically switch between the red and green LED lights in 
accordance with the frame rate of the camera. Signal recording using this setup is in such a way that one frame data recorded will have only the red light turned on 
(thereby recording voltage signal alone) and the next frame data recorded will have only the green light turned on (thereby recording CaT signal alone), and the 
process is repeated until the desired number of frames are recorded.
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PROTOCOL
Harvest the Mouse Heart and Prepare the 
Sinoatrial Preparation (30 min)
The steps for preparation of the SAP are outlined in Figure 2 
and as described previously (Liu et  al., 2007; Hao et  al., 2011; 
Sharpe et  al., 2016). The details are as follows:
 1. Non-recovery terminal general anesthesia was induced by 
injection of an overdose of 1.2% Avertin solution 
(0.5–0.8 ml i.p., 2,2,2-tribromoethanol, Sigma-Aldrich, Poole, 
Dorset, UK), followed by intraperitoneal injection with 
heparin (200  units).
 2. Following sacrifice via cervical dislocation, the heart was 
rapidly excised and placed in warmed (37°C) and oxygenated 
(95% O2 + 5% CO2 gas) PSS solution in a dissection chamber.
 3. The heart was gently pressed with the tips of fingers to 
push the blood out of heart. Fresh oxygenated PSS was 
then added for further dissection.
 4. SAP containing two atria and the SAN region was dissected 
after clearing off the lung, thymus, ventricles, and connective 
tissues (Figure 2B).
 5.  The right atrium was opened from atrioventricular (AV) 
junction to expose the intercaval region containing the SAN, 
following which left atrium was opened to expose the left 
atrial endocardium. As the pacemaker cells are widely 
distributed throughout the entire region located between 
the superior (SVC) and inferior vena cava (IVC) and between 
the crista terminalis and intra-atrial septum (Glukhov et al., 
2010), the SAP contains the SAN and the two atria intact.
 6. The SAP was pinned onto a small rectangular piece of 
Sylgard gel by using fine insect pins. All dissection steps 
were performed in a dissection chamber with oxygenated 
PSS solution under a stereomicroscope.
Dual Dye Loading of the Sinoatrial 
Preparation (25 min)
 7.  A 50  ml falcon tube was filled with 15  ml of the Rhod-2 
AM  dye loading solution.
 8.  The Sylgard gel (with SAP attached) was then dropped 
into the falcon tube.
 9.  The SAP-containing falcon tube was placed in a 36°C water 
bath. The solution was oxygenated constantly by gently 
bubbling with 95% O2/5% CO2 (Note: heavy bubbling can 
lead to the formation of foam due to the presence of 
Pluronic F-127  in the solution. This can lead to the 
suboptimal dye loading). The SAP was incubated in the 
dye loading solution for 15  min.
 10.  Dual dye loading of the SAP was performed by incubating 
the SAP in Rhod-2 AM  dye loading solution as detailed 
above (points 7–9), following which the Sylgard gel with 
SAP attached was transferred into a new 50  ml falcon tube 
containing 10  µM Di-4-ANBDQPQ dye loading solution. 
Incubation with Di-4-ANBDQPQ was performed for 10 min 
at 36°C and constantly bubbled with 95% O2/5% CO2.
Optical Mapping (30 min)
 11.  The imaging chamber was filled with 15  ml of blebbistatin 
PSS solution and was placed directly under the camera. 
The recording chamber was heated up to 36°C by a 
heating plate.
 12.  The Sylgard (with SAP attached) was removed from the 
falcon tube and pinned down in the imaging chamber. The 
sample was placed between the two field-stimulation electrodes. 
(Note: Removing the SAP from the Sylgard and pinning 
down directly in the chamber cause further damage to the 
SAP. Therefore, pinning down the Sylgard with the intact 
A a b
B
FIGURE 2 | The isolation of mouse SAP. (A) The setup of dissection. (a) The dissection was performed under the stereomicroscope and oxygenated PSS solution. 
(b) Surgical instruments. (B) The preparation of SAP. RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; SAN, sinoatrial node; AV junction, 
atrioventricular junction, SET = septum, SVC = superior vena cava, IVC = inferior vena cava, CT = crista terminalis.
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tissue is recommended). The blebbistatin PSS solution was 
bubbled in the imaging chamber with 95% O2/5% CO2 gas.
 13.  Imaging was performed after cessation of motion by 
blebbistatin. Imaging used the EMCCD camera controlled 
by the acquisition software Metamorph (Molecular Devices). 
During image recordings, the excitation lights were turned 
on, and bubbling was temporarily stopped (to avoid distortion 
of the signals due to bubbles and motion of the solution). 
Since Pnmt+ cell-derived cardiomyocytes (PdCMs) express 
channelrhodopsin-2 (ChR2), they can be excited by exposure 
to 470  nm blue light. The stimulation protocol was then 
run, and baseline calcium transient or action potential 
recordings were taken. Recordings were taken again after 
stimulating the left atrium using blue light (pacing intervals: 
150–160 ms, pulse duration: 13–14 ms, intensity: 1,992 mA). 
The frame rate of these recordings was 0.52  kHz.
 14.  For dual dye imaging, a multistream light switcher (Cairn 
Research, Faversham, Kent, UK) was set up to automatically 
switch between the red (627  nm) and green (530  nm) 
LED lights according to the frame rate of the camera. 
Signal recording using this setup was performed, so that 
one frame of the data was recorded under red light 
illumination (thereby recording Vm signal alone), and the 
next frame was recorded under green light illumination 
(thereby recording CaT signal alone) and so forth until 
the desired number of frames was recorded. This resulted 
in an interlaced signal containing alternate frames of CaT 
and Vm signals. The interlaced signal was separated into 
CaT and voltage signal using ImageJ and saved as separate 
files. Due to the signals being interposed, the frame rate 
recording was 0.26  kHz.
Analysis
 15.  The saved image files were loaded, processed, and analyzed 
using the optical mapping analysis software ElectroMap 
(developed by Dr. Pavlovic’s group, https://github.com/
CXO531/ElectroMap; O’Shea et  al., 2019a).
 16.  Images were pre-processed by applying a 4 × 4 pixel Gaussian 
spatial filter (standard deviation = 1.5), a Top-Hat baseline 
correction (kernel size = 100 ms), and a third order Savitzky-
Golay temporal filter. A window size of 40  ms before 
transient peak to 100 ms after transient peak was used. 
Action potential duration (APD) and CaT duration (CaD) 
were measured at the desired repolarization/decay percentage 
at each pixel across the tissue, as measured from time of 
maximum upstroke velocity (maximum dF/dt).
 17.  For assessment of local conduction velocities, activation 
maps were generated using time of depolarization midpoint. 
Conduction velocity across the SAP was then quantified 
using a multi-vector polynomial method (Bayly et al., 1998) 
with a local window size of 5  ×  5 pixels.
 18.  To further assess conduction across the entire SAP, 
we  used activation curve analysis, where the percentage 
of tissue activated was plotted as a function of time 
(O’Shea et  al., 2019a).
Representative Results
A typical example of an SAP Ca2+ transient activation map 
reconstructed from spontaneous sinus rhythmic Ca2+ transients 
(by Rhod-2 AM) recorded with the optical mapping system 
is shown in Figure 3A for a SAP. The early activation point 
is located within the intercaval region near to where the 
SAN is located. However, as shown in Figure 3B, the calcium 
activation pattern and atrial conduction changed after 
stimulating with blue light (interval: 150 ms; duration: 13 ms; 
intensity: 1,992  mA; pulses per train: 50). The leading 
pacemaker site was shifted to the location of left atrium, 
suggesting that PdCMs were activated earlier than the SAN 
pacemaker cells. This is consistent with our previous report 
that PdCM cells predominantly localized to the left atrium 
and left ventricle, and the heart rate was controlled by 
stimulating PdCMs selectively with blue light (Wang et  al., 
2017). We  hypothesize that PdCM cells overexpressing ChR2 
may be  a viable site for spatially-targeted optical pacing 
when sinus node pacemaker cells are dysfunctional. Further 
A B
FIGURE 3 | The change of atrial conduction in optogenetic mice during after blue light stimulation. Maps produced by mapping the midpoint time of the  
CaT rise. (A) Ca2+ transient activation map during intrinsic pacing, before optical pacing. (B) Ca2+ transient activation map during optical pacing with blue 
(470 nm) light pulses.
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investigation is required. Figure  4 shows representative Vm 
and CaT maps and voltage and calcium traces from different 
regions of the SAP, illustrating the robustness of this preparation 
for murine research. We  monitored the “rundown” of the 
Vm and CaT signals for up to 4  h – the average signal 
“rundown” is less than 25%. Our experiment usually finished 
within 3  h from the beginning of Langendorff perfusion of 
the heart. We  again observe augmentation of the activation 
pattern induced by optical pacing, shown by both the voltage 
(Figure 4, upper panel) and calcium (Figure 4, lower panel) 
activation maps. Activation maps were produced by mapping 
the midpoint time of the AP/CaT rise.
We found that optogenetic pacing of a SAP can shift the 
activation point to the left, creating a new leading pacemaker 
site or “neonode.” Activation patterns in the SAP were plotted 
using ElectroMap (O’Shea et  al., 2019a), with the midpoint of 
the upstroke of the calcium transient used as a pixel-by-pixel 
readout of tissue activation. The earliest-activating pixel—
discarding outliers—was designated the activation point for that 
tissue. The earliest activation point before pacing was always 
in the nodal region. Optogenetic pacing of PdCMs can move 
this activation point to the left (Figure 5), establishing a new 
leading pacemaker site toward the left atrium. This change in 
the location of the leading pacemaker is reversible upon cessation 
of pacing (Figures 5A,E). Left shift of the leading pacemaker 
occurred in four of seven SAPs (Figure 5D). One leftward 
deviation appears more upward relative to the SVC-IVC axis—
this is due to contortion of the tissue. Although no leading 
pacemaker shift occurred in three SAPs, all seven SAPs were 
successfully paced by blue light: with a decrease in mean cycle 
length from 264.3  ±  42.7  ms before optogenetic pacing to 
159.2  ±  1.4  ms during (p  <  0.02). Mean cycle length after 
pacing was 281.9  ±  48.9  ms—not significantly different from 
before (p  =  0.63). Therefore, we  can always successfully and 
reversibly pace PdCMs using selective ChR2 overexpression. 
The variability in pacemaker shift observed (Figure 5D) is 
consistent with the variable distribution of murine PdCMs across 
both the SAN region and the left atrium (Ni et al., 2017; Wang 
et  al., 2017). In summary, we  report the possibility of using 
optogenetic pacing of PdCMs to establish novel left-shifted 
leading pacemaker sites in the murine heart.
To study the effects of optogenetic pacing on overall conduction, 
we  utilized activation curve analysis where the percentage of 
tissue activated is plotted as a function of time (O’Shea et  al., 
2019a). Optogenetic pacing of PdCMs augments conduction in 
the SAP—producing a left shift of the activation curve (Figure 6A). 
This is most noticeable in the first few milliseconds of tissue 
activation (Figure 6A, inset). During optogenetic pacing, the 
rate of tissue activation is initially very rapid (Figure 6B, inset), 
otherwise, there are no major alterations to tissue activation 
rate (Figure 6B). Optogenetic pacing reduces the time to 5% 
tissue activation from 1.59  ±  0.24 to 0.88  ±  0.17  ms (p  =  0.03), 
FIGURE 4 | Simultaneous voltage (top panels) and Ca2+ transient (bottom panels) activation maps reconstructed from spontaneous sinus rhythmic (left panels) and 
light paced (right panels) SAP. Maps were produced by mapping the midpoint time of the voltage and CaT rise with examples of voltage and Ca2+ transient traces 
from indicated regions of the preparation (white and red cross).
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the time to 10% tissue activation from 2.40  ±  0.25 to 
1.46 ± 0.26 ms (p = 0.02), and the time to 20% tissue activation 
from 3.91  ±  0.52 to 2.27  ±  0.33  ms (p  =  0.02) (Figure 6C), 
but at all points ≥30% tissue activation, there is no significant 
difference in activation time (Figures 6A,B).
We also wanted to explore whether the normal conduction 
pathways in the tissue remained intact during optogenetic pacing. 
Using ElectroMap, we computed local conduction velocities using 
the multi-vector method (Bayly et  al., 1998) with a 5  ×  5-pixel 
grid size. The magnitude of conduction velocity vectors 
(Figure 6D) did not change significantly with optogenetic pacing 
from 26.9  ±  3.3 before to 28.6  ±  2.5  cm/s during pacing 
(p = 0.34), and there were no major changes in the directionality 
of conduction vectors either (Figure 6E). In summary, we report 
the possibility of establishing a novel left-shifted leading pacemaker 
site, with only minimal, controlled disturbance to normal tissue 
activation rate, and little or no disturbance to the pathways 





FIGURE 5 | Mapping of activation in SAPs under sinus rhythm and under optogenetic pacing. (A) (i ) Representative SAP—camera view. (ii ) Activation map for this 
SAP before optogenetic pacing. (iii ) Activation map during pacing (note formation of “neonode”, white asterisk). (iv) Activation map after pacing. Activation maps are 
calculated from Ca2+ transients. Fifty pacing spikes given, at 6.67 Hz. Contours drawn at 1/frame rate of the EMCCD. Scale bar, right. (B) 3-D graphical rendering of 
activation maps (i) before pacing, (ii ) during pacing. SVC-IVC axis in red. Activation time on z-axis. (C) Representative SAP—microscope view. Pacemaker shift 
overlaid. SVC-IVC axis shown. Distances in mm. (D) SVC-IVC axis with relative pacemaker shifts plotted (n = 7). (E) Mean change in “shiftedness.” LA, left atrium; 
RA, right atrium; SAN, sinoatrial node; SVC, superior vena cava; IVC, inferior vena cava; SEP, septum; NeoN, neonode.
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We  found small alterations to calcium cycling in our tissues, 
but for the most part, there was no significant change in the 
characteristics of calcium transient rise time, calcium transient 
duration to 50% of the decay (CaD50), and calcium transient 
duration to 75% of the decay (CaD75) with optogenetic pacing.
We measured the rise time, calcium transient duration to 50% 
of the decay (CaD50), and calcium transient duration to 75% 
of the decay (CaD75) as illustrated in Figure 7A. Rise time is 
a measure of upstroke duration, calculated between 10 and 90% 
of time to peak, which minimizes analytical uncertainty (Choi 
and Salama, 2000; Jaimes et  al., 2016). We  used a mixed-effects 
model, with Tukey’s post hoc tests where required, to examine 
whether there were any significant effects of optogenetic pacing. 
For rise time, there was a significant overall effect of optogenetic 
pacing (p  <  0.0001). Post hoc testing revealed that there was no 
significant effect of pacing on rise time in the right atrium or 
in the neonodal regions—but in the left atrium, rise time fell 
from 17.21  ±  0.94  ms before pacing to 15.24  ±  1.14  ms during 
pacing (p < 0.002) and rose again after pacing to 18.60 ± 1.00 ms 
(p  <  0.05, during vs. after) and in the nodal region, rise time 
fell from 17.48  ±  1.03 to 15.24  ±  1.14  ms (p  <  0.03) and rose 
again after pacing to 18.44 ± 0.95 ms (p = 0.02, during vs. after). 
In both regions, there was no significant difference between the 
before and after conditions (left atrium: p  =  0.39; nodal region: 
p = 0.61)—so the reduction in rise time with optogenetic pacing 
is reversible upon cessation of pacing (Figure 7B). There was 
no overall significant effect of optogenetic pacing on either CaD50 
(p  =  0.15) or CaD75 (p  =  0.34; Figures 7C,D). In summary, 
rise time is shorter in the left atrium and in the SAN region 
during optogenetic pacing, and this is a reversible change. 
Otherwise, calcium handling in the murine SAP appears to 
be  only marginally affected.
DISCUSSION
The success in obtaining high quality Vm and Ca2+ mapping 
results in SAPs requires several important technical 
considerations, including high consumption of oxygen and high 
sensitivity to temperature and pH of the nodal tissue. 
Furthermore, the dense arrangement of nodal cells combined 
with the significant presence of connective tissue makes it 
hard for a Ca2+ dye to reach to the nodal and atrial cells. 




FIGURE 6 | Conduction pattern in the tissue under sinus rhythm and during optogenetic pacing. (A) Grouped activation curve showing mean % tissue activated 
over the time elapsed during a Ca2+ transient. SEM denoted by shading. Inset: zoomed section of first 5 ms. (B) Rate of change of % tissue activation plotted 
against time. Inset as above. (C) (i ) Time to 5% tissue activation. (ii ) Time to 10% tissue activation. (iii ) Time to 20% tissue activation. (D) Mean magnitude of local 
conduction vectors. (A–D) n = 7 throughout. (E) Representative radar plot, showing local conduction vector directionalities. Angles binned into groups of 10°—so 
0° ≤ x < 10° becomes 5°, 10° ≤ x <°20° becomes 15°, and so on. Concentric circles represent increasing frequency of vectors at that angle.
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Tissue Preparation
Intact SAPs were micro-dissected as described previously (Ju 
et  al., 2015). The SAN region was identified from anatomical 
landmarks, including the superior vena cava, the crista terminalis, 
and the interatrial septum. The tissue needs to be  oxygenated 
constantly. At this point, temperature is not critical.
Dye Loading
The Ca2+-sensitive dye used to load the SAP tissue was Rhod-2 
AM, a dye in the acetoxymethyl ester form. Esterification of 
the fluorescent molecule (Rhod-2 AM) results in an uncharged 
molecule that can permeate cell membranes and chelate cytosolic 
Ca2+. A 100-fold increase in the molecule’s fluorescence intensity 
results from Ca2+ chelation (Choi and Salama, 2000). The 
voltage sensitive dye used was Di-4-ANBDQPQ, due to its 
favorable spectral properties for use with Rhod-2 AM. In our 
experiments, dye loading was carried out by incubating the 
tissue in a solution consisting of Pluronic F-127 dissolved in 
DMSO. Pluronic F-127 was incorporated into the dye loading 
solution to better disperse the dye into the physiological solution. 
Dye loading was observed to be  generally better in younger 
mice than old, which may be  related to connective tissue 
making up a smaller volume of the node.
The SAP’s repetitive contractions may have disrupted dye 
loading and/or aided the leaking of the dye out from the 
tissue, making it a challenge to optimize dye loading conditions. 
A fluorescent dye that diffuses across the cell membrane well 
can also exit from the cytoplasm at a high rate. Reagents like 
probenecid help prevent this to an extent. Combining these 
with optimized temperatures, timings and oxygen supply are 
necessary for effective loading of the tissue with dye.
Optical Imaging
During imaging, motion artifacts caused disruption in the 
measurement of optical signals. Hence, to reduce contraction of 
the tissue, blebbistatin was used. Blebbistatin is an inhibitor of 
the adenosine triphosphatases associated with class II isoforms 
of myosin (Allingham et  al., 2005). This compound has been 
identified as an effective excitation-contraction uncoupler, and 
previous investigators have used it at several different concentrations 
(Fedorov et al., 2007). The use of blebbistatin at 10 µM appeared 
to effectively abolish any motion artifact due to contraction of 
the SAP without harming SAP.
Pnmt+ Cell-Derived Cardiomyocytes 
(PdCMs) and Biopacemaking Strategies
The advent of cardiac optogenetics has facilitated the identification 
of a new cardiomyocyte subpopulation in the murine heart, 
phenylethanolamine-N-methyl transferase Pnmt+-derived 
cardiomyocytes (PdCMs; Wang et  al., 2017). Through selective 
A B
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FIGURE 7 | (A) Characteristics of Ca2+ transients recorded from different regions under sinus rhythm and optogenetic pacing. Representative Ca2+ transient 
illustrating rise time; CaD50 (Ca2+ transient duration to 50% of the decay); and CaD75 (Ca2+ transient duration to 75% of the decay). CaD50 and CaD75 are 
calculated from max. dF/dt (max. upstroke) as detailed in the protocol. (B) Mean rise time, before (n = 7), during (n = 7), and after (n = 6) optogenetic pacing. Key at 
center. Grouping is by region: LA, left atrium; RA, right atrium; NeoN, neonodal region (n = 4); SAN, nodal region. (C) Mean CaD50 values, no overall significant 
effect of optogenetic pacing. (D) Mean CaD75 values, no overall significant effect of optogenetic pacing.
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manipulation of these cells using optogenetics, our study 
demonstrated how optogenetics can be  used to target specific 
cardiomyocyte subpopulations, overcoming many of the issues 
associated with traditional electrophysiological techniques. 
Selectively stimulating PdCMs with rhythmic blue (470  nm) 
light pulses was sufficient to maintain sinus rhythm in murine 
atria, supporting previous observations from whole heart studies 
(Wang et  al., 2017). It has also been found previously that 
the left atrium alone – dissected out– can be  paced by light 
(Wang et  al., 2017), but a capacity to optogenetically control 
the SAP has not been tested before.
The observation that a “neonode” is typically set up toward 
the left is consistent with previous findings that PdCMs occupy 
a left-sided distribution in murine heart (Wang et  al., 2017). 
We therefore assessed the effect of pacing on left atrial activation. 
Optogenetic pacing of PdCMs leads to alterations in the 
conduction pattern across murine atria. We  found (Figure 5) 
that optogenetic pacing of Pnmt-cre/Ai27D SAPs can often 
set up new sites of earliest activation (“neonodes”) toward the 
left of the tissue. Our proof-of-principle studies clearly 
demonstrate feasibility of optogenetic control of heart rate via 
the specific cell population. Indeed, in four of seven SAPs, 
we observed “neonode” formation, with the leading pacemaker 
shifting toward the left atrium. Lack of leftward shift in three 
of seven preparations may be  due to the heterogeneity in cell 
numbers and clustering of the Pnmt cells in the SAPs, thus 
altering sink-source properties of the myocardium. While the 
physiological consequences of the studies presented here 
(specifically using Pnmt cells) are not immediately clear, 
application of such approaches is of interest to the community 
and may lead to important findings on the consequences of 
the spatial shift in the leading pacemaker.
As recently reviewed by Boyle et  al. (2018), initial work in 
this area assessed possibility to override the intrinsic pacing 
frequency of a beating heart using optical stimuli. Bruegmann 
et  al. (2010) explored this question in a preclinical model by 
generating ChR2+ transgenic mice. They showed in an open-
chest configuration that pulses of light from a focused light 
source could be  used to maintain ventricular activation at rates 
faster than intrinsic sinus rhythm. Light-induced wavefronts 
were initiated from different parts of the heart (e.g., atrial or 
ventricular sites). Remarkably, the authors found that 1:1 capture 
could be  maintained when the illuminated area was small 
(0.05  mm2, ∼50 myocytes), suggesting that optogenetic pacing 
via a small population of cells is possible and robust. Several recent 
studies also provided evidence for the development of optogenetic 
defibrillating device for termination of tachyarrhythmias (Nyns 
et  al., 2016; Bruegmann et  al., 2017). Bruegmann et  al. (2017) 
reported optogenetic termination of atrial tachyarrhythmia in 
intact hearts from transgenic as well as wild-type mice ex and 
in vivo. Thus, they suggested that their report could lay the 
foundation for the development of implantable devices for pain-
free termination of AF. Nyns et  al. (2016) demonstrated that 
forced expression of a light-gated depolarizing ion channel 
(ReaChR) in the adult rat heart allows contact- and shock-free 
termination of VTs through brief local illumination of the 
ventricular surface, i.e., without relying on conventional drugs, 
tissue ablation, or electroshocks. Both mono- and polymorphic 
VTs could be  terminated in an effective and repetitive manner 
by a light-induced electrical current driven by natural 
electrochemical gradients, providing proof-of-concept for 
biological arrhythmia termination. Our study also provides 
proof-of-concept evidence supporting the development of light-
based pacing devices targeted to a particular cellular population.
Limitations of the Protocol
There are a number of possible limitations in this protocol 
including: (1) possibility of injury during the dissection of the 
preparation; (2) effectiveness of dye loading may vary between 
preparations, thereby affecting the results; and (3) partial 
uncoupling (reduction in conductance) due to the use of 
blebbistatin, which could increase the regional differences in 
Ca2+ dynamics in SAPs.
Conclusions and Future Directions
Here, we  have described a detailed protocol for dual optical 
mapping of murine SAPs with optogenetic pacing. Combination 
of high-resolution optical imaging with cell-specific optogenetic 
stimulation allows unique spatial control and study of 
electrophysiology of the SAP, not possible with traditional direct 
or field electrode techniques. In the present protocol, we  have 
demonstrated this principle with PdCMs; however, the protocol 
can be  valuable for any mouse models that cell specifically 
express opsins such as ChR2 within the sinoatrial region of 
the heart. Therefore, such an approach represents a powerful 
tool for enhanced electrophysiological understanding of 
supraventricular physiology and pathophysiology.
Future improvements may focus on exploring dual dye 
imaging and improved image processing software. Higher 
resolution and novel optical imaging modalities for 3D optical 
mapping are also important future directions of optical mapping.
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Chapter 5
Optical mapping of transverse mouse ventricular slices
The heart is known to exhibit transmural gradients. Cardiomyocytes in the
epicardial, myocardial and endocardial layers possess distinct electrical current
contributions and hence distinct action potential morphologies. Changes in the
distribution of action potential (AP) morphology can alter the dispersion of
repolarisation, and has been observed in diseased hearts. It is important
therefore we have robust methods to study transmural gradeints in experimental
models, including mouse hearts.
Tissue slices have been shown to be an effective platform for cardiac
electrophysiological (EP) investigation in several species. Cardiac slices (also
known as ‘organotypic heart slices’) are multicellular preparations, and hence
overcome some of the drawbacks of studying isolated cardiomyocytes such as
the loss of cell to cell communication and extracellular matrix components during
enzymatic isolation.
Commonly, cardiac slices have been prepared longitudinally (i.e. from apex to
base or in the ‘long axis’), preventing study of transmural heterogeneity, and/or
studied using low spatial resolution electrode techniques. The following chapter
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discusses a protocol designed for harvest of transversely (‘short axis’) cut mouse
ventricular slices. Although similar preparations have been described, these
slices were then loaded with transmembrane voltage and/or intracellular calcium
dyes. Slices could therefore be studied with high spatial resolution optical
mapping to reveal transmural and regional gradients in the mouse ventricle.
The presented work consists of two publications detailing preparation of
transverse cardiac slices and analysis of their electrophysiological behaviour
using optical mapping. The first article (section 5.1) uses the described platform
to study the transmural EP properties of the mouse heart. The mouse is shown
to exhibit significant transmural gradients, including prolonged action potential
and calcium transient durations in the endocardium compared to the epicardium,
as seen in larger mammals. Conduction analysis of these slices revealed
physiologically healthy conduction velocities and response to pacing in these
slices. However, this analysis was limited by the use of field pacing, which cause
simultaneous activation in large areas of the slices which is not due to cell to cell
conduction of the electrical impulse.
The second publication (section 5.2) provides a detailed and updated protocol
for preparation of mouse transverse cardiac slices. Two key advances are
demonstrated. The first is dual dye loading of slices, allowing detailed
investigation of voltage-calcium coupling. The second is the demonstration that
slices can be paced using optical excitation (Chapter 4), which benefits from
improved spatial control in comparison to field pacing techniques.
Several features of the ElectroMap software (Chapter 3) were used to analyse
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data from these slice preparations. The slices often exhibited low and variable
signal quality, and only via processing with ensemble averaging (section 3.3.1) of
multiple stimuli did subtle transmural gradients become apparent. The conduction
analysis module was utilised to quantify conduction speed across the slices as a
sign on physiological health. Furthermore, activation mapping allowed the study
of changes in conduction dynamics when utilising optical rather than field pacing.
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5.1 Transverse cardiac slicing and optical imaging for
analysis of transmural gradients in membrane potential
and Ca2+transients in murine heart
Publication 4. This research was originally published in The Journal of
Physiology.
Transverse cardiac slicing and optical imaging for analysis of transmural gradients
in membrane potential and Ca2+ transients in murine heart. Q Wen, K Gandhi, R
A Capel, G Hao, C O’Shea, G Neagu, S Pearcey, D Pavlovic, D A Terrar, J Wu, P
Camelliti, M Lei. J. Physiol. 596, 3951–3965. 2018
Author contributions in publication 4
I performed data analysis of activation and conduction (Figure 6). Additionally, I
performed confirmatory analysis of observed action potential, calcium transient
and alternans heterogeneity. By utilising the ensemble averaging in ElectroMap
(Chapter 3), lowered signal to noise ratio signals were produced to confirm initial
results using single beat analysis. Experiments described were carried out at
Southwest Medical University or University of Oxford, and not conducted by
myself.
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Key points A robust cardiac slicing approach was developed for optical mapping of transmural gradients
in transmembrane potential (Vm) and intracellular Ca2+ transient (CaT) of murine heart. Significant transmural gradients in Vm and CaT were observed in the left ventricle. Frequency-dependent action potentials and CaT alternans were observed in all ventricular
regions with rapid pacing, with significantly greater incidence in the endocardium than
epicardium. The observations demonstrate the feasibility of our new approach to cardiac slicing for
systematic analysis of intrinsic transmural and regional gradients in Vm and CaT.
Abstract Transmural and regional gradients in membrane potential and Ca2+ transient in the
murine heart are largely unexplored. Here, we developed and validated a robust approach which
combines transverse ultra-thin cardiac slices and high resolution optical mapping to enable
systematic analysis of transmural and regional gradients in transmembrane potential (Vm) and
intracellular Ca2+ transient (CaT) across the entire murine ventricles. The voltage dye RH237
or Ca2+ dye Rhod-2 AM were loaded through the coronary circulation using a Langendorff
perfusion system. Short-axis slices (300 μm thick) were prepared from the entire ventricles (from
the apex to the base) by using a high-precision vibratome. Action potentials (APs) and CaTs
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were recorded with optical mapping during steady-state baseline and rapid pacing. Significant
transmural gradients in Vm and CaT were observed in the left ventricle, with longer AP duration
(APD50 and APD75) and CaT duration (CaTD50 and CaTD75) in the endocardium compared with
that in the epicardium. No significant regional gradients were observed along the apico-basal axis
of the left ventricle. Interventricular gradients were detected with significantly shorter APD50,
APD75 and CaTD50 in the right ventricle compared with left ventricle and ventricular septum.
During rapid pacing, AP and CaT alternans were observed in most ventricular regions, with
significantly greater incidence in the endocardium in comparison with epicardium. In conclusion,
these observations demonstrate the feasibility of our new approach to cardiac slicing for systematic
analysis of intrinsic transmural and regional gradients in Vm and CaT in murine ventricular tissue.
(Received 11 April 2018; accepted after revision 12 June 2018; first published online 21 June 2018)
Corresponding author M. Lei: Department of Pharmacology, University of Oxford, Mansfield Road, OX1
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Introduction
Because of its feasibility for genetic modification, the
mouse has been the most popular animal species for
modelling human disease conditions and for mechanistic
research, as well as therapeutic exploration, despite distinct
differences in its cardiac electrophysiological properties
compared to the human heart, including marked
differences in heart size, heart rates and action potential
waveforms. The mouse is also the second mammalian
species, after humans (Lander et al. 2001), in which a sub-
stantial amount of genomic information has been analysed
(Waterston et al. 2002). Within the cardiovascular research
community, the mouse has been widely used for exploring
molecular, cellular and systemic mechanisms underlying
inherited and acquired ventricular arrhythmic diseases
(Nerbonne, 2014). As transgenic technology has advanced,
mutagenesis has become much easier to carry out in mice
and an increasing number of genetically modified mouse
systems have been generated for the study of cardiac
arrhythmias (Sabir et al. 2008). The models include ion
channelopathies with minimal structural abnormalities,
and those of structural heart disease (Choy et al. 2016). The
former group includes catecholaminergic polymorphic
ventricular tachycardia (CPVT) (Wehrens et al. 2003), the
long (Wu et al. 2012) and short QT syndromes (LQTS
and SQTS), and Brugada syndrome (BrS) (Papadatos
et al. 2002; Choy et al. 2016). The latter group includes
several types of cardiomyopathies, such as arrhythmogenic
right ventricular dysplasia (ARVD) (Asano et al. 2004),
dilated cardiomyopathy (DCM) and hypertrophic cardio-
myopathy (HCM) (Choy et al. 2016).
Surprisingly, despite the popularity of mouse
models in heart research, little is known about
murine heart transmural and regional electro-
physiological heterogeneities such as action potential
and Ca2+transient characteristics. These are vitally
important for phenotypic and mechanistic research
into cardiac disease conditions, in particular cardiac
arrhythmias. In this species, the transmural and regional
electrophysiological heterogeneities have been largely
unexplored.
Thin tissue slices, a well-established experimental pre-
paration for electrophysiological studies of the brain,
have recently emerged as a promising model for cardiac
electrophysiology investigations. Thin slices, prepared
from the ventricle of a number of different species
(Halbach et al. 2006; Bussek et al. 2009; Camelliti et al.
2011; Wang et al. 2014), have been shown to retain
structural and functional properties of the native myo-
cardium, including tissue architecture, cell type ratio, cell
distribution, cell–cell electrical and mechanical coupling,
and extracellular matrix (Bussek et al. 2009; Camelliti
et al. 2011). Importantly, cardiac slices exhibit similar
electrophysiological characteristics to the intact heart and
respond to the application of pharmacological compounds
similarly to the whole heart (Camelliti et al. 2011; Himmel
et al. 2012), thus providing a promising experimental
model for electrophysiology, Ca2+ handling, and drug
action investigations.
Most previous electrophysiology studies on cardiac
slices have employed low spatial resolution recording
methods, including patch clamp (Burnashev et al. 1990),
sharp electrodes (Halbach et al. 2006; Bussek et al. 2009;
Himmel et al. 2012) and low-density multi-electrode
arrays (Bussek et al. 2009; Camelliti et al. 2011). Higher
spatial resolution methods, such as optical mapping,
provide exciting opportunities to monitor dynamic
cellular electrophysiological events as they occur in real
time (Wang et al. 2015; Kang et al. 2016). Furthermore,
prior studies have been limited to the analysis of
sub-epicardial (Wang et al. 2015) or sub-endocardial
tangentially cut slices (Kang et al. 2016), or a few trans-
murally cut slices (Bussek et al. 2009), an approach
inadequate for accurate capture of regional and trans-
mural cardiac electrophysiological properties. A method
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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for systematic analysis of regional and transmural electro-
physiological heterogeneities across the whole ventricles
in mouse is currently missing.
In order to address the issues described above, in
the present study we developed a feasible transverse
slicing method and combined it with a high-throughput
optical imaging technique as a new approach for studying
cellular electrophysiology of murine heart in intact sliced
ventricular tissue. These transverse slices were cut at
right angles to the long axis of the heart. Our approach
enables, for the first time, the use of a series of slices pre-
pared from ventricle to measure transmembrane potential
(Vm) and intracellular Ca2+ transient (CaT) with high
temporal and spatial resolution, allowing (i) comparison
of successive slices which form a stack representing the
original geometry of the heart; (ii) profiling of the trans-
mural and regional gradients in Vm and CaT in the
ventricle; (iii) characterisation of transmural and regional
profiles of action potential and CaT alternans.
Methods
Ethical approval
All animal experiments were performed on adult mice
(CD1, 12–20 weeks old) in accordance with the United
Kingdom Animals (Scientific Procedures) Act 1986 and
were approved by the University of Oxford Pharmacology
ethical committee (approval ref. PPL: 30–3340) and the
national guidelines under which the institution operates.
All mice used in this study were maintained in a
pathogen-free facility at the University of Oxford. Mice
were given ad libitum access to food and water. The authors
confirm that they have taken all steps to minimise the
animals’ pain and suffering. Our work complies with the
journal policy and regulations (Grundy, 2015).
Heart isolation
Mice were killed by cervical dislocation in accordance with
Schedule 1 killing method. Hearts were rapidly excised
and Langendorff-perfused with oxygenated Krebs solution
(containing in mM: NaCl 119, NaHCO3 25, sodium
pyruvate 1.8, KH2PO4 1.2, KCl 4.7, MgCl2 1.0, CaCl2
1.8, and glucose 10; equilibrated with 95% O2/5% CO2,
pH 7.4) at 37°C and at constant rate of 3.5–4 ml/min
for 10 min. To prevent formation of blood clots in
the coronary circulatory system, animals were treated
with heparin (200 units) under non-recovery terminal
general anaesthesia by injection of an overdose of 1.2%
Avertin solution (0.50.8 ml I.P. (2,2,2-tribromoethanol,
Sigma-Aldrich Poole, Dorset, UK) prior to killing and
hearts were injected with streptokinase (400 units) via
the coronary system after organ excision according to
approved procedure by the Home Office.
Dye loading
Fluorescent dyes were loaded via the coronary circulation
during Langendorff perfusion, applied by injection into
the aortic cannula. The voltage sensitive dye RH237
(Thermo Fisher Scientific, UK) was delivered as a
15 μl bolus of 2 mM concentration, injected into
the cannula in small volume steps over a period of
5 min. The Ca2+ dye Rhod-2 AM (Thermo Fisher
Scientific, UK) was administered as a 50 μl bolus (stock
solution: 1 mg/ml in DMSO) over a 5 min period,
and recirculated for 45 min in the presence of 0.5 mM
probenecid. After dye loading, hearts were perfused
with Krebs solution containing 10 μM blebbistatin,
a myosin II inhibitor used to stop contractions and
avoid movement artefacts during optical mapping
recordings.
Slice preparation
Table 1 summarises the slice preparation procedure.
Hearts were removed from the Langendorff set-up and
dissected in cold (4°C) oxygenated (99.5% O2) Tyrode
solution (in mM: NaCl 140; KCl 4.7; glucose 10;
HEPES 10; MgCl2 1; CaCl2 1.8; pH 7.4) containing
the excitation–contraction uncoupler 2,3-butanedione
monoxime (BDM, 10 mM). Atria and valves were
removed using a sharp scalpel blade, leaving the ventricles
intact. Ventricles were glued base-down (histoacryl tissue
adhesive; Braun, Melsungen, Germany) onto a pre-made
4% agar block, previously fixed onto the vibratome
specimen holder (VF-300 vibrating microtome; Pre-
cisionary Instruments Inc., Greenville, USA). Ventricles
were subsequently embedded in 4% low-melt agarose
and cooled on ice at 4°C. The specimen holder with
agarose-embedded ventricles was mounted onto the stage
of the vibratome filled with cold (4°C) oxygenated (99.5%
O2) Tyrode solution containing BDM. Short-axis slices
were cut at a thickness of 100 μm, 300 μm or 500 μm,
using a razor blade at a speed of 0.02 mm/s and vibration
frequency of 82 Hz. After initial experiments aiming
to determine the best slice thickness for dye loading,
dye retention and optical mapping recordings, short-axis
slices of 300 μm thickness were prepared from the entire
ventricles (from the apex to the base) for the study of
regional and transmural Vm and Ca2+ properties. As
summarised in Table 1, the total cold ischaemic time
during slicing is between 1.5 and 4 min. Slices were
then transferred to recovery solutions for recovery in
a pre-incubation chamber filled with Krebs solution
containing 10 μM blebbistatin at room temperature for
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
3954 Q. Wen and others J Physiol 596.17
Table 1. Summary of the slicing and imaging protocol
Dye loading Perfusion Slicing Recovery 1 Recovery 2 Recovery 3 Pre-imaging Imaging
Temperature 37°C 37°C 4°C 4°C RT RT 37°C 37°C
Solution Krebs Krebs Tyrode Tyrode Krebs Krebs Krebs Krebs
BDM (10 mM) No No Yes Yes No No No No
Blebbistatin (10 μM) No Yes No No Yes Yes Yes Yes
Ca2+ 1.8 mM 1.8 mM 1.8 mM 1.8 mM 1.8 mM 1.8 mM 1.8mM 1.8mM
O2 95% 95% 100% 100% 95% 95% 95% 95%
CO2 5% 5% 0% 0% 5% 5% 5% 5%
Duration 5–7 min 20 min 1.5–4 min 10 min 10 min 5 min 3 min <1 min
RT, room temperature; Krebs, Krebs-Henseleit solution; Tyrode, Tyrode solution.
30 min before electrophysiological investigations. To pre-
vent tissue from curling, slices were collected on Sylgard
blocks and held in position using a nylon mesh in the
pre-incubation chamber.
Optical mapping
Slices were electrophysiologically assessed with the optical
mapping method, using a custom-designed optical
mapping system equipped with an EMCCD camera
(Evolve 128 Photometrics, Tucson, AZ, USA). Figure 1F
shows a schematic diagram of the mapping set-up. Slices
were kept in Krebs solution containing 10 μM blebbistatin
at 37°C during imaging. Four 530 nm LEDs were used
for excitation of the Ca2+-sensitive dye Rhod-2. CaT
fluorescence was collected at 585 ± 40 nm. For Vm signals,
four 530 nm LEDs were used for excitation of RH237,
and emission was collected using a 662 nm long pass
filter. Vm and CaT measurements were taken at maximal
resolution (128 × 128 pixels; pixel area 47 × 47 μm) at
a rate of 1000 frames/s. Slices were electrically stimulated
with bipolar pulses of 2 ms duration, at voltages 1.5 times
above threshold (5–10 V) and initial frequency of 2 Hz. For
AP and CaT alternans investigations, slices were stimulated
at frequencies of 2, 4, 8 and 16 Hz.
Data analysis
AP duration (APD) and CaT duration (CaTD) were
analysed using OPTIQ (program developed by Dr Burton,
University of Glasgow). AP and CaT signals were filtered
using a Gaussian spatial filter (radius 2 pixels) before
relevant parameters were extracted. APD was measured as
the time from the upstroke to 50% and 75% repolarisation
(APD50 and APD75). Similarly, the CaTD was measured
as the time from the upstroke to 50% and 75% recovery
(CaTD50 and CaTD75). AP and CaT alternans are defined
as the electrical or calcium transient discordant in duration
or in amplitude. These phenomena depend on the under-































Figure 1. Optimisation of murine cardiac slice methodology
A, voltage (RH237) or calcium (Rhod-2 AM) dyes were loaded via coronary circulation using the Langendorff
perfusion system. B, ventricles were embedded in 4% low-melt agarose and mounted onto the vibratome specimen
holder. C, up to 24 transverse slices were cut from the apex to the base in ice-cold BDM Tyrode solution. D, slices
were recovered at room temperature in Krebs solution containing 10 μM blebbistatin for 30 min, before optical
mapping studies. E, Vm signals in slices cut at 150 μm and 300 μm thickness. F, optical mapping setup with four
530 nm excitation LEDs and a 128 × 128 EMCCD camera.
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and the coupling between AP and CaT alternans
cycling.
For assessment of conduction velocity (CV), the
multi-vector polynomial method (Bayly et al. 1998)
was used within bespoke analysis software, Electro-
Map (O’Shea et al. 2017). Following Gaussian filtering
(3 × 3 pixel area, σ = 1.5), activation maps, generated from
measuring the time of the depolarisation midpoint, were
spatially segmented into regions of 5 × 5 pixels. A poly-
nomial surface was then fitted to local activation times to
describe propagation in the area, and local CV quantified
as the gradient vector of the polynomial surface. Mean CV
was then calculated from the local CVs across the tissue
slice.
Statistical analysis
Transmural and regional APD/CaTD distributions were
analysed using a Student’s paired t test or one-way
ANOVA with post hoc Tukey’s test and repeated
measures correlation among tissue regions. Regional
frequency-dependent AP/CaT alternans and arrhythmia
heterogeneity were analysed using a chi-squared test. A
value of P < 0.05 was considered statistically significant.
Values are expressed as means ± SEM.
Results
Optimisation of murine transverse ventricular slices
for Vm and CaT measurements
Adult murine ventricular slices have been previously
developed for electrophysiology applications (Halbach
et al. 2006), but optimisation of the slice preparation
to enable systematic analysis of Vm and CaT across
the whole murine ventricles has yet to be achieved.
Figure 1 illustrates the methodology implemented in this
study. Critical steps included determination of an efficient
dye loading method, a slice thickness able to maintain
intact tissue morphology and generate optimal voltage
and calcium signals, and a recovery period necessary to
reach stable signals after slice preparation. As shown in
Fig. 1, to achieve optimal dye loading, the voltage dye
RH237 or Ca2+ dye Rhod-2 AM were loaded through
the coronary circulation using the Langendorff perfusion
system. Prevention of blood clot formation was essential
for optimal dye loading and was achieved by initial
injection of heparin (200 units) before killing, and sub-
sequent injection of streptokinase (400 units) directly into
the coronary system after heart excision. Ventricles were
embedded in low-melting temperature agarose to provide
structural support to the tissue during sectioning. Slices
were cut at right angles to the long axis of the heart from the
apex to the base, and thicknesses from 100 μm to 500 μm
were tested, with 300 μm found to be the best thickness
to achieve optimal recordings for both Vm and CaT. Slices
less than 300 μm thick showed markedly lower Vm and
CaT signals (Fig. 1E), while slices thicker than 300 μm
suffered from poor oxygenation. After preparation, slices
were pre-incubated at room temperature in Krebs solution
containing 10 μM blebbistatin for an optimal recovery
time of 30 min, prior to electrophysiological assessment
using a custom-designed optical mapping system (Fig. 1F).
Figure 2 shows viable slices obtained with the optimised
protocol, summarised in Table 1, and representative Vm
and CaT signals from different regions, illustrating the
robustness of this preparation for murine research. We
monitored the ‘rundown’ of the Vm and CaT signals for
up to 4 h, the average signal ‘rundown’ is less than 25%.
Our experiments usually finished within 3 h.
Transmural and regional characteristics of Vm
After successful optimisation of the methodology, we
tested the feasibility of combining murine slices with
high resolution optical mapping for systematic trans-
mural and regional profiling of Vm and CaT across the
murine ventricles. Transverse slices (300 μm thick) were
prepared from the entire ventricles (from apex to base;
Fig. 2A), and AP duration (APD) and CaT duration
(CaTD) were mapped with high spatial and temporal
resolution. Examples are shown in Fig. 2B corresponding
to slice 10 shown in Fig. 2A.
Figure 3 summarises the distribution of APD at
50% repolarisation (APD50) and 75% repolarisation
(APD75) across the entire murine ventricles at 2 Hz
pacing frequency. Figure 3A and B show typical APD75
colour-coded maps and action potentials from a series
of transverse ventricular slices, suggesting the presence
of APD heterogeneities in the mouse ventricles. An
important advantage of the cardiac slice model is the
ability to study any region of the mouse ventricle and
thus simultaneously investigate transmural, apico-basal
(apex–base), and interventricular APD gradients. As
shown in Fig. 3C, there are significant transmural
gradients in APD50 and APD75 in the left ventricle at
2 Hz pacing frequency (Fig. 3Ca and c), with the shortest
APDs occurring in the epicardium and the longest APDs
occurring in the endocardium (APD50: Epi 50 ± 7 ms,
Endo 58 ± 8 ms, P < 0.01; APD75: Epi 71 ± 8 ms,
Endo 83± 8 ms, P = 0.0001, paired t test; n = 5 hearts).
Differences between longest and shortest APD (trans-
mural APD dispersion) in LV free wall were 8 ± 1 ms at
APD50 and 11± 1 ms at APD75. Importantly transmural
heterogeneities were not restricted to a particular region
of the left ventricle, but were present along the entire left
ventricle free wall from the apex to the base (Fig. 3Ca
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and c), with the highest transmural APD dispersion
occurring in the apical region (apex transmural dispersion:
16 ± 1 ms at APD75; P < 0.05, one-way ANOVA
comparing apex-centre-base transmural dispersion).
In addition to transmural APD distribution, cardiac
slices allowed us to investigate APD gradients across the
apico-basal axis of the left ventricle free wall. As shown
in Fig. 3Ca and c, there is no significant apico-basal
gradient in APD50 and APD75 in either epicardium or
endocardium (P > 0.05, one-way ANOVA with post hoc
Tukey’s test; n = 5 hearts).
Finally, as each slice contains left ventricle free wall,
right ventricle and septum, we were able to assess inter-
ventricular APD gradients. As shown in Fig. 3Cb and d,
there are significant interventricular differences in APD50
and APD75 at the base and centre, but not at the apex.
APD was shorter in the right ventricle in comparison to
the left ventricle and the septum, in the basal and centre
regions (P < 0.05, one-way ANOVA with post hoc Tukey’s
test; n = 5 hearts), with interventricular APD75 dispersion
of 23 ± 6 ms and 13 ± 3 ms, respectively.
Transmural and regional characteristics of CaT
Analysis of transmural and regional heterogeneity in
calcium handling are summarised in Fig. 4. Figure 4A
and B show representative maps of CaT duration (CaTD)
at 75% recovery (CaTD75) from apical, centre and basal
ventricular mouse slices during electrical pacing at 2 Hz
frequency (Fig. 4A), and typical optical CaT recordings
from corresponding regions (Fig. 4B). As shown in Fig. 4C,
there are significant transmural gradients in CaTD at 50%
recovery (CaTD50) in apical, centre and basal regions
of the left ventricle free wall at 2 Hz pacing frequency
(Fig. 4Ca), with significantly longer CaTD50 in the end-
ocardium compared to the epicardium (apex: 13% longer,
P < 0.01; centre: 8%, P < 0.05; base: 10%, P < 0.01;
n = 6–8 hearts). A significant transmural gradient in
CaTD75 (Fig. 4Cc) was also observed in the basal and
centre regions of the left ventricle (P < 0.05, paired t test;
n = 5–7 hearts), but not in the apical region.
We further assessed the distribution of CaTD along the
apico-basal axis of the left ventricle free wall. As shown






































Figure 2. Vm and CaT measurements in murine ventricular slices
A, bright field images of transverse ventricular slices (300 μm thick) prepared from both ventricles of a mouse
heart (from the apex to the base). Scale bar: 2 cm. B, AP duration (APD; Ba) and CaT duration (CaTD; Bb) maps
generated from a slice prepared from the central region of the ventricles, with raw AP and CaT signals acquired
from the epicardium (Epi) and endocardium (Endo) of the left ventricle, the ventricular septum (SEP) and the right
ventricle (RV). APD scale bar: 80 ms.
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CaTD50 and CaTD75 was observed in the murine left
ventricle (P > 0.05, one-way ANOVA; n = 5–7 hearts).
Finally, we compared CaTD measured in left ventricle
free wall regions with CaTD recorded in right ventricle
and ventricular septum regions for each tissue slice, to
investigate interventricular CaTD gradients. As shown in
Fig. 4Cb and d, there are significant regional differences
in CaTD50 but not CaTD75 at the apex and base, with
the shortest CaTD50 occurring in the right ventricle, and
an interventricular CaTD50 dispersion of 4 ± 1 ms and
6 ± 1 ms at the apex and base, respectively (n = 6–7
hearts).
Transmural and regional heterogeneity of
frequency-dependent AP and CaT alternans
Further experiments were carried out to assess the
feasibility of using murine transverse ventricular slices and
optical mapping to characterise transmural and regional
differences in frequency-dependent AP and CaT alternans
and arrhythmias. Slices were paced at frequencies of 2, 4,
8 and 16 Hz, and AP and CaT were recorded at each
frequency (Figs 5A and 7A). As shown in Figs 5 and
7, AP and CaT alternans and arrhythmic events often
occurred at higher pacing frequencies of 8 Hz and 16 Hz,
indicating a frequency-dependent relationship. At a high
pacing rate of 16 Hz, alternans often converted into
arrhythmia. An increase in AP alternans and arrhythmic
events occurred in all regions (LV, septum and RV) during
incremental pacing from 8 Hz to 16 Hz frequency (Fig. 5B).
Transmural heterogeneities were observed in the LV free
wall, with greater AP alternans and arrhythmic events
in the endocardium in comparison with epicardium at
both 8 Hz and 16 Hz frequencies (Fig. 5B; P < 0.05,
n = 6 hearts). There are no significant interventricular
differences observed in the incidence of AP alternans,
with a similar number occurring in the left ventricle, right

















































































































































Figure 3. Transmural and regional distribution of AP duration across the murine ventricles
A, representative maps of AP duration (APD75) at 2 Hz pacing frequency (500 ms pacing cycle length) recorded
from apex to base in transverse ventricular slices. B, typical optical AP recordings (unfiltered signals) obtained from
different regions of the murine ventricles at 2 Hz pacing frequency. Scale bar: 80 ms. C, quantitative summary of
transmural and regional APD50 (Ca and Cb) and APD75 distribution (Cc and Cd) at 2 Hz pacing (n = 5 hearts;
∗∗P < 0.01; ∗P < 0.05). Values expressed as means ± SEM. Epi, epicardium; Endo, endocardium; SEP, septum; RV,
right ventricle; LV, left ventricle.
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Figure 6 illustrates the activation maps generated within
bespoke ElectroMap analysis software (O’Shea et al. 2017).
A polynomial surface was then fitted to local activation
times to describe propagation in the area, and local CV
quantified as the gradient vector of the polynomial surface.
Mean CV was then calculated from the local CVs across
the tissue slice. As seen in Fig. 6, there is a clear slowing of
conduction at higher pacing frequencies. This is apparent
when CV data is analysed across all the slices (Fig. 6A-C)
or across individual hearts (Fig. 6A-C). In some slices we
analysed there is evidence of steep activation gradients and
focal activity, which may contribute to the arrhythmias
observed.
As shown in Fig. 7B, a significant increase in
CaT alternans and arrhythmic events occurred in the
epicardium and endocardium of the left ventricle, in the
ventricular septum and in the right ventricle with increase
of pacing frequency from 8 Hz to 16 Hz. Transmural
heterogeneities were also observed, with lower occurrence
of CaT alternans and arrhythmic events in the epicardium
in comparison with endocardium at both 8 Hz and 16 Hz
frequencies (Fig. 7B; P < 0.05, n = 6 hearts).
Discussion
In the present study we developed and validated a trans-
verse ventricular tissue slice model to enable systematic
analysis of Vm and CaT across the whole murine ventricles.
Our investigation of murine transverse slices, prepared
from both ventricles (from apex to base) combined with
high resolution optical mapping, revealed transmural and
regional heterogeneities in both physiological APD and
CaTD, and in the incidence of frequency-dependent AP
and CaT alternans in the murine ventricles.
Optimisation of cardiac slices for Vm and CaT
measurements
Cardiac slice technology has previously been employed





































































































































Figure 4. Transmural and regional distribution of CaT duration in the murine ventricles
A, representative maps of CaT duration (CaTD75) at 2 Hz pacing frequency (500 ms pacing cycle length) recorded
from apex to base in transverse ventricular slices. B, representative optical CaT raw traces obtained from different
regions of the murine ventricles at 2 Hz pacing frequency. Scale bar: 80 ms. C, quantitative summary of transmural
and regional CaTD50 (Ca and Cb) and CaTD75 distribution (Cc and Cd) at 2 Hz pacing (n = 5–8 hearts; ∗∗P < 0.01;
∗P < 0.05). Values expressed as means ± SEM. Epi, epicardium; Endo, endocardium; SEP, septum; RV, right
ventricle; LV, left ventricle.
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and animal hearts (Halbach et al. 2006; Bussek et al.
2009; Camelliti et al. 2011), but application of the pre-
paration in optical mapping studies is only starting to
emerge (Wang et al. 2015; Kang et al. 2016). This report
is the first to present a detailed protocol for successful
preparation of transverse ventricular slices for transmural
and regional profiling of Vm and CaT with high resolution
optical mapping. Important steps include dye loading via
Langendorff perfusion; slice cutting perpendicular to the
long axis of the heart; a slice thickness of 300 μm; and a
post-cutting recovery period of 30 min.
In contrast to prior reports of cardiac slice preparation,
slices were cut at right angles to the long axis of the heart
(transverse slices) and not tangentially to the epicardial
surface (Bussek et al. 2009; Camelliti et al. 2011). This
allowed us to prepare a complete series of slices containing
left ventricle, right ventricle and ventricular septum
regions from apex to base. Given the curvature of the
mouse ventricles and the different thickness of LV, RV
and septum at the apex and base, preparing tangential
slices containing well aligned cardiomyocytes covering the
entire ventricular tissue, for the study of transmural and
regional heterogeneities, was not feasible. Importantly our
study demonstrates that transverse mouse slices are viable
and show robust voltage and calcium signals. We identified
slice thickness as a critical parameter for successful pre-
paration of viable transverse slices. Previous studies have















































Figure 5. Regional and frequency-dependent distribution of AP alternans and arrhythmic events in
murine ventricular slices
A, representative optical AP traces obtained from different regions within a ventricular slice during electrical pacing
at 2, 4, 8 and 16 Hz frequency. Scale bar: 1s. B, transmural and regional occurrence of alternans and arrhythmias
at 8 Hz and 16 Hz pacing frequency. Epi, epicardium; Endo, endocardium; SEP, septum; RV, right ventricle; LV, left
ventricle. n = 6 hearts.
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1993; Halbach et al. 2006; Camelliti et al. 2011; Wang et al.
2015), but in this study we determined that 300 μm was the
best slice thickness to guarantee cell viability and achieve
optimal Vm and Ca2+ signals using optical mapping
techniques. Transverse slices less than 300 μm showed
significantly reduced Vm and CaT signals (Fig. 1E). We
suggest that, with mouse ventricular myocyte dimensions
estimated as 90 μm (length) × 25 μm (width) (Toischer
et al. 2010), overly thin slices may result in damage to
the vast majority of available cells within the slice. Slices
thicker than 400 μm, on the other hand, required larger
electrical stimulation pulses, longer post-cutting recovery
time, and suffered from poor oxygenation and limited
BDM washout. BDM, if not completely washed out, is
known to have residual effects on cardiac ion channels
(Coulombe et al. 1990). Oxygen supply, in the absence of
vascular perfusion, is guaranteed by diffusion in cardiac
slices. However, as the maximum diffusion distance for
cardiac contracting muscle is estimated to be 150 μm
(Barclay, 2005), slices thicker than 300 μm will be exposed
to hypoxic conditions, resulting in limited viability.
In previous studies, post-cutting recovery times ranging
from 30 min (Burnashev et al. 1990) to 2 h (Yasuhara et al.
1996) were reported. For transverse mouse ventricular
slices we determined an optimal recovery period to be
30 min. Slices cut in cold (4°C), oxygenated (99.5%
O2) Tyrode solution containing BDM were placed in
Krebs solution containing 10 μM blebbistatin at room
temperature (equilibrated with 95% O2/5% CO2) to
recover. The recovery time of 30 min allowed washout
of BDM and returned the slices to a more physiological
temperature. Our findings are consistent with previous
reports indicating recovery times for adult guinea-pig
slices and neonatal rat slices of, respectively, 36 min (Wang
et al. 2015) and 30 min (Pertsov et al. 1993; Davidenko et al.
1995).
Conduction velocity as an indicator of physiological
state is shown in Fig. 6. We demonstrate that conduction
velocity in our cardiac slices is comparable to conduction
velocity measured in whole mouse hearts by epicardial
optical mapping (Baker et al. 2000; Baudenbacher et al.
2008; Myles et al. 2012; Bao et al. 2016). As expected, higher
pacing frequencies lead to reduced conduction velocities,
further demonstrating physiological responsiveness of the
slices (Weber et al. 2011).
Cardiac slices for the study of transmural and
regional heterogeneity of Vm and CaT
A critical advantage of the cardiac slice model is the
ability to provide access to any region of the ventricles,
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Figure 6. Analysis of conduction velocity (CV)
A, activation maps of slices (apex to base) paced at 2 Hz and 16 Hz. Conduction velocity (CV) was calculated using
a multi-vector polynomial method within bespoke ElectroMap analysis software. A polynomial surface was fitted
to local activation times to describe propagation in the area, and local CV quantified as the gradient vector of the
polynomial surface. Mean CV was then calculated from the local CVs across the tissue slice. B, mean data for CV
at a range of pacing frequencies calculated across all the slices (n = 38 slices/3 hearts). C, mean data for CV at a
range of pacing frequencies calculated across all the hearts (n = 3 hearts).
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differences. This is particularly important for the mouse
heart, given that other in vitro tissue preparations, such as
ventricular wedges, are not feasible for small hearts.
Action potential and calcium handling heterogeneities,
and their role in the generation of arrhythmias, are
well documented in hearts from larger mammals (Yan
et al. 1998; Burton & Cobbe, 2001; Laurita et al. 2003;
Cordeiro et al. 2004; Patel et al. 2009; Glukhov et al. 2010;
Lou et al. 2011). However, experimental data on trans-
mural and regional electrophysiological characteristics
in the murine heart are still limited. In this study we
have combined transverse murine cardiac slices with high
resolution optical mapping for systematic transmural and
regional profiling of both Vm and CaT across the murine
ventricles. Our results indicate the presence of transmural
APD heterogeneities within the wall of the left ventricle
(Fig. 3), with the shortest APD observed in the epicardium,
in agreement with previously published results for single
isolated myocytes (Brunet et al. 2004) and ventricular
tissue (Knollmann et al. 2001). However, no significant
apico-basal APD gradients were found in our study
(Fig. 3), in contrast with previously reported findings on
single isolated myocytes (Xu et al. 1999; Bondarenko et al.
2004). Transmural and apico-basal gradients in the trans-
ient outward K+ current (Ito) are thought to be the main
determinant of APD heterogeneities in the mouse ventricle
(Xu et al. 1999; Brunet et al. 2004; Rossow et al. 2006).
Our results also indicate the presence of significant
interventricular differences in APD, with shorter APD in




















































Figure 7. Regional and frequency-dependent distribution of CaT alternans and arrhythmic events in
murine ventricular slices
A, representative optical CaT traces obtained from different regions within a ventricular slice during electrical
pacing at 2, 4, 8 and 16 Hz frequency. Scale bar: 1s. B, transmural and regional occurrence of alternans and
arrhythmias at 8 Hz and 16 Hz pacing frequency. Epi, epicardium; Endo, endocardium; SEP, septum; RV, right
ventricle; LV, left ventricle. n = 6 hearts.
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ventricular septum (Fig. 3). This is in agreement with data
from rodent studies (Watanabe et al. 1983; Knollmann
et al. 2001) and larger mammals investigations (Di Diego
et al. 1996; Volders et al. 1999), and it is likely to be the
result of differences in repolarisation currents which are
significantly higher in cells isolated from the right than the
left ventricle (Brunet et al. 2004; Molina et al. 2016).
Analysis of Ca2+ transients revealed the presence
of transmural and regional heterogeneity of calcium
handling in the murine ventricles, in addition to action
potential gradients. A significant transmural gradient
of CaTD50 and CaTD75 was found in the LV wall,
with a longer CaTD in the endocardium compared
to the epicardium (Fig. 4). Similar results have been
reported for hearts of other species (Figueredo et al.
1993; Laurita et al. 2003). Regional differences in the
expression of calcium regulatory proteins could explain
the observed transmural CaTD heterogeneity. Differences
in sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) and
ryanodine receptor type 2 (RyR2) protein expression, and
sodium–calcium exchanger function, have been reported
between epicardial and endocardial cells in different
species including mouse (Laurita et al. 2003; Cordeiro et al.
2004; Dilly et al. 2006; Lou et al. 2011). We also observed
interventricular differences in CaTD50 in our study, with a
shorter CaTD50 in the right ventricle in comparison to the
left ventricle and ventricular septum (Fig. 4), consistent
with previously reported interventricular differences in
Ca2+ handling and contractility in rodent hearts (Kondo
et al. 2006; Molina et al. 2016).
AP and CaT alternans during rapid pacing
Cardiac alternans in the form of T-wave alternans in
the ECG, corresponding to beat-to-beat alternations
in ventricular repolarisation, has demonstrated clinical
utility in stratifying risk for malignant arrhythmias
and sudden cardiac death, providing guidance for anti-
arrhythmic therapy (Verrier et al. 2011). At the cellular
level, cardiac alternans manifests as rate-dependent
beat-to-beat alternations in contraction, AP morphology
and CaT amplitude (Kanaporis & Blatter, 2015). In
our study, we observed alternans in AP amplitude as
well as in CaT amplitude when murine slices were
electrically stimulated at high pacing rates (Figs 5 and 6).
Alternans in AP amplitude have been reported previously
in left ventricular wedge preparations from normal and
post-infarction rabbit hearts during rapid pacing (Myles
et al. 2011). Importantly, alternans in AP amplitude were
related to the development of arrhythmias during rapid
pacing in the rabbit wedge, indicating that amplitude
alternans may be an important mechanism for ventricular
arrhythmia (Myles et al. 2011). As we demonstrated
in Figs 5–7, arrhythmia was clearly triggered by high
pacing frequency, when we observed reduced conduction
velocities and areas of steep activation gradients. The
majority of the events we observed were the non-sustained
ventricular tachycardia (VT) form; such non-sustained VT
is likely to be caused by focal activity and steep activation
gradients.
Our results indicate the presence of significant trans-
mural differences in pacing-induced AP and CaT alternans
in the mouse LV free wall, with greater incidence
of alternans in the endocardium compared with the
epicardium at both 8 Hz and 16 Hz pacing frequencies
(Figs 5B and 7B). To the best of our knowledge, this is
the first report describing transmural heterogeneities in
frequency-dependent AP and CaT alternans in the murine
heart. Regional differences in CaT alternans have been
previously described in the canine LV during rapid pacing
in studies using wedge preparations and isolated myo-
cytes (Laurita et al. 2003; Cordeiro et al. 2007). In these
published studies, larger levels of alternans were observed
in cells near the endocardium compared with cells near
the epicardium (Laurita et al. 2003; Cordeiro et al. 2007),
consistent with the findings of our study.
In the current study, we observed similar transmural
and regional distributions of AP and CaT alternans.
Electrical and CaT alternans are known to be highly
correlated, although it remains controversial whether
the primary cause of cardiac alternans is a disturbance
of intracellular Ca2+ signalling or electrical membrane
properties. In a recent study by Kanaporis and Blatter
(2015), the mechanisms of calcium cycling and action
potential dynamics in cardiac alternans have been
investigated in single rabbit atrial and ventricular myo-
cytes using combined [Ca2+]i and electrophysiological
measurements. The findings indicate that suppression of
Ca2+ release from the sarcoplasmic reticulum abolished
APD alternans, supporting a central role for intracellular
Ca2+ cycling in the development of cardiac alternans
(Kanaporis & Blatter, 2015). Cardiac slices, simultaneously
loaded with voltage- and Ca2+-sensitive dyes, will allow us
to examine the cellular mechanisms of cardiac alternans
in a more representative multicellular model system.
Study limitations
A limitation to the study is the possibility of injury
and uncoupling; partial uncoupling (reduction in
conductance) could increase the differences in APDs
between epicardial and endocardial regions.
Conclusions
We have developed and validated a robust experimental
methodology which combines transverse ultra-thin
cardiac slices and high resolution optical mapping to
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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enable systematic analysis of transmural and regional
gradients in Vm and CaT across the entire murine
ventricles.
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Thin living tissue slices have recently emerged as a new tissue model for cardiac
electrophysiological research. Slices can be produced from human cardiac tissue, in
addition to small and large mammalian hearts, representing a powerful in vitro model
system for preclinical and translational heart research. In the present protocol, we
describe a detailed mouse heart transverse slicing and optical imaging methodology.
The use of this technology for high-throughput optical imaging allows study of
electrophysiology of murine hearts in an organotypic pseudo two-dimensional model.
The slices are cut at right angles to the long axis of the heart, permitting robust
interrogation of transmembrane potential (Vm) and calcium transients (CaT) throughout
the entire heart with exceptional regional precision. This approach enables the use
of a series of slices prepared from the ventricles to measure Vm and CaT with high
temporal and spatial resolution, allowing (i) comparison of successive slices which form
a stack representing the original geometry of the heart; (ii) profiling of transmural and
regional gradients in Vm and CaT in the ventricle; (iii) characterization of transmural and
regional profiles of action potential and CaT alternans under stress (e.g., high frequency
pacing or β-adrenergic stimulation) or pathological conditions (e.g., hypertrophy). Thus,
the protocol described here provides a powerful platform for innovative research on
electrical and calcium handling heterogeneity within the heart. It can be also combined
with optogenetic technology to carry out optical stimulation; aiding studies of cellular Vm
and CaT in a cell type specific manner.
Keywords: optical mapping, transverse cardiac slice, membrane potentials, Ca2+ transients, murine heart
INTRODUCTION
Thin living tissue slices are a widely used experimental preparation for electrophysiological studies
of the brain (Accardi et al., 2016). Slices have recently been adopted as a promising model for the
investigations of cardiac electrophysiology in different species, for example: viral delivery, culturing,
and mechanical stimulation (Halbach et al., 2006; Bussek et al., 2009; Camelliti et al., 2011;
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Wang et al., 2015; Kang et al., 2016; Thomas et al., 2016;
Randi et al., 2017; Watson et al., 2017, 2019; Wen et al., 2018).
Importantly, cardiac slices exhibit similar electrophysiological
characteristics to the intact heart and respond to the application
of pharmacological compounds similarly to the whole heart
(Bussek et al., 2009; Camelliti et al., 2011; Wen et al., 2018).
They have advantages for investigating transmural and regional
characteristics of a variety of physiological parameters of
the heart, thus providing a promising experimental model
for heart research.
Because of feasibility for genetic modification, the mouse
has been widely used for exploring molecular, cellular and
systemic mechanisms underlying inherited and acquired cardiac
arrhythmic diseases (Nerbonne and Kass, 2005; Huang, 2017).
Despite the popularity of mouse models in cardiac arrhythmic
research, cardiac transmural heterogeneities of action potential
and Ca2+ transient characteristics, which are vitally important
for phenotypic and mechanistic research in cardiac disease
conditions, have only been explored recently in the mouse
heart (Wen et al., 2018). We reported a robust approach for
transverse cardiac slicing and optical mapping of transmembrane
potential (Vm) and intracellular Ca2+ transient (CaT) in
murine hearts, providing unprecedented and potentially high-
throughput characterization of action potentials (APs) and
intracellular Ca2+ transients everywhere in the mouse ventricles
(Wen et al., 2018). Such an approach can be potentially adapted
for large mammalian hearts and human tissue, thus representing
a powerful in vitro model system for translational cardiovascular
research (Thomas et al., 2016; Randi et al., 2017; Watson et al.,
2017, 2019). Using this technique, we demonstrated the feasibility
of our new approach to cardiac slicing for systematic analysis of
intrinsic transmural and regional gradients in Vm and CaT in
murine ventricular tissue (Wen et al., 2018).
In the present protocol, we describe a detailed feasible
transverse slicing method, cutting slices at right angles to the
long axis of the heart and combined it with a high-throughput
optical imaging technique as a new approach for studying
cellular electrophysiology of murine heart in an organotypic
pseudo two-dimensional ventricular tissue model. Our method
enables the use of a series of slices prepared from the ventricles
to simultaneously measure Vm and CaT with high temporal
and spatial resolution allowing comparison of transmural and
regional profiles of APs and CaTs. This technique can potentially
be combined with other molecular techniques such as in situ
immunostaining and virus transfection to gain insight into
arrhythmia mechanisms in various heart disease conditions.
MATERIALS AND EQUIPMENT
Animals
Animals used were 10–12 weeks, 20–25 g, male C57BL mice or
Pnmt-Cre/ Channelrhodopsin 2 (ChR2) mice as we previously
reported (Wang et al., 2017). The Pnmt-Cre/ChR2 mouse
line exhibits cell-type specific expression of ChR2 by crossing
B6.Cg-Gt (ROSA)26Sortm27.1(CAG−COP4H134R/tdTomato)Hze/J
strain (Stock No. 012567, Jackson Labs) with a Cre transgenic
strain under the control of a Pnmt promoter (Wang et al., 2017).
ChR2 was specifically introduced into murine cells expressing
the Phenylethanolamine n-methyltransferase (Pnmt) gene,
which encodes for the enzyme responsible for conversion
of noradrenaline to adrenaline. The murine model led to
the identification of a distinctive class of Pnmt-expressing
neuroendocrine cells and their descendants (i.e., Pnmt+ cell
derived cardiomyocytes) within the heart (Wang et al., 2017).
All procedures including animal subjects have been
approved by Institutional Animals Ethics Committees at
Southwest Medical University, Luzhou, China or Department
of Pharmacology at University of Oxford, United Kingdom and
the national guidelines under which the institution operates. All
mice used in this study were maintained in a pathogen−free
facility at Southwest Medical University or University of Oxford.
Mice were given ad libitum access to food and water. The authors
confirm that they have taken all steps to minimize the animals’
pain and suffering.
Chemicals and Reagents
The relevant information of the chemicals and reagents are
described in Table 1.
Instruments and Equipment
- Dumont forceps (Medical Equipment Factory of Shanghai
Medical Instruments Co., Ltd., Shanghai, China).
- Mayo scissors (Medical Equipment Factory of Shanghai
Medical Instruments Co., Ltd., Shanghai, China).
- Kelly hemostatic forceps (Medical Equipment Factory of
Shanghai Medical Instruments Co., Ltd., Shanghai, China).
- Iris forceps (Medical Equipment Factory of Shanghai
Medical Instruments Co., Ltd., Shanghai, China).
- Syringe Filter, Aquo-system, 0.45 µm/13 mm (Sangon
Biotech Shanghai, China, F513143-0001).
- Langendorff perfusion system.
- Perfusion pump (Longer Precision Pump Co., Ltd.,
Baoding, China, BT100-2J).
- Vibration slicer (Leica VT1000s, Nussloch, Germany).
- EMCCD camera (Evolve 512, Photometrics, Tucson,
AZ, United States).
- MacroLED light source (Cairn Research, Faversham,
United Kingdom).
- MyoPacer EP field stimulator (Ion Optix Co., Milton, MA,
United States S006152).
- Electrical stimulation chamber (custom-made by
the workshop of Department of Pharmacology,
University of Oxford).
- Heater Controller (custom-made by the workshop of
Department of Pharmacology, University of Oxford).
Solutions
- Krebs solution (containing in mM: NaCl 119, NaHCO3
25, NaH2PO4 1.0, KCl 4.7, MgCl2 1.05, CaCl2 1.35, and
glucose 10; equilibrated with 95% O2/5% CO2, pH 7.4) at
37◦C, pH = 7.35–7.4.
- HEPES buffered BDM solution (in mM: NaCl 140; KCl 4.7;
glucose 10; HEPES 10; MgCl2 1.05; CaCl2 1.35; pH 7.4)
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TABLE 1 | Reagents utilized.
Chemical and catalog references Supplier







HEPES (W1122DO10) Sangon biological, Shanghai, China
2,3-butanedione monoxime (BDM) (29297) Sigma-Aldrich
Blebbistatin (SLBV5564) Tocris Bioscience, Minneapolis, MN, United States
Voltage-sensitive dye RH237 (1971387) Thermo Fisher Scientific, Waltham, MA, United States
Calcium indicator Rhod-2AM (1890519) Invitrogen, Carlsbad, CA, United States
Dimethyl sulfoxide (DMSO) (RNBT7442) Sigma-Aldrich
Heparin Sodium (H51021209) Chengdu Haitong Pharmaceutical Co., Ltd., Chengdu, China
Avertin (2,2,2-tribromoethanol) Sigma-Aldrich Poole, Dorset, United Kingdom
Pluronic F127 (1899021) Invitrogen, Carlsbad, CA, United States
Low-melt agarose (A600015.0005) BBI Life Sciences, Shanghai, China
containing the excitation–contraction uncoupler 2,3-
butanedione monoxime (BDM, 10 mM) and was stored
at 4◦C.
- Blebbistatin stock solution, 10 mM in DMSO.
- Voltage-sensitive dye RH237 stock solution,
1.25 mg/mL in DMSO.
- Calcium indicator Rhod-2AM stock solution,
1 mg/mL in DMSO.
Preparation of Experimental Setup(s)
- Prepare the Langendorff perfusion system. Turn on the
perfusion system pump. Starting the peristaltic pump
that is used for retrograde perfusion. Wash the perfusion
system with 1 L deionized water with initial flow rate at
90 ml/min. Once all the deionized water has evacuated
from the chamber, circulate the Krebs solution and pass
it through a 0.45 µm filter. Keep Krebs solution at 37◦C
with a water jacket, circulated and oxygenated by bubbling
O2/CO2 (95%/5%) gas into the solution. Adjust the flow
rate to 4 ml/min.
- Prepare the optical mapping system (Figure 1), a custom-
designed system equipped with an EMCCD camera. The
excitation light for Ca2+ sensitive dye Rhod-2 and voltage
sensitive dye RH237 is provided by four MacroLED lamps
(525 nm, 1750 lumen, 7 mm2 emitters, Cairn Research)
with aspheric condensers driven using MacroLED control
boxes and digitally modulated from Metamorph software.
LEDs are directed onto the slices from the four corners of
the bath, to produce an even, near-critical, illumination at
approximately 30 mm, with equal distance from 4 corners.
An ET525/50 sputter coated filter (Chroma Technology) is
used to remove any out-of-band light for each LED.
Samples are imaged using a custom MacroScope (Cairn
Research) with an F/0.95, 25 mm C-mount camera lens,
spaced to give a working distance of approximately 40 mm.
The fluorescence emission light is split with a 635 nm
longpass dichroic mirror and subsequently filtered (Vm:
662 nm LP, CaT: 585/40 nm) to separate the Ca2+
and voltage signals based on their wavelengths using the
OptoSplit apparatus (Cairn Research). Once split, the Vm
and CaT signals are imaged on to the camera such that they
are reproduced side-by-side on the sensor and recorded
simultaneously (Vm imaged on one side of the chip,
CaT on the other).
- Prepare the vibratome. Install a new blade at the holder and
fill the cooling chamber with crushed ice.
PROCEDURE
Figure 2 shows the major steps of the protocol.
Harvest, Cannulation, and Perfusion of
Mouse Heart (30 min)
(1) Anesthetize the animal with 1.2% Avertin solution (0.5–
0.8 ml I.P.) containing heparin (200 units I.P.), ensuring
lack of pain reflex, prior to sacrifice (Complete in 10 min).
(2) Open the chest, quickly remove the heart and keep the
heart in oxygenated (95% O2, 5% CO2), (37 ± 1◦C) Krebs
solution. Using a dissecting microscope, identify the aorta
and make a clean cut across the ascending aorta below
the right subclavian artery. Cannulate the aorta onto a
custom-made cannula and tie with 4-0 black-braided silk
suture around the cannula. After cannulation, retrogradely
perfuse the heart and superfuse with constant-temperature
(37 ± 1◦C) Krebs solution. The retrograde perfusion rate
was adjusted in the range of 3.5–4.0 mL/min (Complete
this step in 3 min).
(3) Important! Insert a small silicon tube (0.7 mm diameter)
into the left ventricular cavity through the left atrial
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FIGURE 1 | Optical mapping set-up. The system consists of a camera (Photometrics Evolve Delta 512) running under Metamorph (Molecular Devices) in
Light-speed mode, giving a high temporal resolution of sub-frames, up to 1000 frames/sec, and spatial resolution at the sample of 74 × 74 µm per pixel. The
sample was imaged using a custom MacroScope (Cairn Research) with an F/0.95, 25 mm C-mount camera lens, spaced so as to give a working distance of
approximately 40 mm. The excitation light was provided by a four light emitting diode MacroLED lamps (525 nm, 1750 lumen, 7 mm2 emitters, Cairn Research) with
aspheric condensers directed onto the slices from the four corners of the bath, so as to produce an even, near-critical, illumination at approximately 30 mm. The
LEDs were driven using MacroLED control boxes and digitally modulated from Metamorph software with a National Instruments multifunction card. The LEDs were
individually filtered using ET525/50 sputter coated filters (Chroma Technology) to remove any out-of-band light. The fluorescence emission light was split with a
610 nm long-pass dichroic mirror and corresponding emitters to separate the Ca2+ and voltage signals based on their wavelengths. The voltage-sensitive dye,
RH237, emits signals which exhibit a peak at 670 nm, while Rhod-2 AM has a peak emission at approximately 600 nm and, once split by the dichroic mirror, these
two signals are imaged on to the camera such that they are reproduced side-by-side on the sensor and recorded simultaneously. This dichroic and adjustable mirror
unit, the OptoSplit, was provided by Cairn Research with filters from Chroma Technologies (United States). CaT fluorescence was collected at 585 ± 40 nm and Vm
using a 662 nm long pass filter. Vm and CaT measurements were taken at maximal resolution (128 × 128 pixels; pixel area 74 × 74 µm) at a rate of 1000 frames/s.
FIGURE 2 | The major steps of the protocol. Representative harvested mouse heart and transverse slices from apex to base. Briefly, after the Langendoff perfusion
steps (A), embed the heart in 4% low-melting agarose and cut with right angle to the long axis by Leica VT1000s vibratome (B). Slices are transferred to petri dishes
(C) and voltage and calcium transients recorded (D).
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appendage in order to prevent ventricular pressure
increasing due to solution congestion and to prevent
acidification of the perfusate trapped in the left
ventricular cavity. This is especially important after
the suppression of ventricular contractions with an
excitation-contraction uncoupler.
After the dyes are loaded, the steps described in Sections
“Chemicals and Reagents,” “Instruments and equipment,” and
“Solutions” should be performed in the dark.
Load Calcium and Voltage Sensitive
Dyes and Excitation-Contraction
Uncoupler (50–60 min)
(1) Before dye loading, ensure the isolated heart is beating
rhythmically without ischemia (10 min).
(2) Mix 50 µl calcium indicator Rhod-2 AM 1:1 with Pluronic
F127 (20% solution in DMSO) and then dilute in 1 ml
Krebs solution. Recirculate oxygenated (95% O2, 5% CO2)
Krebs solution at constant-temperature (37 ± 1◦C) and
then inject Rhod-2 AM solution slowly over 7–10 min
through the injection port near the cannula.
(3) Continue to recirculate Krebs solution after finishing
injection (now, the perfusate contains Rhod-2 AM and
Pluronic F127) (20 min).
(4) During this time, dilute 30 µl voltage-sensitive dye RH237
(1.25 mg/ml stock) in 1 ml Krebs solution.
(5) Switch to perfusion with oxygenated (95% O2, 5% CO2),
constant-temperature (37 ± 1◦C), Krebs solution and
perfuse the heart for 2–3 min. Then inject RH237 solution
slowly over 7–10 min through the injection port.
(6) After loading the voltage dye, recirculate oxygenated
Krebs solution containing 10 µM blebbistatin [maintaining
constant temperature at 37 ± 1◦C] until the heart stops
beating (10–15 min).
(7) Whilst waiting for the heart to stop beating, prepare
equipment and solutions for ventricular slicer. A standard
razor blade is cut into half and placed on the blade holder
so that the blunt side of the blade was tight up against
the holder. A circle of solidified agar is mounted on the
ventricular slicer’s plunger using superglue.
Ventricular Slicing, Harvest, and
Recovery (60–70 min)
(1) Take the heart off the Langendorff setup.
(2) Carry out all dissections in ice cold HEPES buffered BDM
solution. Remove atria and connective tissue from the
ventricles to flatten the base.
(3) Mount base of the heart on solidified 4% agarose of slicer’s
plunger using surgical glue.
(4) Freshly prepare 4% low-melt agarose, cool on ice, and pour
to cover the whole heart. Surround the plastic cap with
the metal support.
(5) After the agarose is solidified, place the ventricular slicer
plunger inside the metal merged into vibratome bath until
it reaches stop point. Fill the ventricular slicer bath with
ice-cold HEPES buffered BDM solution.
(6) Cut slices transversally at a thickness of 300–350 µm, with
speed of 0.05 mm/s, amplitude of 1 mm and vibration
frequency of 80 Hz (2 min per slice).
(7) On average 14 ventricular slices are harvested. Transfer
each slice (other than the first which was usually discarded)
to a petri dish containing ice-cold HEPES buffered BDM
solution for 10 min. Pin the slices on small pieces of thin
square shape Sylgard sheets (1 × 1 cm in diameter, 0.2 cm
thickness), cover with mesh. Then transfer the slices to 1st,
2nd, and 3rd petri dishes filled with oxygenated blebbistatin
Krebs solution (10 µM) at room temperature (RT) for
10 min in each dish.
(8) Repeat slicing procedure until the last slice is harvested.
Optical Mapping
(1) Place each slice in oxygenated blebbistatin Krebs solution
(10 µM) in 37◦C tissue bath for 2–3 min to equilibrate.
(2) Place the slice into a custom-made stimulation chamber
filled with 37◦C oxygenated blebbistatin Krebs solution
(10 µM) between the two pacing electrodes. Use pin(s) and
mesh to flatten the slice.
(3) Place the slices into the optical mapping setup (Figure 2,
details in Materials and equipment). For field pacing,
stimulate with square pulses of 2 ms duration, at voltages
1.5 times above threshold (minimum voltage required to
pace tissue) with 1:1 coupling.
(4) For optical pacing, the tissues are paced through the
activation of ChR2 light-sensitive channels. This is achieved
by the delivery of 470 nm blue light pulses (2–10 ms
pulse width) generated by OptoFlash (Cairn Research,
Faversham, United Kingdom). Pulses are triggered by a
1401 digitiser and Spike 2 software (Cambridge Electronic
Design). Approximate blue light intensity is measured with
a 818-ST2 Wand Detector connected to a 843 R Power
meter (both Newport Corporation, CA, United States) and
we estimate an average irradiance in our experiments of
0.1–0.3 mW/mm2 based on an approximate distance of
1–2 cm between Sylgard and liquid light guide (Oriel
instruments Model No 77525).
(5) For AP and CaT alternans investigations, stimulate slices at
frequencies of 2, 4, 8 and 16 Hz. Between pacing protocols,
turn off the LED lights to minimize photobleaching (and
other possible side effects, including phototoxicity). When
testing, turn off the oxygenation to avoid motion artifacts.
(6) After experiment is finished, clean the perfusion system
with deionized water.
Data Analysis
(1) Recorded image files are loaded into an optical mapping
analysis software ElectroMap1 (O’Shea et al., 2019). Pre-
process images with application of 3 × 3 pixel Gaussian
spatial filter and top-hat (kernel length = 100 ms)
baseline correction.
1https://github.com/CXO531/ElectroMap
Frontiers in Physiology | www.frontiersin.org 5 June 2019 | Volume 10 | Article 755
fphys-10-00755 June 24, 2019 Time: 15:59 # 6
He et al. Cardiac Slicing and Optical Mapping
(2) Measure action potential duration (APD)/Calcium
transient duration (CaTD) at desired repolarization/decay
percentage at each pixel across the tissue, as measured
from time of maximum upstroke velocity. Voltage-calcium
latency can be measured as time difference between
AP and CaT peak.
(3) For assessment of conduction velocity, render activation
map by measuring activation time, for example by
measuring depolarization midpoint or upstroke time
(dV/dt max). Conduction velocity across the slice can then
be quantified using multi-vector polynomial method with a
local window size of 5× 5 pixels (Bayly et al., 1998).
Exemplar Results
Figure 1 shows the optical mapping set-up. After the slices
were prepared, slices were pre-incubated at room temperature
in Krebs solution containing 10 µM blebbistatin for an optimal
recovery time, prior to electrophysiological assessment using a
custom-designed optical mapping system.
Figure 2 shows the major steps of the protocol. To achieve
optimal dye loading, the voltage dye RH237 and/or Ca2+ dye
Rhod-2 AM were loaded through the coronary circulation using
the Langendorff perfusion system (Figure 2A). Prevention of
blood clot formation was essential for optimal dye loading and
was achieved by initial injection of heparin (200–300 units)
before animal sacrifice. Ventricles were embedded in low-melting
temperature agarose as illustrated in Figure 2B to provide
structural support to the tissue during sectioning. Slices were
cut at right angles to the long axis of the heart from the
apex to the base, and thicknesses from 300–350 µm found
to be the best thickness to achieve optimal recordings for
both Vm and CaT (Figure 2B). Figure 2C shows viable slices
obtained with the optimized protocol and representative Vm
and CaT signals.
Figure 3A shows fluorescence images of voltage dye RH237
and Ca2+ dye Rhod-2 AM as imaged using the optical mapping
setup. Using this protocol, and the optical imaging setup, we
are able to dually measure parameters such as AP duration
(Figure 3B) and CaT duration and (Figure 3C). The “rundown”
of the Vm and CaT signals was monitored for up to 4 h, the
average signal “rundown” being less than 25%. Our experiments
usually finished within 3 h from the beginning of Langendorff
perfusion of the heart.
Figure 4 shows an example of activation (Figure 4A) and
APD75 (Figure 4B) maps reconstructed from electrical and light-
paced APs in a ventricular slice from Pnmt-Cre/ChR2 mouse
heart. Also shown are exemplar Vm signals from different regions
of the ventricle.
DISCUSSION
The protocol described here allows high resolution mapping
of Vm and CaT on thin transverse slices cut at right angles
to the long axis of the heart, permitting robust interrogation
of Vm and CaT throughout the entire heart with exceptional
regional precision. Since the apico-basal location of each
FIGURE 3 | Dual Vm and CaT imaging in murine transverse ventricular slices.
(A) Fluorescence image (voltage-RH237) of transverse slices of murine
ventricles from apex to base, dual loaded with both transmembrane voltage
(RH237) and intracellular calcium dyes (Rhod-2 AM). (B) Representative maps
of AP duration (APD50) at 2 Hz pacing frequency (500 ms pacing cycle length)
recorded from apex to base ventricular slices. (C) Representative maps of
Calcium transient duration (CaTD50) at 2 Hz pacing frequency recorded from
apex to base ventricular slices.
slice is known and every slice is fully transmural, such rich
data allows for characterization of regional AP and CaT
properties. This includes AP and CaT durations, alternans
threshold, transmural activation and conduction velocities, and
correlation of AP and CaT properties such as voltage-calcium
coupling latency in each slice. The main processes of the
protocol include: (i) Preparing solutions and experimental
setup; (ii) Harvesting, cannulation and perfusion of the mouse
heart by Langendorff perfusion; (iii) Loading calcium and
voltage sensitive dyes and excitation-contraction uncoupler; (iv)
Ventricular Slicing; (v) Optical mapping; (vi) Image processing
and analysis. The protocol was further developed since it
was first published (Wen et al., 2018) in two major aspects:
(i) simultaneous dual dye images allowing correlation of AP
and CaT properties in each slice; (ii) implementing improved
image processing and analysis such as correlation of AP
and CaT properties.
Applications
Our novel approach potentially provides not only a unique
technique applicable to hearts of other species (such as
widely used rat and rabbit), but also other tissues such as
brain, adrenal medullary tissue, gut, etc. As we demonstrate
here (Figure 4), such slice imaging technique can be
also combined with optogenetic technology to carry out
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FIGURE 4 | Comparison of electrical (field stimulation) and light (470 nm pulses) pacing in murine transverse ventricular slices. (A) Activation map and example
signals (transmembrane voltage, RH237) from slice paced using electrical field stimulation. (B) Activation map and example signals from the same slice paced using
blue light stimulation of ChR2. (C) APD75 map from slice during electrical field stimulation. (D) APD75 map from slice during blue light stimulation.
optogenetic light stimulation of specific cells. Such an approach
could be further extended by use of genetically encoded
reporter proteins allowing cell-type specific study of Vm
and Ca2+ signals, as well as cell-specific activation. We
believe that the approach would be of considerable interest
to researchers in manifold biomedical research fields and
would serve as a useful platform for further innovative
biomedical research.
Advantages
Firstly, a critical advantage of our cardiac slice model is the
ability to provide access to any region of the ventricles, thus
enabling exploration of regional and transmural differences.
This is particularly important for the mouse heart, given
that other in vitro tissue preparations, such as ventricular
wedges, are not feasible for small hearts. Secondly, this
technique may prove extremely valuable for characterizing
regional arrhythmogenic changes in genetic murine models
of cardiovascular disease (e.g., catecholaminergic polymorphic
ventricular tachycardia, hypertrophic cardiomyopathy), as well
as comprehensive regional characterization of remodeling in
acquired pathologies (myocardial infarction, pressure-overload
heart failure). Thirdly, depending on the optics, camera
resolution, and slice size and position, it may be possible to image
several or all slices from a single mouse heart simultaneously,
giving a high throughput platform to electrophysiological
investigations. Finally, it can also be combined with optogenetic
technology to carry out optogenetic light stimulation –
aiding studies requiring precise manipulation of cellular
Vm and CaT.
Limitations and Adaptations
(i) Possibility of tissue injury increasing regional Vm and CaT
differences. This can be overcome by optimized protocol with
very slow cutting speed, embedding in supportive but oxygen
permeable medium, and use of blebbistatin as uncoupler during
slice preparation. (ii) Rundown of the Vm and CaT signals. The
“rundown” of the Vm and CaT signals was also monitored for up
to 4 h, the average signal “rundown” being less than 25%. Our
experiments usually finished within 3 h. This can be overcome
by eÿcient imaging processes, and the application of 0.5 mM
Probenecid in the recovery and recording solutions to reduce the
Ca2+ dye loss. (iii) The measurements of the parameters under
electrical pacing condition was conducted by field stimulation
(considering the fragile dedicated slice preparation), thus our
approach may suffer from tissue activation occurring at the same
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time point across the preparation. Whilst this is not what we
observed regularly in our data, this approach may affect the
conduction velocity (CV) measurement. A better approach with
point stimulation or selective optical activation of a subset of cells
(Figure 4) should be pursued.
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Chapter 6
Temporal irregularity quantification and mapping of optical
action potentials using wave morphology similarity
Within the ElectroMap software we incorporated several established processing
and analysis methods. However, in producing the software we also wanted to
introduce novel methods for analysis of optical mapping data. Here, we
introduce semi-automated analysis of temporal regularity from optically recorded
action potentials. This is important as temporal alterations in action potential
morphology are both predictive and consequent of arrhythmia, so robust
methods to quantify temporal heterogeneity are valuable tools for optical
mapping research. In this chapter, we tested both direct application of clinically
used methodologies, namely the regularity index, and also adaption of existing
techniques for use with optically recorded action potentials.
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a b s t r a c t
Background: Cardiac optical mapping enables direct and high spatio-temporal resolution recording of
action potential (AP) morphology. Temporal alterations in AP morphology are both predictive and
consequent of arrhythmia. Here we sought to test if methods that quantify regularity of recorded
waveforms could be applied to detect and quantify periods of temporal instability in optical mapping
datasets in a semi-automated, user-unbiased manner.
Methods and results: We developed, tested and applied algorithms to quantify optical wave similarity
(OWS) to study morphological temporal similarity of optically recorded APs. Unlike other measures (e.g.
alternans ratio, beat-to-beat variability, arrhythmia scoring), the quantification of OWS is achieved
without a restrictive definition of specific signal points/features and is instead derived by analysing the
complete morphology from the entire AP waveform.
Using model datasets, we validated the ability of OWS to measure changes in AP morphology, and tested
OWS mapping in guinea pig hearts and mouse atria. OWS successfully detected and measured alterations
in temporal regularity in response to several proarrhythmic stimuli, including alterations in pacing
frequency, premature contractions, alternans and ventricular fibrillation.
Conclusion: OWS mapping provides an effective measure of temporal regularity that can be applied to
optical datasets to detect and quantify temporal alterations in action potential morphology. This
methodology provides a new metric for arrhythmia inducibility and scoring in optical mapping datasets.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Cardiac arrhythmias, such as ventricular and atrial fibrillation
(VF/AF), are characterised by complex spatiotemporal activation
and repolarisation dynamics (Moe and Abildskov, 1959; Ten
Tusscher et al., 2007; Pandit and Jalife, 2013). Advances in knowl-
edge of the mechanistic drivers or origins of these events (Atienza
et al., 2012; Schotten et al., 2011) could be used to develop more
effective therapies, for example, leading to improvements in radi-
ofrequency ablation procedures (Ravelli and Mase, 2014; Li et al.,
2017). However, recordings of cardiac electrical activity in the
time preceding and during an arrhythmia are often temporally
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disorganised and/or irregular. In the case of electrogram recordings,
such signals are termed ‘fractionated’ and the more complex
morphology reflects local differences in activation, repolarisation
and/or fibrotic areas within the tissue, leading to alterations in the
amplitude and temporal regularity of the recorded signal (Caldwell
and Redfearn, 2012; Baher et al., 2019). In optical mapping, where
action potentials (APs) are recorded using voltage sensitive fluo-
rescent indicators, arrhythmias are associated with similar alter-
ations in signal amplitude and temporal heterogeneity (Laughner
et al., 2012). For these reasons, signal parameters such as cycle
length and AP duration (APD) become inconsistent and hard to
define/measure. Thus, novel temporal heterogeneity measures not
reliant on definedwaveform points/features consisting of repetitive
periods of depolarisation and repolarisation are required.
For both electrogram and optical mapping datasets, strategies
have been proposed for quantification of electrophysiological
properties in the time prior to and during an arrhythmia. Beat to
beat analyses have been successfully utilised in several optical
mapping studies to highlight temporal instability (Wang et al.,
2014; Winter et al., 2018; O’Shea et al., 2019a). These approaches
however can be labour intensive, while high throughput method-
ologies rely on the automated identification of specific signal
points, features (e.g. activation and repolarisation times) and phe-
nomena (e.g. alternans) (O’Shea et al., 2019a; Fabritz et al., 2003).
These features can become challenging to algorithmically and
accurately measure when signal amplitude decreases, as is
observed at fast pacing frequencies and during polymorphic
arrhythmia (Laughner et al., 2012; O’Shea et al., 2019a). Further-
more, dominant frequency (Laughner et al., 2012) and phase
analysis (Umapathy et al., 2010; Kirchhof et al., 1998) have been
employed to map regions of the heart that may act as drivers of
arrhythmia (e.g. mother rotors) and to predict termination of
arrhythmia episodes. However, these methodologies either forgo
‘direct’ analysis of the signal waveforms or rely on manual in-
spection. Instead, they use mathematical techniques to transform
the signal into another form, for example, into the frequency
domain via the fast Fourier transformation.
In electrogram-based electrophysiological mapping, the ‘regu-
larity index (RI)’ has been shown to be an effective method to
quantify temporal organisation directly (Faes et al., 2002; Ravelli
et al., 2005). This method, as first set out in 2002 for atrial elec-
trograms (Faes et al., 2002), computes the similarity between local
activationwaves with the hypothesis that waves with a lower index
are representative of tissue areas with dyssynchronous activation
and repolarisation. RI and similar methods have the advantage of
quantifying temporal regularity using simple signal processing
methods across the entire waveform morphology (Baher et al.,
2019; Faes et al., 2002). The RI approach relies on the setting of a
threshold value for ‘similarity’. The use of such an approach for
analysis of optical signals has not been evaluated, in particular the
effects of setting a similarity threshold.
In this study, we have developed and utilised RI mapping in
optical mapping datasets, and further develop an analogous but
updated approach for use in optical mapping datasets which we
term optical wave similarity (OWS). RI and OWS metrics are
compared. OWS is measured from optical mapping datasets to
demonstrate its utility in detecting and quantifying temporal ho-
mogeneity/regularity of model and optical action potentials (OAPs).
Temporal heterogeneity is induced by changes in pacing cycle
length and sympathetic nervous stimulation (SNS) in guinea pig
ventricles and isolated mouse left atria. Robust measures of tem-
poral heterogeneity across the myocardium, recorded using optical
mapping methodologies and integrated into freely available soft-
ware, will potentially help researchers identify novel drivers of




All animal procedures were undertaken in accordance with
ethical guidelines set out by the UK Animals (Scientific Procedures)
Act 1986 and Directive 2010/63/EU of the European Parliament on
the protection of animals used for scientific purposes. Experiments
were approved by the home office (mouse: PPL 30/2967 and
PFDAAF77F, guinea pig: PPL PF75E5F7F) and the institutional re-
view boards at University of Birmingham (mouse) and King’s Col-
lege London (guinea pig).
2.2. Optical mapping
All data utilised in this study were acquired previously, full
details of experimental procedures can be found in the relevant
publications (Winter et al., 2018; Holmes et al., 2016; Yu et al.,
2014).
Briefly, ex vivo isolated intact guinea pig whole hearts were
imaged utilising an innervated preparation (Ng et al., 2001). Hearts
were loaded with voltage dye Di-8-ANEPPS (1 mg/ml in DMSO,
200e300 ml), paced via silver bipolar electrodes and imaged at
0.5 kHz at 64  64 pixel resolution (320 mm pixel width). Sym-
pathetic nervous stimulation (SNS) was achieved by bi-lateral
stimulation of efferent sympathetic nerves by a decapolar 5-
French catheter in the spinal column. Hearts were paced at
170 ms pacing cycle length (PCL), and PCL reduced by 10 ms every
10 beats until induction of ventricular fibrillation (Winter et al.,
2018).
Isolated ex vivo mouse hearts were loaded with Di-4-ANEPPS
(0.125 mg/ml in DMSO, 1 ml), left atria isolated, pinned down in
the superfusion chamber and paced using platinum bipolar elec-
trodes and imaged at 0.987 kHz with maximal resolution of
200  2048 pixels (Holmes et al., 2016) (71 mm pixel width). Atria
were paced at 150 ms PCL, and PCL was reduced by 10 ms every 20
stimuli down to 50 ms. Some atria were also paced at 150 ms PCL
for 1 min to observe instances of spontaneous activity, such as
premature atrial activity (PAA).
In both sets of experiments the electromechanical un-coupler
blebbistatin (15 mM for guinea pig, 42.75 mM for mouse atria) was
used to preventmovement of the tissue andmotion artefacts on the
recordings.
2.3. Optical data pre-processing
Spatial filtering of the optical mapping images was performed
via a 3  3 pixel Gaussian filter. Baseline correction was performed
using a top-hat kernel (200 ms length for guinea pig data, 100 ms
for mouse) (Yu et al., 2017). No temporal filtering was applied.
Image stacks were then segmented based on PCL. PCL seg-






where fnðtÞ is the fluorescent value of pixel n at time t. Only the N
pixels which were selected following thresholding (i.e. pixels inside
the red outline in Fig. 1A) were included for summation in equation
(1) and all subsequent analysis. Peaks in FtissueðtÞ were then iden-
tified by setting a threshold amplitude (half of maximum FtissueðtÞ)
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and minimum peak distance (40 ms for both guinea pig and
mouse). The PCL was then defined as the time period between one
peak and the previous. The signal was then segmented when
changes in PCL of 10 ms were identified. During ventricular fibril-
lation (VF), automatic PCL based segmentation was not used due to
variable time intervals and lower signal amplitude. Instead, a
custom selection of time period where the tissue averaged signal
clearly demonstrated VF was performed (O’Shea et al., 2019a).
2.4. Computationally modelled action potentials
Alongside application of OWS to optically mapped datasets,
mathematical models of guinea pig (Luo and Rudy, 1994) and
mouse (Bondarenko, 2004) ventricular action potentials were used
to validate use of OWS for AP waveforms. Temporal alterations in
the action potential morphology were induced by altering the
conductance of the respective repolarising potassium channels in
each model for odd beats only. This induced alternans like behav-
iour in the models. For the guinea pig action potentials, potassium
channel (IK and IK1) conductance was increased by 70%, while for
the mouse potassium channel (Ito, IKss, IKs, IK1, IKur) conductance
was decreased by 45% (Clerx et al., 2016). 1000 beats were simu-
lated in total to allow the models to reach steady-state, and the last
20 beats used for analysis (see below).
The model traces were down sampled to match the recording
rates of the optical mapping systems used in this study (0.5 kHz for
guinea pig, 1 kHz for mouse). To study the effects of signal quality,
noise was added to the datasets by altering the AP by a value
selected from a set of normally distributed pseudorandom
numbers, the standard deviation of which was set as a percentage
value of the action potential amplitude. Due to its pseudorandom
nature, this operation was repeated 15 times for each noise level
tested. Note: For direct comparison to noise levels of experimental
recording, optical noise values were retrieved in the inverse
manner, i.e. the amplitude of the optical action potential (OAP) was
compared to the standard deviation of the signal at diastolic
baseline. These studies were performed using the myokit software
(http://myokit.org) (Clerx et al., 2016) and MATLAB (The
MathWorks).
2.5. Optical wave similarity
2.5.1. Windowing
Optical wave similarity (OWS) and regularity index (RI) were
calculated via adaptation of the method set out by Faes et al. for use
in bipolar electrograms (Faes et al., 2002). Following the PCL
detection, signals were time windowed, Fig. 1B. Unless stated
otherwise, for guinea pig action potentials, window timeframe was
set at 50 ms before and 150 ms after the peak in the tissue averaged
signal (FtissueðtÞ;equation (1)). Due to the shortening of the diastolic
interval at faster PCLs (Shattock et al., 2017), the signals were
further windowed by the minimum before and after each peak
before OWS calculation. The time window used for measuring the
OWS between two OAPs was from the closest minima (of either
OAP) before and after the peak in the signals. Due to the shorter
OAP morphology and smaller tissue area of murine atria (Riley
et al., 2012), a constant windowing timeframe of 20 ms before
and 40 ms after the peak was utilised for these recordings and no
further windowing based on signal minima was required.
2.5.2. Normalisation and signal alignment
Following PCL detection, segmentation and windowing of in-
dividual OAPs, the image stack was split into sections (up to 10
sections of 10 beats for guinea pig hearts, 7 sections of 20 beats for
Fig. 1. Calculation of optical wave similarity (OWS) from voltage optical mapping data. A) Fluorescence image of voltage dye loaded guinea pig whole heart. Representative signals
are shown from the locations marked in blue and red on the fluorescence image. B) Windowing of optical signals based on signal minima. C) Normalisation and alignment of
individual optical action potentials (OAPs) in the recorded optical signal. D) Example calculations of OWS from OAP pairs. E) Constructed map of OWS following analysis steps set out
in A-D.
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mouse atria) matching the PCL protocols described above. For
single beat OWS analysis, the individual OAP was compared with
the subsequent OAP. Signals were aligned according to the peak
times in tissue average signal, equation (1).
For the computationally modelled datasets, OWS analysis was
applied to the final 20 beats of 1000 stimulations, to ensure the
models had reached steady state. The model APs were aligned by
the peak.
2.5.3. Calculation of wave similarity
To calculate wave similarity, we utilised the cosine similarity
metric. First, the individual, windowed OAPs (A) were zero cor-
rected (translated so the mean value was zero) and normalised as





where An is the normalised signal and K is the number of samples in
the OAP after windowing, Fig. 1C. The wave similarity, s, between
two successive normalised and aligned OAPs, A1 and A2, was then
calculated as,
sðA1;A2Þ¼ ðA1:A2Þ 3
where A1:A2 denotes the scalar dot product (Fig. 1D). The result of
equation (3) is a value approaching 1 when A1 and A2 exhibit a
similar morphology, 0 when the two OAPs are morphologically
distinct (e.g. two signals of just noise), and 1 if the signals are
identical but of opposite phase. For a sequence of OAPs from each













where M is the number of OAPs in the sequence. As previously
stated, when undertaking single beat OWS analysis, an individual
OAP was compared with the subsequent OAP.
To calculate regularity index (RI), the method of Faes et al.
originally applied to atrial electrograms was employed (Faes et al.,
2002). The wave distance, d, between two normalised and aligned
OAPs, A1 and A2 was calculated as,
dðA1;A2Þ¼ arccosðA1:A2Þ (5)
where arccos is the inverse cosine function.













where H is a Heaviside step function which equals 1 when dðAi;AjÞ
 ε (i.e. when two OAPs are similar) and 0 when dðAi;AjÞ> ε (i.e.
when two OAPs are dissimilar). By the definitions in equations (4)
and (6), both higher OWS and RI indicate a greater temporal
regularity.
2.6. Alternative metrics
To compare the results of OWS analysis with other methodol-
ogies, we also conducted APD alternans and dominant frequency
analysis.
2.6.1. APD alternans (DAPD80)
APD80 was calculated as the interval between the maximum
upstroke velocity during depolarisation (dF/dtmax) and the time of
80% repolarisation to baseline. APD80 alternans magnitude
(DAPD80) was then calculated as the absolute difference between
APD80 of one OAP compared to the previous at each location in the
image (Winter et al., 2018; O’Shea et al., 2019b). In some cases,
especially at short PCLs, 80% repolarisationwas not observed before
the next depolarisation. These areas were excluded from analysis
(see blue areas in Fig. 6Aii). The results were then averaged for each
PCL.
2.6.2. Dominant frequency analysis
For dominant frequency mapping, the frequency spectrum of
the signal was computed using fast Fourier transform, with a Hann
window applied. Zero padding was applied to achieve a frequency
resolution of 0.05 Hz, and the frequency range studied was from 0.5
to 50 Hz (Li et al., 2017).
2.7. Statistical analysis and data availability
Unless stated, data are presented as mean ± standard error of
the mean. As all interventions are paired in the same samples,
group mean differences were tested via two-tailed paired student’s
t-test. Significance was defined as P < 0.05.
The pre-processing and signal segmentation described here, as
well as all subsequent steps to calculate wave similarity and regu-
larity index have been integrated into an updated version of our
electrophysiological mapping software ElectroMap (O’Shea et al.,
2019a) (https://github.com/CXO531/ElectroMap).
3. Results
3.1. Principles of wave similarity measurements
The steps for calculating OWS from optically recorded samples
are illustrated in Fig. 1. The key steps in OWS analysis from optically
recorded signals (Fig. 1A) are windowing (Fig. 1B), normalisation
(equation (2)), feature alignment (Fig. 1C) and OWS calculation
(Fig. 1D and equations (3) and (4)). These steps result in a wave
similarity map such as shown in Fig. 1E. The application of OWS
during arrhythmia (ventricular fibrillation, VF) is shown in
Supplementary Fig. S1. The calculation of the regularity index (RI)
follows the same processing steps of windowing, normalisation
and alignment. However, for calculation of RI the wave distance is
instead calculated (equation (5)) and collapsed to 0 or 1 based on a
defined distance threshold (equation (6)). The relationship be-
tween these two measures is explored below.
3.2. Wave similarity detects temporal heterogeneity in
computationally modelled and optically recorded action potentials
To initially validate whether this approach could be utilised to
quantify temporal regularity, we measured OWS in model action
potentials. Guinea pig and mouse model action potentials were
utilised, with and without temporal alterations. Temporal alter-
ations replicating alternans (Fig. 2A and B) were generated by
altering the conductance of the respective repolarising potassium
channels in each model for odd beats only, as described in the
methods. In the absence of noise, OWS was reduced by the pres-
ence of alternans. For guinea pig action potentials, alternans
reduced OWS from 1 to 0.68 (Fig. 2Aii), while mouse alternans
reduced OWS from 1 to 0.80 (Fig. 2Bii). These differences in
measured OWS values are maintained as noise levels are increased
to those expected in experimental setups (noise of 8e20% as
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observed in our experimental work, highlighted in grey in Fig. 2A
and B). As noise is increased beyond these levels however, both the
temporally regular and irregular signals exhibit similar and low
OWS values, reducing to circa 0.050 and 0.11 for the guinea pig and
mouse respectively.
APD alternans magnitude (DAPD80) is increased in the model
data without noise, from 0 ms to 268 ms and 17.1 ms for guinea pig
and mouse action potentials respectively, Fig. 2Aiii and Biii.
Increased DAPD80 in the temporally irregular signals is maintained
at experimental noise levels. As noise is increased beyond these
experimental values, it is no longer possible to detect the differ-
ences in APD alternans magnitude between the temporally regular
and irregular signals. This convergence occurs quicker than for
OWS, suggesting improved sensitivity for alternans detection
compared to standard alternans quantification method. For
example, at 25% noise level OWS is still significantly lower in the
guinea pig temporally regular signal (0.29± 0.01 vs 0.20± 0.004, no
alternans vs alternans, P < 0.0001). For DAPD80 however, there is no
significant difference (187.4 ± 8.4 ms vs 187.5 ± 9.7ms, no alternans
vs alternans, P ¼ 0.99). Similarly, for mouse action potentials at 25%
noise OWS is still lower (0.38 ± 0.01 vs 0.28 ± 0.01, no alternans vs
alternans, P < 0.0001), but there is no difference in DAPD80
amplitude (18.8±1 ms vs 17.2 ± 0.9 ms, no alternans vs alternans,
P ¼ 0.26).
Dynamic decreases in PCL are known to induce greater temporal
action potential variability due to the occurrence of AP alternans
(Johnson et al., 2010). As an initial investigation into the use of OWS
analysis in optically recorded action potentials, we therefore
quantified OWS at progressively shorter PCLs in guinea pig whole
hearts and mouse atria, Fig. 3. In both experimental models, OWS
decreases with decreasing PCL as expected, Fig. 3A and B. OWS
analysis therefore is an effective measure of temporal homogeneity
in optically mapped datasets. To test the sensitivity of OWS mea-
sure to window setting, we repeated the analysis of OWS as a
function of PCL in the guinea pig heart with altering window
lengths (50e1000 ms). In all cases, OWS reduced with decreasing
PCL, Supplementary Fig. S2A.
3.3. Correlation of wave similarity and regularity index measures
The measurement of OWS and the electrogram derived regu-
larity index (RI) (Faes et al., 2002) is set out by equations (4) and (6)
respectively. To test the correlation between these two methods, RI
analysis was applied to guinea pig whole hearts at different dis-
tance thresholds (ε). Fig. 4A and B demonstrate that, as expected,
areas of low OWS in an individual heart concurrently demonstrate
low RI when an appropriate threshold value is set (e.g. when ε ¼ p/
6, r2 ¼ 0.79). However, when a small distance (high similarity)
threshold is set, correlation between themeasures is lost (e.g. when
ε ¼ p/18, r2 ¼ 0.012). Furthermore, setting a large distance
threshold such as ε ¼ p/3 is observed to reduce the dynamic range
of the RI measure, as many areas are measured to have RI¼ 1 when
the OWS measure suggests there are differences in temporal ho-
mogeneity (OWS values ranging from 0.77 to 0.94). Setting of the
threshold value is also observed to affect mean RI measurements
across whole hearts at various PCLs, Fig. 4C. Again, setting a large
distance threshold of p/3 leads to many samples of RI ¼ 1, reducing
dynamic range. A high similarity, low distance, threshold of p/18
reduces correlation with OWS measure, (r2 ¼ 0.51 compared to
r2 ¼ 0.86 when ε ¼ p/6).
Fig. 2. Validation of the use of optical wave similarity (OWS) for measurement of modelled alternans behaviour. Ai) Example modelled guinea pig action potentials without (black)
noise and with addition of 15% noise (grey). ii) OWS measurement of computationally modelled guinea pig action potentials without (black) and with (red) temporal irregularity as
a function of noise. Inset shows the two modelled, normalised, signals used (with no noise). iii) APD80 alternans (DAPD80) of computationally modelled guinea pig action potentials
without (black) and with (red) temporal irregularity as a function of noise. Grey areas show the noise range observed in our experimental optical recordings from guinea pig whole
hearts. Bi) Example modelled mouse action potentials with (15%, grey) and without (black) noise addition. ii) OWS measurement of computationally modelled mouse action
potentials without (black) and with (red) temporal irregularity as a function of noise. Inset shows the two modelled, normalised, signals used (with no noise). iii) DAPD80 of
computationally modelled mouse action potentials without (black) and with (red) temporal irregularity as a function of noise. Grey areas show the noise range observed in our
experimental optical recordings from mouse atria.
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These results demonstrate that a key aspect of RI analysis is
setting of an appropriate threshold value, ε. We thereforemeasured
RI in guinea pig whole hearts as a function of changing threshold as
shown in Fig. 4D. As expected, and proportional to the OWS
response (Fig. 3C), RI decreased with decreasing PCL. RI therefore,
like OWS, appears to be an effective measure of temporal homo-
geneity in optically mapped datasets. However, considering that
the choice of ε dramatically alters ‘baseline’ values and response to
decreasing PCL we opted to utilise OWS in subsequent studies.
3.4. Beat-to-beat wave similarity detects short periods of temporal
instability
Acute variations in pacing cycle length are known to induce
temporal instability in the electrical behaviour of the heart (O’Shea
et al., 2019a). To test OWS analysis in this context, we utilised this
parameter to analyse beat-to-beat heterogeneity in a guinea pig
whole heart which underwent a sudden increase in pacing fre-
quency from 5 Hz to 8Hz and then returned to 5Hz, Fig. 5AeD. OWS
analysis identified a transient period of temporal heterogeneity
immediately after the onset of 8 Hz pacing (Fig. 5A and B). Similarly,
return to 5 Hz pacing induces a reduction in OWS from 0.99 to 0.75,
but again the temporal stability of the heart recovers quickly, Fig. 5C
and D. Interestingly, immediately after the cycle length change a
substantive heterogeneity in OWS is observed between the apex
and the base of the heart. Follow up studies will address the
pathophysiological significance of this regional heterogeneity.
We also investigated how OWS performs in the setting of
spontaneous electrical premature atrial activity (PAA). Mouse left
atriumwas exposed to 150 ms PCL and areas of the trace exhibiting
PAAs were analysed, Fig. 5E. The morphology of the OAPs of the
PAAs is seen to be markedly distinct, with OWS ¼ 0.49 ± 0.02 and
Fig. 3. Validation of the use of optical wave similarity (OWS) for measuring action potential regularity. A) OWS as a function of pacing cycle length (PCL) in optically mapped guinea
pig hearts, n ¼ 6. Inset shows example OWS maps at PCL ¼ 170 ms and 90 ms respectively. B) OWS as a function of PCL in optically mapped mouse left atria, n ¼ 7. Inset shows
example OWS maps at PCL ¼ 150 ms and 50 ms respectively.
Fig. 4. Correlation of regularity index (RI) and optical wave similarity (OWS) measures in guinea pig whole hearts. A) Example OWS (i) and RI maps (ii, ε ¼ p/6) at PCL ¼ 90 ms. B)
Spatial correlation between OWS and RI measures in the guinea pig heart (r2 ¼ 0.86). C) Correlation of mean OWS and RI measures in guinea pig whole hearts across PCLs. D) RI
measure as a function of distance threshold (ε). n ¼ 6 hearts, 9 PCLs per heart.
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0.53 ± 0.02 when compared to the APs immediately before and
after the PAA. In contrast, OWS ¼ 0.73 ± 0.03 for APs following the
PAA, and 0.77 ± 0.02 for all other ‘control’ beats, Fig. 5E and F. These
results are collaborated by traditional action potential duration
(APD) analysis. APD70 of the ‘control’ beats in this study was
13.3 ± 0.02, vs 12.9 ± 0.07 for the PAAs for example. OWS mapping
therefore suggests that the PAAs are associated with potentially
proarrhythmic periods of temporal instability.
3.5. Optical wave similarity detects and quantifies alternans and
predicts ventricular fibrillation onset
Dynamic pacing at shorter PCLs induces alternans thereby
increasing temporal heterogeneity. Previous work has demon-
strated that the PCL required to initiate VF is shorter during SNS of
intact guinea pig hearts, showing that SNS is protective against the
onset of ventricular fibrillation by the suppression of alternans
(Winter et al., 2018). To test how the OWS analysis compares to
established measures of beat to beat heterogeneity, namely APD
alternans, OWS and alternans magnitude were quantified in guinea
pig hearts loaded with a voltage-sensitive dye during SNS and
control (no SNS) conditions (preceding onset of VF), Fig. 6AeC. As
previously shown, APD alternans magnitude at increased PCL was
shortened (Fig. 6Aii and C). Control hearts showed a significantly
increased alternans amplitude compared to SNS at PCL of 100 ms
(DAPD80 ¼ 9.95 ± 1.6 ms vs 4.07 ± 0.9 ms, control vs SNS,
P¼ 0.0078). OWS analysis showed comparable changes in temporal
heterogeneity. As PCL is decreased, OWS decreases (Fig. 6Ai and B)
and at PCL of 100 ms OWS ¼ 0.91 ± 0.02 vs 0.98 ± 0.02 (control vs
SNS, P ¼ 0.0106). Similar results were seen at all but the longest
window settings tested, Supplementary Fig. S2B. There were also
regional differences in the onset of temporal heterogeneity,
Fig. 6EeF. In control conditions at PCL ¼ 90 ms, the left ventricular
(LV) apex is observed to exhibit low OWS when compared to the
right ventricle (RV), OWS ¼ 0.82 ± 0.03 vs 0.94 ± 0.01, LV apex vs
RV, P ¼ 0.045). In SNS at PCL ¼ 90 ms, the LV apex
(OWS¼ 0.89 ± 0.02) is again observed to exhibit lower OWS versus
both the RV (0.96 ± 0.01, P ¼ 0.0317) and LV base (0.96 ± 0.01,
P ¼ 0.0362). Therefore, OWS effectively distinguishes between
physiological interventions that affect temporal homogeneity in
optically recorded action potentials, demonstrating here that hearts
without SNS are less temporally stable at the same PCLs. OWS also
highlights regional variations in temporal stability, whichmay have
arrhythmogenic consequences.
The hearts without SNS (control) enter VF at slower PCLs (Fig. 6)
(Winter et al., 2018), demonstrating the use of OWS in a similar
Fig. 5. Single beat optical wave similarity mapping. A) Single beat OWS as a guinea pig heart transitions from 5 Hz to 8 Hz pacing. B) OWS maps immediately before (Beat 46) and
after (Beat 47e49) pacing frequency change. C) Single beat OWS as the heart transitions from 8 Hz to 5 Hz pacing. D) OWS maps immediately before (Beat 299) and after (Beat
300e302) pacing frequency change. E) Example trace of a premature atrial activity (PAA, red) and example OWS maps. F) Mean data of OWS for all beats in the experiment classified
as control (black), pre-PAA (green), PAA (red) and post-PAA (blue).
C. O’Shea et al. / Progress in Biophysics and Molecular Biology xxx (xxxx) xxx 7
Please cite this article as: O’Shea, C et al., Temporal irregularity quantification and mapping of optical action potentials using wave morphology
similarity, Progress in Biophysics and Molecular Biology, https://doi.org/10.1016/j.pbiomolbio.2019.12.004
manner as APD alternans as a metric for arrhythmia inducibility.
The rapid and disorganised OAPs recorded in arrhythmic data such
as during VF makes traditional parameter measurements (APD,
alternans, cycle lengths etc) difficult to perform (Kirchhof et al.,
1998), Fig. 6D. We therefore tested whether OWS analysis could
be used to quantify data during VF. Indeed, OWS is greatly
decreased during VF, Fig. 6B, suggestive of large temporal hetero-
geneity in OAPs recorded during arrhythmia. OWS during VF was
0.37 ± 0.02 and 0.37 ± 0.01 for control and SNS respectively, and
there was no difference between conditions (P ¼ 0.90).
We also mapped dominant frequency in the hearts during VF.
No correlation was found between the two measures
(Supplementary Figs. S3AeB). Dominant frequency during VF was
reduced in control hearts compared to thosewith SNS (14.4 ± 0.3 vs
Hz 16.4 ± 0.5 Hz, P ¼ 0.0085, Supplementary Fig. S3C).
4. Discussion
Here, we have developed and tested the application of OWS
mapping as an approach for analysis of pro-arrhythmic and
Fig. 6. Effects of sympathetic nervous stimulation on optical wave similarity (OWS) and APD alternans (DAPD80) measures. A) Example OWS (i) and APD80 alternans (ii) maps from
130 to 70 ms PCL in a guinea pig heart without (control, black) and with SNS (red). The transition to ventricular fibrillation (VF) is marked by the dashed line in both conditions. Blue
areas in APD alternans maps denote areas not analysed due to 80% repolarisation not being reached. B) Grouped data of mean OWS values as a function of PCL in control hearts with/
without SNS, before (solid line) and during (dashed line) VF. C) Grouped data of mean DAPD80 as a function of PCL in control hearts before and during SNS, before onset of VF. D)
Example single pixel optical traces recorded during 170 ms PCL stimulation and during VF induced via pacing. E) Anatomical locations of left ventricle (LV) Apex (blue), base (purple)
and right ventricle (RV, green) on fluorescence image of voltage dye loaded guinea pig whole heart used for regional studies of OWS. F) Grouped data of regional OWS values as a
function of PCL in control hearts with (i) and without (ii) SNS. n ¼ 6 hearts, *P < 0.05, **P < 0.01 control vs SNS, #P < 0.05 LV Apex vs RV (green) or LV Base (purple).
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arrhythmic activity in cardiac optical mapping datasets, Fig. 1. This
approach has been inspired primarily from the development of
‘regularity index’ measures, originally designed for use in atrial
electrograms during AF (Faes et al., 2002; Ravelli et al., 2005).
Arguably, however, the results shown here demonstrate that the
most promising use of OWS analysis in optical datasets may be
mapping temporal stability of OAPs before the occurrence of ar-
rhythmias, thus providing a novel index identifying period of
electrical instability directly preceding arrhythmias. In Fig. 6 for
example, SNS stimulation is shown to supress temporal heteroge-
neity induced by decreasing PCL, Fig. 6B. These results align with
alternans analysis of the datasets with the same sensitivity, with a
significant difference between the control and SNS groups evident
with both measures at PCL ¼ 100 ms, Fig. 6B and C (Winter et al.,
2018). Measuring APD alternans however requires the measure-
ment of baseline signal level, activation time (for which several
different methods are proposed (O’Shea et al., 2019a)), peak time
and repolarisation time from the OAPs. As shown in Fig. 2, noise can
therefore corrupt APD alternans measures, and restrictive defini-
tions on activation and repolarisation times can prevent analysis of
APD, Fig. 6Aii. In contrast, OWS analysis foregoes the need for
quantification of these specific and inconsistently defined signal
features/points (Laughner et al., 2012).
Furthermore, misidentification of these parameters may lead to
false positives or false negatives and may explain the loss of sig-
nificant difference between the two conditions at PCL ¼ 90 ms,
which is evident with OWS analysis. OWS analysis therefore pro-
vides a simpler and more easily reproducible processing and
analysis pipeline that incorporates entire OAP signal morphology
alternations. Additionally, OWS measurement, like alternans anal-
ysis, can be performed on a beat-to-beat basis to highlight acute
periods of instability, Fig. 5. However, in contrast to alternans
analysis, OWS is not designed to study a specific form of temporal
instability, and hence can be applied to analyse nonperiodic alter-
ations in cardiac electrophysiology, such as apparently random al-
terations in beat-to-beat variability that are observed in varied
proarrhythmic conditions (Johnson et al., 2010).
OWS, as expected, is proportional to RI mapping results as
shown in Fig. 4. RI analysis has been utilised in several important
studies of temporal regularity including deciphering the difference
in electrical behaviour during paroxysmal and chronic AF (Ravelli
et al., 2005). Fig. 4D however shows that the selection of the
threshold value ε impacts greatly on the measured baseline RI
values (at slowest PCL), and the response to decreased PCL. OWS
analysis did not involve the setting of such a cut off value, so was
deemed more appropriate for these initial studies into the effec-
tiveness of regularity-based measures in optical mapping.
Furthermore, the dynamic range of measured OWS values can be
reduced by threshold selection. For example, many samples
demonstrate mean RI values of 1 when ε¼ p/3, despite exhibiting a
range of OWS values (0.77e0.94), Fig. 4C. RI mapping thereforemay
result in subtle changes in waveform morphology temporal sta-
bility, for example with small changes in PCL, not being identified.
During arrhythmia (in this case VF), OWS detects an increase in
temporal heterogeneity, Fig. 6B and D. This demonstrates that it can
be used as a simple marker for arrhythmia onset. However, further
studies are required to extend its use to classify sub-types of
arrhythmia or arrhythmia severity in optical mapping data. The
same alignment and windowing strategy as used for the non-
arrhythmic (minima before and after the alignment time) was
used to analyse the hearts during VF. Furthermore, during VF the
use of equation (1) to detect peaks and hence define alignment
times is potentially flawed due to low signal amplitude and regional
heterogeneity in activation rates. An important future study
therefore would be optimisation of identifying active times for
arrhythmic data (Hajimolahoseini et al., 2018).
Another important consideration is how much lower OWS
values report noise in the signal compared to physiological varia-
tions. From the model studies conducted, it is observed that OWS
decreases with increased noise, and asymptotically approaches a
low but non-zero value as noise is increased to levels far beyond
those we saw in our experimental recordings, where it can be
assumed that any underlying regularity is completely masked by
noise. The values of OWS observed in the extreme noise model
signals (circa 0.05 and 0.11 for guinea pig and mouse respectively)
are much less than the values of OWS measured during VF
(0.37 ± 0.02), signifying that there is still regularity in the signals.
This suggests that, although noise clearly impacts OWS analysis
(Fig. 2A and B), it could still be utilised as a method of sub-
classifying arrhythmias based on temporal stability. Further
studies looking into distinct arrhythmia types are required to
confirm this hypothesis, as in the present study only VF was
studied, with and without SNS. Analysis resulted in the same values
of OWS being recorded in both conditions, suggesting no difference
in these arrhythmias in terms of temporal stability (Fig. 6B).
OWS provides a single metric designed to report temporal sta-
bility. Analysis of electrogram recordings however suggest that
value is gained by utilising these measures concurrently with other
measures to identify critical sources or substrates. These measures
can combine OWS analysis with other time domain (Baher et al.,
2019) (e.g. cycle length by barycentre estimation (Ravelli and
Mase, 2014)) or frequency domain metrics (Chang et al., 2013).
Therefore, rate and regularity are combined, and it has previously
been shown how drivers of AF can exhibit rapid (i.e. high dominant
frequency) but regular (high OWS) electrical impulses (Warren
et al., 2006). The fact that (i) no correlation was observed be-
tween dominant frequency and OWS measures (Supplementary
Figs. S3AeB) and (ii) dominant frequency analysis distinguished
between control and SNS conditions when OWS does not (Fig. 6E
and Supplementary Fig. S3C) supports the idea that these two
measures contain divergent information about the electrical
behaviour of cardiac tissue. It is suggested that a combined
approach, in electrogram mapping, allows classification of sites not
just simply by temporal regularity, but also into drivers/sources of
arrhythmia and arrhythmia substrates (Ravelli and Mase, 2014).
The application of such an approach for optical data therefore
warrants further investigation.
As highlighted, a potential advantage of OWS over other
methods is the more limited number of signal features that need to
be identified, increasing ability for automated analysis. However,
optical mapping experiments are conducted in several experi-
mental models with distinct AP morphologies. Furthermore,
alongside OAPs, cytosolic and sarcoplasmic reticulum calcium
concentrations can be optically measured with calcium sensitive
dyes (Wang et al., 2014; Jaimes et al., 2016). The recorded optical
calcium transients will also exhibit a distinct wave morphology
compared to OAPs. Therefore, further validation and optimisation
of OWS is required with different models and fluorescent dyes. In
these studies, OWS is shown to be slightly dependent on window
size, although only very long window size is shown to effect results
of decreasing PCL or applying SNS, Supplementary Fig. S2. More
automated windowing methods, including using time or frequency
domain based measured features, may improve the method.
A key aspect of this work is the incorporation of these tech-
niques into our freely available mapping software ElectroMap
(www.github/CXO531/ElectroMap) (O’Shea et al., 2019a). From
ElectroMaps updated user interface, OWS and RI mapping can be
applied with user defined alignment strategy, distance threshold
and windowing options, broadening the application of these ana-
lyses to different experimental models and fluorescent sensors not
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presently tested.
5. Conclusion
OWS mapping provides effective measures of temporal regu-
larity that can be applied in optical datasets. Using these methods,
physiological alternations down to single beat timescales can be
quantified, and different states can be classified which are known
to suppress arrhythmia. By considering the whole signal mor-
phologies of OAPs, the definition of specific signal features is not
required, and alterations in any part of the AP will contribute to the
local OWS measure.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.pbiomolbio.2019.12.004.
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Supplementary Figure S1: Calculation of optical wave similarity (OWS) from voltage optical 
mapping data from a heart during ventricular fibrillation (VF). A) Fluorescence image of voltage 
dye loaded guinea pig whole heart. Representative signals are shown from the locations marked in 
blue and red on the fluorescence image. B) Windowing of optical signals based on signal minima. C)  
Normalisation and alignment of individual optical action potentials (OAPs) in the recorded optical 
signal. D) Example calculations of OWS from OAP pairs. E) Constructed map of OWS following 











Supplementary Figure S2: Optical wave similarity (OWS) measure as a function of window size 
in guinea pig whole hearts. Window length refers to time after peak, and time before peak was 
held at 50ms. A) OWS as a function of pacing cycle length for different window sizes from 50ms 
(blue) to 1000ms (green). B) OWS at different window lengths with (red) and without (black) 




Supplementary Figure S3: Correlation between optical wave similarity (OWS) and dominant 
frequency measures during ventricular fibrillation (VF). A) Mean OWS and dominant frequency 
values of each heart. B) Correlation between OWS and dominant frequency values. Each colour 
represents a different heart, while each point represents a different pixel. C) Dominant frequency with 
(red) and without (black) sympathetic nervous stimulation in hearts during VF. n=6 hearts, **p<0.01 




Effects of high fat diet and pitx2 deficiency on left atrial
electrophysiology
The following section details unpublished data on the effects of high fat diet on
left atrial electrophysiology in wild type and pitx2 deficient mice. Optical mapping
experiments were conducted as detailed in section 2. Experiments were
conducted by myself in conjunction with Simon Wells.
Data were analysed by myself using the ElectroMap software (Chapter 3,
publication 1). Inhomogeneous dye loading, imaging with a high resolution
camera (pixel size = 71.4µm) and the thin profile of the mouse left atria meant
the isolated left atrial preparations often exhibited low signal quality. Utilising the
software and applying spatial filtering and ensemble averaging however allowed
effective analysis of these data. Data analysis was further aided by automated
pacing frequency identification which segmented the data into pacing cycle
lengths without user input. Conduction velocity module was used to quantify
conduction, while action potential waveform analysis was performed using
duration and time to peak analyses. High throughput single beat analysis was
also performed to study beat-to-beat variations.
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7.1 Introduction
Obesity is a known risk factor for atrial fibrillation (AF) [1]. The underlying
mechanisms by which obesity promotes AF development are not fully
understood. It has been demonstrated that the presence of pericardial fat (i.e.
adipose tissue in or near the heart) is associated with AF development and
recurrence of AF following ablation procedures. Importantly, the link between
pericardial fat and AF is independent of other risk factors suggesting that the
local fat deposits directly contribute to AF [2], [3]. Obesity and aging are both
associated with an increase in pericardial adipose tissue [4]. Adipose tissue
releases a range of peptides with autocrine, paracrine and endocrine effects [5],
including sex steroids [6], and has been observed both outside the heart
(paracardial fat), but also in the pericardial, epicardial and myocardial layers [7].
Fatty deposits, both infiltrating or surrounding the heart, can therefore cause
structural remodelling directly or via paracrine effects of pro-fibrotic,
pro-inflammatory or other adipocyte mediators [7]. One such mediator may be
oestrogens such as oestradiol. In aged and aged-high fat diet (HFD) mice for
example, a strong correlation was observed between pericardial adipose
expression of aromatase (final enzyme responsible for conversion of androgens
to oestrogens) and atrial arrhythmia inducibility. Effects of aging were
exacerbated by HFD, and increased arrhythmia inducibility was also observed in
hearts acutely perfused with 17β-oestradiol [8], suggesting a possible
association between local oestrogen levels and atrial arrythmias.
Alongside lifestyle factors such as obesity, it is well established that there is a
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genetic component to AF [9]. Chromosomal gene variants close to the Paired like
homeodomain-2 (PITX2) gene for example are associated with an increased risk
of AF [10]. The PITX2 gene encodes for the transcription factor pitx2, the cardiac
isoform of which (pitx2c) is found primarily in the left atrium (LA) and is crucial
for healthy development of left-right atrial asymmetry as it regulates expression of
LA ion channels [11], as well as having multiple other targets [12], [13]. Reduced
levels of pitx2 promote sinoatrial like gene expression in the LA [14], depolarises
resting membrane potential [15], [16], shortens action potential duration [15] and
increases atrial arrhythmia inducibility [9], [14], [15].
To further elucidate the affects HFD may exert on atrial electrophysiology,
cardiac optical mapping of isolated mouse LA was utilised to allow high
resolution study on the effects of HFD on action potential morphology and
conduction. Experiments were performed in mice at ages of 26-32 weeks,
following 20 weeks of high fat diet (HFD) lifestyle. Mice at this age can be
considered mature adults, and so fully developed, but with little senescence
biomarkers [17]. Therefore, effects of age induced cardiac remodelling or
pericardial adipose tissue are thought to be minimally confounding to the effects
of the HFD lifestyle [8]. Due to the strong association of pitx2 deficiency in AF,
an additional aim of this study was to investigate if mice with a heterozygous
expression of a PITX2 null allele (pitx2null mice) would exhibit differential
responses to HFD compared to wild type (WT) littermates.
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7.2 Methods
Wild type and pitx2null littermate mice were fed on a high fat “SDS Western” diet
(HFD) for 20 weeks. Western diet chow consisted of 21% fat and 20% protein
with drinking water supplemented with 15% fructose. Diet was started between
the ages of 6-12 weeks, meaning mice were aged between 26 and 32 weeks at
time of experiment. Simultaneously, age-matched mice were fed on the control
diet. Control diet chow consisted of 2.5% fat and 14% protein, with standard
drinking water. For both control and HFD mice, food and water were available ad
libitum. Mice were monitored weekly for weight gain or any health complications.
On completion of the diet, left atrial optical mapping experiments using
transmembrane voltage dye Di-4-ANEPPS were performed as described in
section 2.1. Isolated atria were paced in dark conditions for a minimum of 10
minutes at 1Hz pacing rate to allow the tissue to equilibrate in the optical
mapping setup. Once motion artefacts were observed to cease via blebbistatin
superfusion, LED illumination was switched on and 1minute recordings made at
0.987kHz sampling rate. Atria were paced at 120ms, 100ms and 80ms pacing
cycle length for 100 stimuli at each.
For analysis, the last 20 beats of the 100 stimuli were ensemble averaged, other
than in investigations of beat-to-beat variability. Images were spatially filtered
with a 4x4 Gaussian filter and temporally filtered with a 3rd order Savitzky-Golay
filter. Non-physiological alterations in baseline fluorescence were corrected for
by use of a top-hat filter (length 100ms). These processing methods differ
compared to other analyses presented in this thesis, and were chosen to match
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those used in ongoing optical mapping studies of the sex steroids on atrial
electrophysiology [18]. Conduction Velocity (CV), action potential duration (APD)
and time to peak (TTP) were mapped across the tissue as described in section
2.1. APD30,50 and 70 were quantified, and APD heterogeneity was assessed
as the standard deviation of APD distribution across the LA. Beat-to-beat
variability of repolarisation was quantified as the mean difference of the tissue
averaged APD in the nth beat (APDn) and subsequent beat (APDn+1) [19]. This
measure of beat-to-beat variability restricts analysis to only consecutive beats.
Hence, the coefficient of variability was also quantified as the standard deviation
of the measured individual beat APD values divided by the mean APD [20].
Beat-to-beat variability and coefficient of variability was quantified from the final
20 beats of the 100 stimuli at each respective pacing cycle length.
7.3 Results
7.3.1 High fat diet increases mouse body weight of both WT
and pitx2 deficient mice
There was no significant difference in body weight of animals at the start of the
feeding protocol, Figure 7.1A. However, 20 weeks of HFD feeding led to a
significant increase in body weight for both WT and pitx2null mice compared to
controls, Figure 7.1B. HFD increased WT body weight to 48.6±1.5g versus
40.0±1.8g for WT animals on control diet (P=0.0032). Similarly, pitx2null mice
fed on HFD had a body weight of 47.0±1.3g versus 35.5±1.3g for control diet
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Figure 7.1: Effects of high fat diet (HFD) on body weight of wild type and
pitx2null mice. A) Body weight before 20 weeks of control or high fat diet.
B) Body weight after 20 weeks of control or high fat diet. n=4-8, **P<0.01,
***P<0.001
(P=0.0004). There was a non-significant trend for pitx2 deficient animals to
exhibit a lower body weight, both before and after 20 weeks control/HFD diet
feeding.
7.3.2 High fat diet prolongs left atrial action potential duration
in both wild type and pitx2null mice
Left atrial electrophysiology was assessed by voltage optical mapping. Figure
7.2A shows APD70 distribution of WT and pitx2null mice following 20 weeks
control or HFD diet. APD70 was prolonged by HFD when compared to control
conditions (23.5±2.2 vs 16.7±2.5ms; P=0.0002) in WT mice. Similarly, HFD
prolonged APD70 of pitx2null mice (20.7±2.0 vs 15.94±2.0ms; p=0.0095),
Figure 7.2A-C. Both control and HFD pitx2null mice exhibited shorter APD70
than WT mice on the same diet, however these differences were not significant.
HFD induced prolongation of APD was evident at all pacing cycle lengths, and
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Figure 7.2: Action potential duration (APD) 70 mapping of wild type (WT)
and pitx2null mouse left atria, with and without high fat diet (HFD). A)
Representative left atria APD70 maps from WT and pitx2null mice, after 20
weeks control or high fat diet. B) Representative optical mapping recordings.
C) Grouped APD70 data at 120ms pacing cycle length. D) AP70 as a function
of pacing cycle length. E) Grouped APD70 heterogeneity (measured as standard
deviation) data at 120ms pacing cycle length. n=5-8, **P<0.01, ***P<0.001
APD similarly shortened in all groups as pacing cycle length was reduced
(increase in pacing frequency), Figure 7.2D.
As well as localised alterations, heterogeneity of action potential morphology
across cardiac tissue (also referred to as dispersion of repolarisation) is known
to contribute to arrhythmogenesis [21]–[23]. Heterogeneity of APD was therefore
quantified as the standard deviation of the LA APD distribution. Despite HFD
induced prolongation of APD, APD heterogeneity was not changed by either diet
or pitx2 deficiency, Figure 7.2E.
To see if effects of HFD were consistent throughout repolarisation, APD30 and
APD50 were also quantified. When studying these earlier phases of
depolarisation, trends identified at APD70 (prolonged APD by HFD in both
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Figure 7.3: Action potential duration (APD)30 and APD50 mapping of wild
type (WT) and pitx2null mouse left atria, with and without high fat diet (HFD).
A) Grouped APD30 data at 120ms pacing cycle length. B) APD30 as a function of
pacing cycle length. C) Grouped APD30 heterogeneity. D) Grouped APD50 data
at 120ms pacing cycle length. B) APD50 as a function of pacing cycle length. C)
Grouped APD50 heterogeneity. n=5-8, *P<0.05, **P<0.01
genotypes) are observed, although not significantly at the early (APD30)
repolarisation phase, Figure 7.3.
7.3.3 High fat diet does not alter beat-to-beat variability of
repolarisation
Increase in beat-to-beat variability at both single cell and whole tissue levels has
been reported as arrhythmogenic, both concurrently and independently of AP
alterations such as prolongation [19], [24]. Optical mapping images were
therefore segmented into single beats and APD70 mapped, Figure 7.4A. Mean
APD70 was then quantified for each individual beat, Figure 7.4B. Mean APD70
of the nth beat (APD70n) was then compared to the mean APD70 of the
174
Figure 7.4: Beat-to-beat variability of wild type (WT) and pitx2null mouse
left atria, with and without high fat diet A)Representative single beat action
potential duration (APD) 70 maps. B) Grouped data of mean APD70 at single
beats. C) Example Poincare plots of APD70n+1 as a function of APD70n. D)
Grouped data of beat-to-beat variability between groups. E) Grouped data of the
coefficient of variability in APD70 between groups
subsequent, n+1th beat, (APD70n+1) Figure 7.4C. No significant differences
were observed in consecutive beat-to-beat variability in either diet or genotype.
Figure 7.4D. To test overall variability, not just between consecutive beats, the
coefficient of variability was also quantified. Again, no significant differences
were observed, Figure 7.4E.
7.3.4 High fat diet does not alter left atrial optical time to peak
or conduction velocity
As APD measurements (primarily) reflect changes in repolarisation, TTP was
also quantified to study alterations in depolarisation owing to diet or genotype.
No differences were observed in TTP at any pacing cycle length (Figure 7.5A-
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Figure 7.5: Conduction velocity (CV) and time to peak (TTP) mapping of
wild type (WT) and pitx2null mouse left atria, with and without high fat diet
(HFD). A) Grouped TTP data at 120ms pacing cycle length. B) TTP as a function
of pacing cycle length. C) Grouped TTP heterogeneity. D) Grouped CV data
at 120ms pacing cycle length. E) CV as a function of pacing cycle length. F)
Grouped CV heterogeneity. n=5-8
C), and spatial heterogeneity in TTP was similar in all experimental groups. LA
CV was also quantified using the polynomial multi-vector method. HFD did not
alter conduction in either WT or pixt2null mice at any pacing cycle length, Figure
7.5D-F.
7.4 Discussion
In this study, cardiac optical mapping was used to investigate the effects of HFD
lifestyle on LA electrophysiology in both WT and pitx2null mice. HFD prolonged
APD50 and APD70 measured at multiple pacing cycle lengths. APD
prolongation is a fundamental condition underlying the occurrence of both
delayed (DADs) and early after depolarisations (EADs). HFD induced
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prolongation of APD therefore may result in increased incidence of triggered
activity in the left atrium, a known mechanism for arrhythmia initiation [25].
Furthermore, localised APD lengthening at/or near fat infiltration can increase
repolarisation dispersion. The increase in heterogeneity can become even more
pronounced on the background of shortening APD in other areas of the tissue,
as often observed in AF [26]. Modelling studies have demonstrated that
prolongation of APD (and depolarisation of the resting membrane potential) in
response to adipocytes can result in complex spiral like spatio-temporal
excitation patterns, with and without AF induced electrical remodelling [27]. APD
prolongation may therefore be a mechanism by which obesity increases
incidence of atrial arrhythmia.
Prolongation of APD suggests HFD induced electrical remodelling in the mouse
LA. Structural remodelling, for example via fibrosis or fat infiltration was not
directly measured in these studies. Maintained LA CV (and CV heterogeneity) in
HFD mice studied here however suggests that pro-fibrotic activity is not present
in the left atrium as a result of HFD, as areas of fibrosis would expect to be
evident as areas of conduction slowing and therefore reduced overall CV and
increased CV heterogeneity. Previous reports have shown that long-term HFD
increases pericardial fat and fibrosis in sheep atria [28]. In these studies where
structural remodelling was directly observed, CV slowed, and CV heterogeneity
increased [28]. Direct analysis of structural remodelling in HFD fed mice is
however warranted to confirm no fat inflation/fibrosis as inferred by conduction
analysis.
Findings of HFD prolonging APD herein match findings observed in isolated
177
rabbit LA cells, where co-culturing with adipocytes induced electrophysiology
remodelling and prolonged APD90 induced by larger late sodium (INaL) and
L-type calcium currents (ICaL), among other EP changes [29]. However, there
are inconsistent reports on the effects of HFD and/or peri- and epicardial fat on
atrial EP. In the studies of Takahashi et al for example it was shown that young
adult mice (3 to 4 months) fed with HFD for 2 months show reduced expression
levels of connexin 40 (Cx40) in mouse atria, but not major sodium or potassium
channels [30]. No atrial fibrosis or dilation was seen, but conduction slowing was
observed without alterations in APD, in line with the measured expression
profiles of the HFD mice. Furthermore, chronic HFD in rats leads to gap junction
remodelling and down regulation of connexin proteins Cx40 and Cx43, again
expecting to result in conduction changes not observed here [31]. The results
obtained herein contradict these previous findings, as no conduction slowing
was observed but AP morphology was altered. Takahashi et al used optical
mapping of the intact RA, measured APD90 (a repolarisation level where
significance was lost in our findings) and utilised single vector CV quantification
[30]. The diet content and length were also different between the two studies.
These methodology differences may explain in some part the discrepancies
between the two optical mapping studies.
In guinea pig atria, HFD did induce alterations in AP morphology, but with HFD
inducing shortening of APD [32]. The shortening of APD was attributed to an
increase in outward rapid (IKr) and slow (IKs) potassium currents, which are not
expressed by mouse models [33]. In contrast, a decrease in ultra-rapid potassium
(IKur) was observed (when combined with rapid atrial pacing), which is present
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in the adult mouse atria and could potentially lead to an increased APD [34].
Decrease of IKur could therefore be a possible mechanism, in conjunction with
changes in INaL and ICaL, by which HFD induces APD prolongation in mouse
left atria. In other studies of adipocyte effects on cardiomyocytes however (co-
cultured for 2 to 4 hours), IKur is increased [29], showing that adipose tissue may
exert differing acute and chronic responses.
A possible mechanism by which HFD induces APD prolongation may be the
paracrine effects of adipose tissue synthesised oestrogens. Conventionally,
oestrogens are thought to be cardioprotective, with lower incidence of
cardiovascular diseases in women during reproductive age attributed to, partly,
higher levels of circulating oestrogens when compared to men and
post-menopausal women [35]. However, oestrogen-only therapy has been
shown to elevate AF incidence in women [36], while acute oestrogen exposure in
mouse hearts increases atrial arrhythmia vulnerability [8], [37]. Furthermore, it
has been reported that acute oestrogen at physiological concentrations
supresses repolarising potassium currents, prolonging APD and potentially
explaining the greater susceptibly of females to drug induced torsades de
pointes with QT interval prolongation [38].
Depolarisation of the optical recorded APs (quantified as TTP) was not altered
by either HFD. However, these results may be artefactual owing to the nature of
optically recording APs [39]. Further work using electrode techniques in intact
and/or isolated cardiomyocytes is therefore required to fully elucidate effects on
cellular depolarisation.
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Pitx2 deficiency was not observed to substantially change the response of atrial
EP to HFD. In line with previous reports, both control and HFD fed pitx2null mice
showed a shorter APD when compared to WT littermates, although this was not
significant [15]. Interestingly, the results here suggest pitx2 deficient APD
shortening may be greater when comparing between HFD fed mice than
controls, suggesting a possible link between pitx2 expression and HFD induced
electrophysiological changes. It has recently been shown that pitx2 deficiency
leads to increased fat infiltration in cardiac tissue following myocardial infarction,
showing a role for pitx2 in cardiac tissue regeneration by maintaining
mitochondrial function [40]. The link between HFD, cardiac injury and pitx2
deficiency therefore warrants further studies.
7.5 Conclusion
HFD caused APD prolongation without changing conduction in mouse left atria.
These effects are not substantially altered between WT mice and those with pitx2
deficiency. Further studies are required to elucidate the mechanisms by which
APD is prolonged by HFD, and the role of adipocyte mediators such as oestrogen.
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The major aim of this thesis was to develop novel processing and analysis tools
for cardiac optical mapping datasets, and to use these tools to analyse data from
a variety of pre-clinical models. A major outcome of this thesis therefore is the
development of a robustly validated and freely available MATLAB based tool for
analysis of optical mapping data, with a graphical user interface, ElectroMap
(Chapter 3) [1], [2]. In developing ElectroMap analysis of key
electrophysiological parameters such as action potential and calcium transient
morphology, activation and repolarisation times, conduction velocity, diastolic
intervals, time to peak and dominant frequency is more readily available.
Furthermore, automated pacing frequency identification and segmentation
permits analysis of entire experimental recording in a semi-automated manner,
increasing both automation and throughput of optical mapping data analysis.
The designed software has been used in several studies. In this thesis, the
software has been used to study:
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• The shift of leading pacemaker site on optical pacing in mouse sinoatrial
nodal preparations with cell selective expression of channelrhodopsin2,
Chapter 4 [3].
• Mouse ventricular cardiac slices, revealing transmural gradient and
conduction dynamics in response to pacing frequency and pacing regime
(electrical field versus optical pacing) (Chapter 5) [4], [5].
• The effects of high fat diet lifestyle on left atrial electrophysiology in wild type
and Pitx2 deficient mice (Chapter 7). These studies revealed high fat diet
to induce action potential prolongation in the left atria. Other parameters,
including temporal and spatial heterogeneity, were unchanged and Pitx2
deficiency did not significantly alter responses.
New techniques have also been explored to increase the automation of optical
mapping data analysis. In Chapter 6, the development of optical wave similarity
(OWS) is described for analysis of temporal heterogeneity. This methodology is
built upon established indices utilised for electrograms. OWS is demonstrated,
in both in silico and experimental datasets, to map changes in temporal stability
due to pacing rate and physiological stimuli. Crucially, unlike other methodologies
such as action potential duration alternans analysis, OWS analyses entire optical
action potential waveforms without identification of user set signal features such
as activation and repolarisation times.
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8.2 Limitations
8.2.1 General limitations of optical mapping
Limitations with respect to specific study design and experimental setup are
discussed throughout the thesis. However, the technique of optical mapping
does have several general limitations that are pertinent its appilcation. The
requirement for motion uncouplers such as Blebbistatin reduces the
physiological relevance of these experiments, including absence of metabolic
deficit and the role of stretch/strain in arrhythmia [6], and it has been suggested
that Blebbistatin alters baseline cardiac parameters [7]. Furthermore, it has been
shown both in this thesis and by others that fluorescent dyes used in optical
mapping may also alter the intrinsic electrophysiological behaviour of cardiac
preparations [8], [9]. The use of motion uncouplers and potentially toxic dyes
(and other issues including light delivery) has limited use of optical mapping to
ex vivo and in vitro preparations, although the possibility of in vivo
implementation has recently been demonstrated [10].
The nature of using light to probe cardiac electrophysiology can distort the
morphology of optically recorded action potentials in comparison to electrode
recordings. This is owing to photon scattering effects and tissue integration by
individual pixels where there are asynchronous activation times [11]–[13]. For
example, it has been shown in this thesis and previously how changing
conduction can alter the morphology of the optically recorded upstroke [13]–[15].
Hence, action potential parameters such at time to peak measured from optical
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signals are not only dependent on the individual cardiomyocyte action potential,
limiting interpretation. In optical mapping setups where only one camera is used,
as is the case for the experiments used here, the resultant image is a
2-dimenonsal projection of the 3- dimensional surface. This means that
assumptions such as equal pixel sizes in the entire image are not valid. In the
case of many of the examples presented here however, the geometry of the
preparations (e.g. atria and tissue slices) means this limitation will not be as
present as in whole heart setups. For whole heart optical mapping, there are
now several reports of the use panoramic multi-camera setups to overcome
these issues [16], [17].
8.2.2 Mouse models in cardiac electrophysiology research
Mouse models have been extensively used throughout this thesis. As in other
areas, mouse models are widely utilised in the study of cardiac
electrophysiology. In comparison to other mammalian models, mice benefit from
large litters, short gestation periods, rapid maturation and ability to reduce
genetic and environmental variability through inbreeding [18]. Possibly most
importantly however, the methodologies to alter the genome of mice have been
used and established for several years [19], [20]. This means that there are now
a plethora of mouse models to study genetic variations that contribute to
cardiovascular disease [21]–[25].
An important consideration however is the numerous differences in cardiac
electrophysiology between mice and humans, as many physiological parameters
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in mammals are known to scale with size. The mouse heart beats between 500
and 700 beats per minute for example, and there are substantial changes in all
ECG parameters [26]. Furthermore, Figure 1.3 shows the human and mouse
action potential, with distinct ionic currents and morphology [24]. These
differences mean that the effects of genetic, physiological or pharmacological
interventions on mouse electrophysiology cannot be directly translated to larger
mammals and humans [26]–[28].
8.2.3 Analysis limitations and future work
A key aim of this thesis was to automate analysis where possible to increase
throughput and reduce levels of user bias. However, there are several areas in
which user input and judgment are still required. Although automated
thresholding techniques were incorporated into the analysis software [29], it was
found in most cases custom region of interest selection was still required due to
inhomogeneous/poor tissue loading and the presence of motion artefacts.
Currently, thresholding is based on the baseline fluorescence values, which do
not necessarily correlate to signal level. Important future work therefore would
be to test the efficacy of techniques using the signal time-course, and not just
the baseline level, to distinguish between cardiac tissue and background [30],
[31], or tissue with and without successful motion uncoupling.
Ideally, optical mapping would be able to be performed in freely beating hearts.
Recent studies have demonstrated the possibility to achieve this through
utilisation of computer vision techniques, and even simultaneous imaging
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voltage, calcium and contraction recording [32], [33]. The use of such
computational techniques would simultaneously improve the physiological
relevance of optical mapping experiments and automate analysis by removing
the need to remove areas of tissue that are still contracting. The incorporation of
motion artefact correction techniques would therefore be an important future
development, although certain experimental criteria (e.g. homogenous
illumination and sufficient contrast areas) are likely to have to be met [34].
Pacing cycle length detection and segmentation and windowing was
automatically applied, but settings such as peak amplitude and time interval
thresholds often required tuning to recognise all pacing regimes. This was
particularly the case when analysing data from different animal species, or in
data which was corrupted by large levels of noise for example due to bubbles.
The need for parameter tuning could potentially be reduced by altering the signal
segmentation is applied on, i.e. currently the whole signal tissue average.
Possibilities to improve automation here are to use pacing stimuli rather than
tissue derived signals, segment based on signal derivatives such as pseudo
electrocardiograms, or to use frequency domain analysis [35]–[37].
Throughout this thesis, traditional and established signal and image processing
have been applied. However, in many areas of medical imaging artificial
intelligence methodologies have shown efficacy for image thresholding,
registration and signal classification [38], [39]. In optically recorded action
potentials, relatively simple methodologies such as spectral clustering [40] have
shown use for phenotyping cardiomyocytes from embryonic stem cells [41]. The
use of artificial intelligence methods therefore is a potential avenue to further
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automate processing and analysis of optical mapping datasets. This includes
non-selective analysis of the entire waveform rather than specific and
inconsistently defined signal points, as explored with optical wave similarity
(Chapter 6).
8.3 Conclusion
The original aims of this thesis were
• To develop processing and analysis tools for optical mapping datasets
• To develop novel analysis approaches to increase automation of optical
mapping data analysis
• To use developed tools and techniques for the analysis of unique pre-clinical
models using optical mapping
Optical mapping is undoubtably an extremely powerful technique for cardiac
electrophysiological research. However, limitations with respect to processing
and analysis of these often large and complex datasets persist. In this thesis, a
MATLAB based software tool and novel methodologies were developed for
processing and analysis datasets. Additionally, novel analysis approaches have
been developed to automate analysis of temporal stability in optically recorded
signals. These tools have been made freely available to other researchers.
Furthermore, developed tools and have applied to several powerful pre-clinical
models, garnering important insights for cardiac electrophysiology. These include
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optogenetic control of sinoatrial preparations, transmural heterogeneity in mouse
ventricles, and the effects of high fat diet and Pitx2 deficiency on left atrial EP.
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Supplementary Information for ElectroMap: High-throughput
open-source software for analysis and mapping of cardiac
electrophysiology, Chapter 3
A.1 Supplementary Material
This appendix provides the supplementary material provided for publication 1,
ElectroMap: High-throughput open-source software for analysis and mapping of
cardiac electrophysiology (Chapter 3). Figure A1-A10 correspond to
supplementay Figures I-V in publication 1.
A.1.1 Detailed Methods
Software Development and Availability
All software, processing algorithms and model datasets were developed and
implemented in MATLAB R2017a (Mathworks, USA), see Figure 3.1A for
graphical user interface (GUI). GUI was designed using MATLAB’s GUIDE
functionality, and the software can be run either within MATLAB (assuming
required toolboxes are present) or from a standalone executable file (e.g. .exe
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on a Windows PC, .dmg for Mac OS). Use of the executable file will require
download of the freely available MATLAB Runtime
(https://uk.mathworks.com/products/compiler/matlab-runtime.html). Total
download size is 1.3GB. To run the software within MATLAB, the Image
Processing, Signal Processing, Statistics and Machine Learning and the Curve
Fitting toolbox are required. The total download size of MATLAB code (.m) files <
3MB.
Software source code can be retrieved at
https://github.com/CXO531/ElectroMap while executable versions are hosted at
https://drive.google.com/open?id=1nJyI07w9WIt5zWcit0aEyIbtg31tANxI. The
software was developed and optimised for use on windows machines and this is
the recommended operating system for the software. However, the software has
also been tested and successfully used on MAC machines.
Optical Mapping
Mouse (MF1 n=8, 129/Sv n=1) optical mapping experiments were conducted as
previously reported [1]–[3]. Animals were anaesthetised using inhaled 4%
isoflurane in O2. Whole hearts were then isolated, mounted on Langendorff
apparatus and perfused via the ascending aorta. A standard bicarbonate
buffered Krebs–Henseleit solution at 37oC was used containing in mM: NaCl
118; KCl 3.52; MgSO4 0.83; KH2PO4 1.18; NaHCO3 24.9; Glucose 11.0; CaCl2
1.8. Fluorescent dye in DMSO (Voltage: DI-4-ANEPPS (0.125mg/ml), Calcium:
Rhod-2-AM (1mg/ml)) was then loaded for 5-10 minutes. The left atrium was
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then isolated, and the posterior atrial surface exposed. The atria were
superfused under normoxic (95%O2/5%CO2) or hypoxic (95%N2/5%CO2)
conditions with Krebs solution containing contraction uncoupler blebbistatin
(10µM) and paced with bipolar platinum electrodes at 2 times diastolic threshold.
Fluorescent dyes were excited by four LEDs at 530nm, and filtered fluorescence
(>630nm for DI-4-ANEPPS; 565-605nm for Rhod-2-AM) captured using ORCA
flash 4.0 camera (1kHz sampling rate, 200x2048 pixels, 71µm/pixel).
Optical mapping experiments in guinea pigs (n=6) were conducted as previously
reported [4], [5]. Adult male guinea pigs were anaesthetised with sodium
pentobarbitone (160mg/Kg, i.p.) along with concomitant heparin. Hearts were
perfused in Langendorff mode through the descending aorta (perfusion pressure
65-75mmHg, 37oC). Buffer solutions contained in mM: NaCl 114.0; KCl 4.0;
CaCl 1.4; NaHCO3 24.0; NaH2PO4 1.1; glucose 11.0 and sodium pyruvate 1.0.
Solutions were filtered using an in-line cellulose filter (5µm pore diameter)).
Hearts were uncoupled with blebbistatin (15µM) and stained with Di-8-ANEPPS
(1mg/ml in DMSO; 200-300µL). Dyes were injected slowly into the perfusion line
over a 5 to 10-minute period. Excitation light was at 530nm, with emission light
collected at >610nm. Hearts were imaged through an Olympus MVX10
stereomicroscope and signals recorded on Evolve Delta 512x512 pixel EMCCD
cameras (500Hz sampling rate, 64x64 pixels, 320µm/pixel).
Optical mapping experiments of human atria were conducted as previously
reported [6]. The left atrial appendage was removed using an endoscopic
stapling device (Endo Gia stapler, Tyco Healthcare Group). The tissue sample
was transported to the optical mapping setup in 100mL cooled superfusion fluid
197
(Na+, 155.5 mmol/L; K+, 4.7 mmol/L; Ca2+, 1.45 mmol/L; Mg2+, 0.6 mmol/L; Cl,
136.6 mmol/L; HCO3, 27 mmol/L; PO43-, 0.4 mmol/L; glucose, 11.1 mmol/L;
and heparin, 1000 IE). In the optical mapping setup the preparation was
submerged in a tissue bath. The superfusion fluid was kept at a temperature of
36.5oC to 37.5oC and oxygenised with a mixture of 95% O2 and 5% CO2 to
maintain a pH of 7.4. The preparations was stimulated at 100 beats per minute
at twice diastolic threshold with a pulse width of 2ms using an epicardial
electrode. The preparation was equilibrated for ≥ 30 minutes. Di-4-ANEPPS
(Tebu Bio) was used as a membrane potential-sensitive fluorescent dye and
Blebbistatin to remove motion artifacts. A MiCAM Ultima camera (SciMedia USA
Ltd) was used to record epicardial images of an area of 1 cm2 with a resolution
of 100 x 100 pixels and a sample time of 0.5ms. Images were stored using
MiCAM Ultima Experiment Manager. The occurrence of small motion artifacts
precluded analysis of the repolarisation across the atrial preparation.
A.1.2 Processing and Analysis Parameters
The software allows a choice of spatial filtering, temporal filtering, and baseline
correction methods. However, in the analysed data presented in this work, a 4x4
pixel Gaussian spatial filter was applied to the raw signal which was subsequently
filtered using a 3rd order Savitzky-Golay temporal filter. Linear top-hat filtering
was used to correct for non-physiological changes in baseline fluorescence.
Results were exported from ElectroMap’s interface in a variety of formats
depending on specific analysis performed. To study both mean values but
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additionally tissue heterogeneity for conduction velocity and calcium decay
constant, all calculated values within the maps were exported as comma
separated value files, as were the results of angular distributions of CV and the
activation curves. The corresponding maps were exported as TIFF files. For
extended beat-to-beat analyses, summary data (mean, standard deviation) for
each individual beat was exported in a single comma separated value file as it
was calculated automatically in ElectroMap once the whole file analysis had
begun. Corresponding maps at each individual beat were also exported as a
single GIF file and additionally AVI video files.
Activation and duration mapping
For the quantification of conduction velocity, it is necessary first to define time of
activation for each pixel in an image to create the activation map. Equally,
activation time requires measurement to quantify both action potential and
calcium transient duration. For the methods for this that are employable in
ElectroMap, see Figure 3.10. For conduction velocity analysis, unless otherwise
stated, the midpoint of depolarisation was used to produce the activation maps.
APD and CaT measurements were taken from upstroke (i.e. dF/dtmax) to 50%
repolarisation/decay, unless otherwise stated.
Conduction Velocity Measurement
A stand-alone conduction velocity module was developed and integrated within
ElectroMap, including two established methodologies for CV calculation, ‘multi-
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vector’ and ‘single vector’ methods (figure 3A and B) while a novel activation
curve method (figure 3C and D) is introduced.
The polynomial ‘multi-vector’ method to quantify CVlocal is the polynomial
surface method developed by Bayly et al, originally proposed for use in
epicardial electrode mapping [7]. For local regions of n x n pixels, a polynomial
surface, T(x,y), is fitted using least squares fitting that describes the relationship
between activation time, t, and spatial position (x,y), where T(x,y) is of the form,
T(x, y) = ax2 + by2 + cxy + dx + ey + f. (A.1)








where Tx = ∂x/∂T and Ty = ∂y/∂T are the ’conduction gradients’ in the x and
y direction respectively, and i and j are unit vector directions. This procedure
therefore computes both a magnitude and direction of conduction in each local
region.
The ‘single vector’ method will measure the time delay (t) in activation between
two points, and then use the distance between the points (r) to estimate
conduction velocity. The single vector velocity, CVsingle , between two points
separated by distance r will then be calculated as:
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CVsingle = r/∆t (A.3)
Additionally, we have developed and implemented a novel ‘activation-curve’
method for conduction analysis. Here, the percentage of tissue activation is
plotted as a function of time as demonstrated in Figure 3.2D. Hence, at time t,
the value of the activation curve as a percentage, Act(t) will be:




in a tissue image series made up of N pixels, where δn(t) becomes 1 at time of
activation (and 0 otherwise). Equation 3.3 can similarly be used to plot a
repolarisation curve, where δn(t) is redefined to become 1 at time of
repolarisation. From this activation curve, it is possible to define an activation
constant, such as time to reach 50% (act50) or 90% (act90) activation.
Comparison between activation constants of each tissue can then allow
objective comparison of changes in conduction kinetics.
Calcium decay constant (τ )
τ was calculated by fitting of a mono-exponential decay model of the form:
F(t) = F0 exp (–t/τ ) + C (A.5)
where the fluorescence level at time t depends on the peak fluorescence, F0, and
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the subsequent decay (C is a constant). For the calculation of τ present in Figure
6, equation 4 was fitted from 30% to 90% (τ30-90) decay from peak cytosolic
Ca2+. However, we also investigated the effects on decay constant mapping of
fitting to other stages of Ca2+ decay, such as from 10% to baseline (τ10-BL, Figure
3.13E).
Cardiac alternans module
Cardiac alternans were defined by four different measures, duration alternans,
peak alternans, load alternans and release alternans (Figure 3.16). Peak
alternans (ALTpeak) between subsequent calcium transients was defined as the
percentage increase in peak value of the larger peak (peakl) compared to the
smaller peak (peaks):
ALTpeak = 100 ∗ (peakl/peaks) (A.6)
Duration alternans (∆APD or ∆CaT) were measured as the time difference
between the duration of one action potential/calcium transient and the next. For
example, in the case of two consequent calcium transients of duration CaT1 and
CaT2:
∆CaT = |CaT1 – CaT2| (A.7)
The effects of cytosolic Ca2+ load and overall amplitude (in contrast to just peak
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value) were investigated by comparing the load alternans amplitude to the release
alternans amplitude, as in Wang et al, 2014 (where similar measures were applied
to study sarcoplasmic reticulum Ca2++ handling) [8]. If L is defined as the peak
amplitude of the large beats (i.e. where the amplitude is greater than the previous
beat), S the amplitude of the small beats, and D the diastolic load of the small
beats the release alternans (ALTrelease) are defined as:
ALTrelease = 1 – (S/L) (A.8)
Conversely, we define load alternans (ALTload) as:
ALTload = D/L (A.9)
Dominant frequency and phase mapping
Dominant frequency analysis is achieved by calculating the frequency spectrum
of the input signal by fast Fourier transform. Dominant frequency was then
defined as the frequency with the most power in the resulting frequency
spectrum in the range of 4-10Hz. Zero padding was applied to deliver a power
spectrum with a frequency resolution of 0.05Hz [9], [10]. Settings such as
frequency range and resolution are controlled within ElectroMap’s interface.
Phase mapping is performed by calculating the Hilbert transform of the signal,
from which the instantaneous phase ranging from -π to π can be calculated at a
given time point [10], [11].
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A.1.3 Production of model murine datasets
The datasets were produced by creating a MATLAB function that for a given
time, t, will return the fluorescence value F(t). This function acts by simply
approximating the murine optical action potential (i.e. that recorded by a
potentiometric dye) in a piecewise manner. Depolarisation of the action potential
was modelled using a simplified Gaussian function:
F(t) = F0 exp (–(t – tp)
2); 0 ≤ t ≤ tp (A.10)
where tp is the time to peak, i.e. time between depolarisation starting and peak
transmembrane voltage and F0 is the maximum fluorescence/voltage value. The
repolarisation was then modelled in two parts:
F(t) = m ∗ (t – tp) + F0; tp < t ≤ (tp + apd20) (A.11)
where m is the line gradient that connects the peak fluorescence at tp to a later
time (tp + apd20) where the fluorescence is 80% of its peak value (as dictated
by the user, apd20). Hence the early repolarisation is modelled as a straight line.
From this point, it is then modelled as an exponential decay:
F(t) = A exp (–Bt); t > tp + apd20 (A.12)
where A and B are constants found by fitting an exponential decay to user defined
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values for the times of 30%,50%,70% and 90% repolarisation occur (i.e. apd30,
apd50, apd70, apd90). Random noise was added to F(t) by selecting a value from
a set of normally distributed pseudorandom numbers, the standard deviation of
which is set as a percentage value of the action potential amplitude. An example
of using this model function is shown in Figure 3.12A, as well as the effect of
different noise levels on simulated action potential morphology (Figure 3.12B).
2D images of a murine atria have then been modelled using this function. The
pseudocode for this is shown below, where factors such as overall velocity, the
presence of a conduction block and sampling rate are used to work out an
‘effective time’ for each pixel in each frame. This model has several limitations
owing to its simplicity both in approximation of the murine action potential (a
morphological approximation) and conduction across the atria. Therefore, it is




Compute frame time, T = Frame_number*(1/sampling_rate)
For each pixel
If pixel not within area of conduction block
Find effective distance,
D = (x2 + (A*y)2)1/2
where x and y are coordinate distance from wave origin (centre
of image) and A is a constant that controls the degree of
anisotropy in conduction. For example, A=1 represents isotopic
conduction, A=2 represents 2 times slower conduction along y
direction compared to x.
End
If pixel inside area of conduction block
Find effective distance
D=D1+D2.
where D1 = effective distance before reaching conduction block
and D2 = effective distance within conduction block. Hence
D1=(x12 + (A*y1)2)1/2
where x1 and y1 are coordinate distance from origin to area
of conduction and
D2=C* (x22 + (A*y2)2)1/2
where x2 and y2 are coordinate distance from edge of conduction
block region along line connecting pixel with origin. C is a constant
that represents the conduction block factor, i.e. C=2 represents 50%
velocity within block region compared to rest of tissue.
End
Compute effective time, t=T-D/V
where V is the velocity of wave propagation.
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Figure A.1: Automatic, pacing frequency, based signal segmentation
options and validation. A and B) We validated our pacing frequency-based
segmentation by created a model dataset where the cycle length was reduced
by 10ms every 1s from 150ms to 50ms (A). B) The measured CL in ElectroMap
exactly matched that of the model throughout. C-G) ElectroMap automatically
detects changes in pacing frequency in real experimental data, as demonstrated
in (C). The signal can then be further segmented into segments of a desired
number of beats, such as 8 shown here in (D). This can be done down to a single
beat level (E). Equally, only the final few beats at a given pacing frequency can
be analysed to allow sufficient frequency adaption, such as the final beats in (F).
G) Along with automatic segmentation, custom region selection is achievable by
selecting the desired time from the signal. H) Example of automatic segmentation
with missing stimulus captures induced by 12.5Hz pacing.
208
Figure A.2: Activation and repolarisation definitions. A) Example activation
maps from both mouse atrium and guinea pig whole heart using the four different
activation definitions employable using ElectroMap. Isochronal line shown at 1ms
(murine data sampling rate) and 2ms (guinea pig data sampling rate) intervals in
maps where interpolation is not applied. B) Example repolarisation maps from
both mouse atrium and guinea pig heart using the three different repolarisation
definitions in ElectroMap. C) Optically measured murine action potential (black,
F(t)) with its first (red, dF/dt) and second (blue d2F/dt2) derivative shown
below. Highlighted are the four measured activation points and three measured
repolarisation points used to construct the upper activation and repolarisation
maps in A and B. D) As C, but from the Guinea Pig action potential to construct
the lower activation/repolarisation maps in A and B. E) Example APD50 maps
from Mouse and Guinea Pig tissue using the four different activation measures in
defining start of the action potential for calculation of APD50.
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Figure A.3: Action potential duration (APD) mapping. A) Example raw trace
from a single pixel (left panel) and mean APD measurements as a function of user
chosen repolarisation percentage in mouse atrium (right panel). B) Example raw
trace from a single pixel (left panel) and mean APD measurements as a function
of repolarisation percentage in guniea pig whole heart (right panel). Data shown
as mean standard deviation. C) APD maps from murine atria and guinea pig
whole heart.
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Figure A.4: Conduction velocity (CV) module. A) Conduction module
user interface, including options for CV quantification method and
activation/repolarisation definition. Here the module is shown to apply the
automatic single vector method, where the user defines a distance and starting
position. Possible single vector velocities are then measured at all angles in 10
degree increments from the staring position, and the results displayed in the
graphical inset which plots velocity as a function of angle. This highlights the wide
variation in single vector CV that can be measured from one position depending
on direction. B-C) Activation maps and curves produced using two activation
definitions, upstroke (B) and depolarisation midpoint (C). Maximum upstroke
velocity measurement will always occur at sampling time, hence the step-wise
nature of the activation curve which can make it difficult to accurately define
activation constants. This is in contrast to the smooth activation curve calculated
from depolarisation midpoint, as linear interpolation circumvents sampling rate
limitations. D-F) Examples of the graphical plots available to the user when using
the multi-vector methods. CV magnitude (E) and angular distribution (F) can be
visualised as a measure of conduction heterogeneity. Equally, CV as a function
of local vector angle (G) can give detailed insights into conduction pathways and
mechanical structure within tissue.
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Figure A.5: Model murine action potential example. An example of the use
of the action potential function described, black points show F(t) for t=1:50ms
at 1ms intervals (i.e. sampling frequency = 1kHz). Three phases of the action
potential are defined as depolarisation (green), early repolarisation (blue) and late
repolarisation (red) and modelled by equations 3.9, 3.10 and 3.11 respectively.
For activation analysis presented, only the depolarisation phase is relevant.
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Figure A.6: Calcium mapping. A) CaT50 map from murine atrium as
measured from time of Ca2+ peak to 50% decay (CaT50peak). B) CaT50 map
from same murine atrium as measured from time of maximum upstroke velocity
(CaT50upstroke , as figure 6A). C) Example of measurement of CaT50peak and
CaT50upstroke from highlighted region of interest (as figure 6A). D) Map of
decay constant, τ , from same atrium. Map shows calculation of τ by fitting of
exponential decay as in equation to points between 30% and 90% decay from
peak (τ30-90 , as figure 6D). E) τ map from same atrium, but instead applying
exponential decay to points between 10% decay and baseline (τ10-BL). F)
Example of measurement of τ30-90 and τ10-BL from highlighted region on interest
(as Figure 3.6D).
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Figure A.7: Alternans module. A) Alternans module user interface, including
beat to beat display of alternans behaviour across the tissue. Analysis can be
performed across whole experiment or on user defined time interval. Equally,
graphical display allows analysis of whole filed average or a selected region (or
single pixel) of interest. All results can easily be exported in the form of .avi/.gif
for video files, a number of file formats for time-averaged images and .csv files
for signal analysis. B-D) Illustrations of alternans measures used in ElectroMap
applied to example Calcium signal.
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Figure A.8: Diastolic interval (DI) mapping. A) Example APD50 maps from
guinea pig heart at decreasing cycle lengths (CL). As CL decreases (pacing
frequency increases), APD50 decreases across the heart. B) Similarly, diastolic
interval (DI) decreases with CL. Notably, areas of longer APD50 within the tissue
concurrently show, as expected, shortened DI at all CLs. C) Mean APD50 as a
function of mean DI shows that both decrease more rapidly at shorter CLs. Data
shown in mean ± standard error. n=5.
Figure A.9: Optogenetic pacing peak removal. A-B) Pseudo-Optogenetic
pacing beats were added to a pre-existing dataset between 2 and 3s, as shown by
the average signal. C-D) These were then automatically identified and removed
using ElectroMap’s ‘remove frames‘ function.
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Figure A.10: Software comparison. A) Activation Map created from whole
guniea pig heart using i) ElectroMap, ii) Rhythm and iii) Optiq (Cairn Research,
UK). In all three cases, maximum upstroke velocity (dF/dtmax) was used to define
time of activation. A 3x3 pixel linear (‘boxcar’) filter was applied to all 3 images.
Other than this, no other filtering (e.g. temporal) was applied to allow direct
comparison between the software. B) Whole heart APD50 maps using the same
software. APD50 measured from time of maximum upstroke. The resulting mean
APD50 (±standarddeviation)wascalculatedas : ElectroMap : 102±5ms, Rhythm :
103 ± 7ms, Optiq : 102 ± 3ms.
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